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Abstract 
The spectrin-ankyrin network assembles diverse plasma membrane domains 
including axon initial segments and nodes of Ranvier, cardiomyocyte T-tubules and 
intercalated discs, epithelial lateral membranes, costameres and photoreceptor inner and 
outer segments. However the mechanism that targets the spectrin-ankyrin network to 
those plasma membrane domains is unknown. This thesis identifies two lipid inputs 
from protein palmitoylation and phosphoinositides that together control the precise 
localization of the spectrin-ankyrin network. In Chapter 2, we identify a linker peptide 
encoded by a single divergent exon that distinguishes the subcellular localization of 
ankyrin-B and -G by selectively suppressing protein binding through autoinhibition. In 
Chapter 3, we demonstrate that ankyrin-G is S-palmitoylated at a conserved C70 residue 
which is required to assemble epithelial lateral membranes and neuronal axon initial 
segments. We continue to interrogate how palmitoylation regulates ankyrin-G activities 
in Chapter 4, and identify DHHC5 and DHHC8 as the palmitoyltransferases in MDCK 
cells. We showed that palmitoylated ankyrin-G, in concert with phosphoinositide lipids, 
determines the polarized localization of beta II spectrin though a co-incidence detection 
mechanism. This palmitoyltransferases/ ankyrin-G/beta II spectrin pathway determines 
the cell height of columnar epithelial cells. In Chapter 5, we elucidated the molecular 
mechanism through which the spectrin-ankyrin network assembles epithelial lateral 
  
v 
membranes. We demonstrated that ankyrin-G and beta II spectrin function by opposing 
clathrin-mediated endocytosis to build the lateral membrane in MDCK cells. Together, 
this thesis dissects the mechanisms of how the spectrin-ankyrin network achieves 
precise membrane targeting and how it assembles lateral membranes to determine the 
morphogenesis of columnar epithelial cells, and provides the first molecular insight to 
understand how cells control the assembly of diverse plasma membrane domains.
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Chapter 1. Background and Overview 
1.1 Plasma membrane domains 
The plasma membrane provides a structural and functional basis for cells to 
interact with surrounding environment. The conventional view of plasma membrane 
was depicted by Singer and Nicolson as the “fluid mosaic” model (Singer and Nicolson, 
1972), where membrane proteins are incorporated into lipid bilayers, and are in constant 
motion. This model provides a biophysical foundation to understand the structure and 
dynamics of plasma membranes. However, at organismal level, when the cells are 
integrated into three dimensional tissues, the cellular plasma membranes are precisely 
organized into unique membrane domains that are enriched in functionally related 
proteins and lipids (Bennett and Healy, 2008). Even at single cell level, taking the yeast 
as an example, the plasma membrane is also highly patterned into distinct patches 
(Berchtold and Walther, 2009; Spira et al., 2012). The “fluid mosaic” model does not 
explain how the membrane proteins achieve specific segregation patterns in the lipid 
bilayers and how the patterns are properly maintained and adapted for cellular 
functions. 
Those plasma membrane domains are critical for physiological functions 
including but not limited to mechanical support, water and salt homeostasis and 
electrical signaling. Examples include neuronal axon initial segments, epithelial lateral 
membranes and cardiomyocyte transverse tubules (Bennett and Healy, 2008). In order to 
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maintain the integrity and identity of those plasma membrane domains, a group of 
functionally related membrane proteins need to be delivered, segregated and 
maintained to those membrane regions (Grubb and Burrone, 2010; Nejsum and Nelson, 
2009; Rasband, 2011; Salle and Brette, 2007). Even though proteins and lipids that are 
enriched in those membrane domains have been identified, the molecular mechanisms 
that control the assembly and maintenance of those domains remain elusive. A few 
models have been proposed to address these questions, but require further 
investigation. 
1.2 Clathrin-mediated editing in maintaining membrane polarity 
Clathrin was identified from purified coated vesicles (Pearse, 1975), and its 
function was first elucidated in the uptake of plasma low density lipoproteins (LDL) 
(Anderson et al., 1977; Anderson et al., 1978; Brown and Goldstein, 1976; Goldstein and 
Brown, 1977). The clathrin lattice is linked to the vesicles through adaptor proteins, 
which bind directly to the phospholipid components or proteins embedded in the 
vesicle membrane (Bonifacino and Lippincott-Schwartz, 2003; Kalthoff et al., 2002a; 
Kalthoff et al., 2002b). The canonical function of clathrin is to coat membrane vesicles at 
the plasma membrane and transport proteins and lipids into intracellular compartments 
(Mousavi et al., 2004; Takei and Haucke, 2001). It was also shown that the clathrin-
coated vesicles can carry proteins and lipids from the trans-Golgi network to lysosomes 
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(Hirst and Robinson, 1998; Kirchhausen, 1999), as well as the related vesicular/tubular 
structures (Bonifacino and Lippincott-Schwartz, 2003).  
In contrast to the conventional function of clathrin, the discovery of basolateral 
targeting motifs which mimic the endocytosis signals recognized by the clathrin 
adaptors (Casanova et al., 1991; Hunziker et al., 1991; Mostov et al., 1986) has led to the 
hypothesis that clathrin is required for the establishment of cell polarity through direct 
protein sorting (Bonifacino, 2014; Bonifacino and Traub, 2003; Deborde et al., 2008; 
Farias et al., 2012; Folsch et al., 2003). However, many of the studies relied on exogenous 
proteins such as the LDL receptor, transferrin receptor and VSV-G viral coat protein 
(Deborde et al., 2008; Gravotta et al., 2012; Rodriguez Boulan and Sabatini, 1978). For the 
endogenous proteins, loss of clathrin heavy chain in MDCK cells only led to partial 
mislocalization of E-cadherin or no detectable effect on the Na/K ATPase (Deborde et al., 
2008). Moreover, E-cadherin and Na/K ATPase both sort to the lateral membranes of 
LLC-PK cells lacking AP1B, which was proposed to be an epithelial-specific clathrin AP1 
adaptor (Folsch et al., 1999; Ohno et al., 1999), suggesting the existence of an AP1B-
independent mechanism (Duffield et al., 2004; Miranda et al., 2001).  Knockout of either 
the mu-1B subunit or Rab8, which regulates AP1B dependent basolateral transport, does 
not affect epithelial morphology in mouse tissues (Sato et al., 2007; Takahashi et al., 
2011). Surprisingly, the μ1B KO mice and AP1-deficient C. elegans also showed 
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abnormal apical protein sorting (Hase et al., 2013; Shafaq-Zadah et al., 2012; Zhang et al., 
2012), which is inconsistent with its proposed function in basolateral sorting. 
Given the fact that the initial plasma membrane localization of many proteins is 
not affected by clathrin/AP knockdown (Bonifacino, 2014), clathrin may function as 
editing machinery instead of sorting machinery to establish cell polarity. Indeed recent 
study of E-cadherin polarity in MDCK cells has shown that polarity motif of the 
cytoplasmic domain of E-cadherin can be recognized by both clathrin adaptors and 
ankyrin-G which work coordinately to regulate E-cadherin polarity (Jenkins et al., 2013). 
Part of this thesis will focus on addressing how the ankyrin/spectrin lattice functions as 
the molecular machinery, opposing clathrin-mediated endocytosis, to build epithelial 
lateral membranes. 
1.3 Lipid rafts 
Another model that has been proposed to understand the plasma membrane 
organization is lipid rafts. This model was introduced to explain the establishment of the 
glycolipid enriched epithelial apical membranes (Simons and van Meer, 1988). Lipid 
rafts are defined as sterol and sphingolipid-enriched membrane regions that can 
organize protein-protein interaction, protein-lipid interaction and lipid-lipid interaction 
at a nano-scale (Simons and Sampaio, 2011). Those lipid rafts have been proposed to 
play a role in signal transduction, apoptosis, cell adhesion and migration and synaptic 
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transmission (Brown and London, 1998; Harris and Siu, 2002; Simons and Toomre, 2000; 
Tsui-Pierchala et al., 2002). 
Due to the technical challenges of detecting lipid rafts, this concept has raised 
many controversies. At early stage of this field, the most common method used for lipid 
raft detection was the resistance to cold Triton X-100 solubilization and sensitivity to 
cholesterol depletion, which now are considered artificial (Brown and Rose, 1992; 
Edidin, 2003; Heerklotz, 2002; Munro, 2003; Pizzo et al., 2002; Yu et al., 1973). Model 
membranes such as giant unilamellar vesicle were also widely used to address 
membrane lipid phase separations (Lentz et al., 1980; Simons and Vaz, 2004). This 
system was considered non-physiological because it lacks the complexity and many 
biophysical properties of biological bilayers. For instance, giant unilamellar vesicles 
normally only contain one or two homogeneous phospholipids, whereas the biological 
bilayers contains diverse components such as the long acyl lipid chains and integral 
proteins which can potentially perform self-organization within the bilayer (Munro, 
2003).  
More recently, with modern imaging technologies, some studies have revealed 
the existence of cholesterol-dependent sphingolipids and the GPI-anchored protein 
clusters that mimic the lipid rafts (Roduit et al., 2008; Sezgin and Schwille, 2011). 
However, there is great inconsistency about the lifetime of those observed nanoscale 
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assemblies, ranging from milliseconds to seconds (Brameshuber et al., 2010; Kusumi et 
al., 2004), raising the arguments of the identities of those structures.  
The lipid raft model emphasizes the separation and organization of lipid and 
protein components in the membrane at nanoscale. However, it has also been shown 
that the proteins on the plasma membrane can be segregated or organized into large 
scale microdomains. For instance, in yeast, most of the plasma membrane associated 
proteins are distributed non-homogeneously into distinct patterns (Spira et al., 2012).  
1.4 Spectrin- and ankyrin-based membrane domain assembly 
The spectrin-ankyrin network forms a membrane skeleton underneath the 
plasma membrane in erythrocytes and provides mechanical supports for the cells to 
adapt to environmental stress (Bennett and Baines, 2001; Liu et al., 1987). The micron-
scale organization of diverse membrane-spanning proteins such as adhesion molecules 
and ion channels through the spectrin-ankyrin network also provides a functional 
support for the cells to sense extracellular signals (Bennett and Healy, 2008; Bennett and 
Healy, 2009; Bennett and Lorenzo, 2013). The spectrin-ankyrin partnership was first 
characterized in human erythrocytes (Bennett and Baines, 2001), and subsequently 
elucidated in organizing multiple membrane domains (Figure 1), including axon initial 
segments and nodes of Ranvier (Dzhashiashvili et al., 2007; Galiano et al., 2012; 
Hedstrom et al., 2008; Hedstrom et al., 2007; Jenkins and Bennett, 2001; Sobotzik et al., 
2009; Susuki et al., 2013; Zhang and Bennett, 1998; Zhang et al., 1998), unmyelinated 
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axons (Scotland et al., 1998), cardiomyocyte T-tubules and intercalated discs (Hund et 
al., 2010; Lowe et al., 2008; Mohler et al., 2005; Mohler et al., 2004c), epithelial lateral 
membranes (Kizhatil and Bennett, 2004; Kizhatil et al., 2007a; Kizhatil et al., 2007b), 
costameres (Ayalon et al., 2008; Ayalon et al., 2011), and photoreceptor inner and outer 
segments (Kizhatil et al., 2009a; Kizhatil et al., 2009b). 
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Figure 1: Spectrin-ankyrin-based plasma membrane domains 
(From Bennett and Lorenzo, 2013) 
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1.4.1 Spectrin 
Spectrin consists of alpha and beta subunits that assemble side-to-side 
antiparallely to form a heterodimer which can further form an extended 200nm tetramer 
through end-to-end interaction (Baines, 2009; Bennett and Baines, 2001; Bennett and 
Lorenzo, 2013; Shotton et al., 1979). The human genome encodes two alpha-spectrins 
that contain a calmodulin-related domain at the C-terminus, a series of spectrin repeats, 
and an SRC Homology 3 (SH3) domain (Bennett and Baines, 2001). Five beta spectrin 
genes are identified in human genome, the beta spectrins are capable of binding to F-
actin through the N-terminal calponin homology (CH) domains (Banuelos et al., 1998; 
Djinovic Carugo et al., 1997), to ankyrin through the 14th and 15th spectrin repeats 
(Davis et al., 2009; Ipsaro et al., 2009; Kennedy et al., 1991; Stabach et al., 2009), and to 
PI(4,5)P2 phosphatidylinositol lipids through a C-terminal pleckstrin homology (PH) 
domain (Hyvonen et al., 1995; Macias et al., 1994). See Figure 2 for details.  
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Figure 2: Domain organization of spectrin molecules 
(From Bennett and Lorenzo, 2013) 
 
The presence of beta-spectrins in sponge and placozoa genomes suggests its 
earlier appearance than ankyrin (Baines, 2009; Bennett and Lorenzo, 2013). These 
spectrins have similar domain organizations as the vertebrate spectrins, but have no 
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recognizable ankyrin-binding site (Davis et al., 2009; Ipsaro and Mondragon, 2010), 
indicating that the ankyrin binding appeared later during evolution and may contribute 
to spectrin activities in more complex tissue. An evident ankyrin binding site on beta 
spectrin emerged in Cnidarians, which also contains ankyrin-like sequences, including a 
ZU5 domain with a potential spectrin-binding site. Therefore the proto-type of this 
spectrin-ankyrin network may appear 555 million years ago when the first bilaterian 
fossil dated to (Baines, 2009; Bennett and Lorenzo, 2013). Given this evidence from 
evolutional analysis, the spectrin-ankyrin network gained its ability to organize 
membrane-spanning proteins during the evolution of bilaterians when the multicellular 
organisms require more complicated tissue.   
The cDNA of beta I spectrin was first isolated and characterized in red blood 
cells, where it lacks the C-terminal PH domain (Winkelmann et al., 1990a). It is the major 
isoform of beta spectrin lattice in erythrocytes, and relies on ankyrin binding to associate 
with the plasma membrane (Bennett, 1982; Bennett and Stenbuck, 1979). Deficiency in 
assembling the spectrin lattice or linking the spectrin lattice to the plasma membrane in 
red blood cells results in severe hemolytic anemia (Agre et al., 1981; Winkelmann and 
Forget, 1993).  
Beta II spectrin was first isolated from brain tissue, and has been shown to have a 
broad expression pattern (Bennett et al., 1982; Hu et al., 1992). Knockout of a beta II 
spectrin/ELF results in embryonic lethality in mice and leads to disruption of TGF-beta 
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signaling by interfering with the nuclear localization of Smad proteins (Tang et al., 2003; 
Tang et al., 2005). Recently, it is also shown that the inactivation of TGF-beta signaling 
pathway by beta II spectrin deficiency is also responsible for the abnormal heart 
development (Lim et al., 2014). In epithelial cells, beta II spectrin collaborates with 
ankyrin-G to establish the lateral membrane domain (Kizhatil et al., 2007b). Loss of βII 
spectrin in neuronal axons also disrupts the paranodal barrier that is required for 
myelinated axon domain organization (Zhang et al., 2013). Beta II spectrin, together with 
ankyrin-B and alpha II spectrin, assembles a distal axonal submembranous cytoskeleton 
that defines a boundary limiting ankyrin-G to the proximal axon (Galiano et al., 2012). 
Stochastic Optical Reconstruction Microscopy (STORM) recently revealed that the actin-
spectrin skeleton in axons formed ring-like structures that were evenly spaced with a 
periodicity of ~180 to 190 nanometers (Xu et al., 2013). 
Beta III spectrin was first identified in brain (Ohara et al., 1998; Stankewich et al., 
1998). It is highly expressed in the cerebellum and mutation of this gene in human 
results in spinocerebellar ataxia type 5 (SCA5) (Ikeda et al., 2006). In addition to its 
function in the cerebellum, beta III spectrin is also implicated in cortical brain 
development and cognition, deficiency of this gene leads to a novel recessive ataxic 
syndrome, Spectrin-associated Autosomal Recessive Cerebellar Ataxia type 1 
(SPARCA1) (Lise et al., 2012). A recent study suggests that beta III spectrin is critical for 
the recruitment and maintenance of ankyrin R at the plasma membrane of Purkinje cell 
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dendrites. Mutations associated with SCA5 showed a reduced ability to maintain 
ankyrin-R levels at the cell membrane (Clarkson et al., 2014). 
Beta IV spectrin is highly expressed in brain (Berghs et al., 2000) where it 
colocalizes and interacts with ankyrin-G at axon initial segments and nodes of Ranvier 
to stabilize the membrane proteins (Jenkins and Bennett, 2001; Komada and Soriano, 
2002). Homozygous mice carrying a null mutation in the beta IV spectrin gene exhibit 
tremors and contraction of hindlimbs (Komada and Soriano, 2002; Parkinson et al., 
2001). Beta IV spectrin differs from beta I, II, III spectrins that it has additional sequence 
between the last spectrin repeat and the C-terminal PH domain (Berghs et al., 2000). This 
extra sequence can interact with calmodulin-dependent protein kinase 2 (CAM kinase 2) 
and recruits CAM kinase 2 to cardiac interacalated discs and axon initial segments 
(Hund et al., 2010). 
Beta V spectrin is the most divergent isoform and lacks ankyrin binding activity. 
The gene for beta V spectrin was first isolated from a human retina cDNA library 
(Stabach and Morrow, 2000). It is a homolog of the Drosophila and Caenorhabditis 
elegans beta H (heavy) spectrin, and has up to 30 spectrin repeats (Stabach and Morrow, 
2000). This beta spectrin isoform can dimerize with alpha II spectrin and localize to 
apical domains of epithelial tissues such as small intestine (Glenney et al., 1983). Beta H 
spectrin lacks ankyrin-binding activity and has been shown to interact with several 
subunits of the microtubule-based motor proteins, kinesin II and the dynein complex, 
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therefore contributing to protein transport in photoreceptors (Papal et al., 2013). 
Moreover, the alpha II-beta V spectrin can directly interact with multiple components of 
the outer hair cell (OHC) cortical lattice, playing a role in organizing the sound-induced 
electromotility of OHCs (Legendre et al., 2008). 
1.4.2 Ankyrin 
The ankyrin family has three members, ankyrin-R, ankyrin-B and ankyrin-G 
encoded by ANK1, ANK2 and ANK3 respectively (Bennett and Baines, 2001; Bennett and 
Healy, 2008). The three mouse homologs are encoded by distinct genes located in 
different chromosomes (Peters et al., 1995). It was proposed that the three vertebrate 
ankyrins originated from a single ankyrin gene from urochordates (Cai and Zhang, 
2006). The canonical ankyrins share highly conserved protein sequences and structures 
(Figure 3). They preserve a well-recognized ankyrin repeats domain, where multiple 
protein interactions occur (Bennett and Healy, 2009; Michaely et al., 2002) , followed by a 
spectrin-binding domain which coordinates the biological interactions with spectrin 
(Davis et al., 2009; Wang et al., 2012). A death domain with unknown function is also 
present in all three ankyrin members. Following the death domain is a C-terminal 
regulatory region with the highest sequence variability. Spliced isoforms of 480/270kD 
ankyrin-G and 440kD ankyrin-B have an large insert between the UPA domain and 
Death domain (Chan et al., 1993; Kordeli et al., 1990; Kunimoto, 1995; Kunimoto et al., 
1991). Previous studies have shown that ankyrin B C-terminal region can 
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intramolecularly interact with the ankyrin repeat domain. This intramolecular 
interaction plays critical role in regulating ankyrin-B functions in cardiomyocytes and 
neurons (Abdi et al., 2006; Galiano et al., 2012).  Despite the significant amino acid 
identity among three ankyrin members, they maintain unique biological functions in 
vivo.  
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Figure 3: Domain organization of ankyrin molecules 
(From Bennett and Lorenzo, 2013) 
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Ankyrin-R was first identified as the spectrin receptor in erythrocytes (Bennett, 
1978; Bennett and Stenbuck, 1979), and is mainly expressed in brain, heart and skeletal 
muscle (Bennett, 1979; Bennett and Baines, 2001). Ankyrin-R links the underlying 
spectrin lattice to the plasma membrane in red blood cells by interacting with the 
transmembrane protein band 3 (anion exchanger 1). Reduction of high affinity 
membrane binding sites for ankyrin-R was identified in patients with hemolytic 
poikilocytic anemia (Agre et al., 1981). Genetic studies also indicate that mutations in 
ankyrin-R are highly responsible for hereditary spherocytosis (Benz, 2010; Edelman et 
al., 2007; Gallagher et al., 2010; Gundel et al., 2011; Huang et al., 2013; Sangerman et al., 
2008). 
In contrast, ankyrin-B and ankyrin-G are co-expressed in most, if not all, cell 
types, but they have no known overlapping functions. Ankyrin-B/-G function in 
conjunction with spectrin to coordinate plasma membrane domains, and different cells 
utilize this spectrin-ankyrin interaction differently (Bennett and Healy, 2008; Bennett 
and Lorenzo, 2013). In rod photoreceptors, ankyrin-G exclusively localizes at the outer 
segment and plays essential roles in segregating cyclic nucleotide-gated channels, while 
ankyrin-B is expressed in the inner segment (Kizhatil et al., 2009a). In the costamere of 
skeletal muscle, the expression and localization of ankyrin-B and ankyrin-G are 
independent of each other. Ankyrin-B, but not ankyrin-G is required for sarcolemmal 
localization of dystrophin and dynactin-4 (Ayalon et al., 2008). In neurons, ankyrin-G 
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and beta IV spectrin colocalize in axon initial segments and nodes of Ranvier and are 
required to cluster multiple voltage-gated channels and adhesion molecules (Hedstrom 
et al., 2008; Jenkins and Bennett, 2001; Jenkins and Bennett, 2002; Koticha et al., 2006; 
Yang et al., 2007), whereas ankyrin-B and beta II spectrin were proposed to assemble a 
distal axonal cytoskeleton that limits ankyrin-G localization and controls axon initial 
segment assembly (Galiano et al., 2012).  
Though the spectrin-ankyrin network has been widely recognized for its 
essential roles in organizing plasma membrane domains, the molecular mechanisms 
underlying the assembly and regulation of this network remains elusive. The main focus 
of this thesis will address the molecular pathways that ensure the cells to achieve precise 
subcellular targeting of the spectrin-ankyrin network, and provides mechanistic insights 
how this network is driving membrane domain assembly. 
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Chapter 2. A Single Divergent Exon Inhibits Ankyrin-B 
Association with the Plasma Membrane 
2.1 Introduction 
As discussed above, the vertebrate ankyrin family contains three members 
comprised of ankyrin-R, ankyrin-B and ankyrin-G, that are encoded by distinct genes 
(ANK 1,2,3) with distinct cellular location and functions (Bennett and Baines, 2001). 
Vertebrate ankyrins evolved from a single ankyrin gene in the invertebrate urochordate 
C. intestinalis, and overall are highly conserved in primary sequence and domain 
organization (Cai and Zhang, 2006). The N-terminal ANK repeat domain (membrane-
binding domain) is involved in diverse protein-protein interactions (Bennett and Healy, 
2009). Following the ANK repeat domain, there is a ZU52-UPA domain module, which 
includes the beta-spectrin binding site (Davis et al., 2009; Mohler et al., 2004e; Wang et 
al., 2012). A death domain of unknown function is also present in all three ankyrin 
members. A C-terminal regulatory domain exhibits the highest diversity among three 
ankyrins (Bennett and Baines, 2001; Davis et al., 1992; Hall and Bennett, 1987). The 
ankyrin-B C-terminal region interacts with its ANK repeat domain, and plays a critical 
role in regulating ankyrin-B functions in cardiomyocytes (Abdi et al., 2006; Mohler et al., 
2002a).   
   Ankyrin-B and ankyrin-G are co-expressed in most tissues, but have distinct 
cellular localization and function. In rod photoreceptors, ankyrin-G exclusively localizes 
at the outer segment and is required for segregating cyclic nucleotide-gated channels to 
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the outer segment (Kizhatil et al., 2009a), while ankyrin-B is expressed in the inner 
segment where it is required for localization of the sodium/calcium exchanger and Na/K 
ATPase (Kizhatil et al., 2009b). In skeletal muscle, ankyrin-B is required for delivery of 
β-dystroglycan to costameres and for a costamere-associated population of 
microtubules, while ankyrin-G is required to retain β-dystroglycan and dystrophin at 
costameres (Ayalon et al., 2008). Additionally, ankyrin-G is a master organizer of the 
axon initial segment and nodes of Ranvier (Hedstrom et al., 2008; Jenkins and Bennett, 
2002; Kordeli et al., 1995; Sobotzik et al., 2009), while ankyrin-B localizes to the distal 
axon together with αII-spectrin and βII-spectrin (Galiano et al., 2012). 
The molecular mechanisms underlying distinct functions of ankyrin-B and 
ankyrin-G remain to be fully elucidated. A previous study showed that the C-terminal 
region determines the specificity of ankyrin-B function in cardiomyocytes (Mohler et al., 
2002a). The ZU52-UPA module determines the distal axonal localization of ankyrin-B in 
neurons (Galiano et al., 2012). Here, we adopted a comprehensive domain-substitution 
strategy to determine effects of exchanging domains or unstructured regions between 
ankyrin-B and ankyrin-G on their ability to associate with epithelial lateral membranes. 
This systematic approach led to identification of a heretofore unrecognized ankyrin-B-
specific linker peptide connecting the ANK repeats and ZU52-UPA module that prevents 
association of ankyrin-B with plasma membranes of epithelial cells and neurons through 
intramolecular association with ANK repeats.  
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2.2 Methods and Materials 
Reagents 
Dynabeads®  Protein G for Immunoprecipitation (Catalog Number 10004D) and 
Lipofectamine®  2000 Transfection Reagent (Catalog Number 11668-027) were purchased 
from Life Technologies Corporation. QuikChange II XL Site-Directed Mutagenesis Kits 
(Catalog Number 200522) were purchased from Agilent Technologies. Mouse 
Monoclonal Anti-HA antibody (Catalog Number H6908) was purchased from Sigma-
Aldrich. Rabbit polyclonal anti-GFP antibody was lab-generated. Rabbit polyclonal anti-
ankyrin B or -ankyrin G antibody was generated using the C-terminal domain as 
antigen.  
Cloning of Chimeric Ankyrin-B/G constructs 
The 1st generation of chimeric GFP tagged Ankyrin-B/G constructs were 
previously described (Mohler et al., 2002a). In ankyrin-B, the linker region was defined 
as amino acids 848-960, the ZU5 domains were defined as amino acids 961-1287, the 
UPA domain was defined as amino acids 1288-1443. In ankyrin-G, the linker region was 
defined as amino acids 874-984, the ZU5 domains were defined as amino acids 985-1312, 
the UPA domain was defined as amino acids 1313-1476. Two restriction sites SphI and 
SpeI were introduced after the linker region and the second ZU5 domain respectively. 
The corresponding regions in ankyrin-G and ankyrin-B were exchanged using standard 
cloning protocols. 
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Transfection and Immunostaining 
105 MDCK cells were plated on MatTek plates, and the next day the cells were 
transfected with 50ng of plasmids using lipofectamine®  2000 following the 
recommended protocol. 24 hours after transfection, cells were washed with cold 
phosphate-buffered saline (PBS) and fixed with 4% paraformaldehyde at room 
temperature for 15 minutes, and permeabilized with 0.2% Triton X-100 at room 
temperature for 10 minutes, followed by a 30-minute blocking in PBS buffer containing 
4% bovine serum albumin. Then cells were incubated with primary antibody at 4oC 
overnight. The next day, cells were washed with PBS buffer three times and then 
incubated with fluorescence-conjugated secondary antibodies (Alexa Fluor 488, 568 or 
663) at room temperature for 2 hours. Fluorescent antibody labeling was visualized 
using Zeiss LSM 510 or 780 laser scanning microscopes. Images were collected using a 
63X NA 1.4 objective lens, and XZ planes were reconstructed from Z stacks with optical 
sections of 0.5µm.  
Membrane recruitment assay 
This assay was previously reported (Zhang et al., 1998). Briefly, 105 HEK293 cells 
were plated in collagen-coated MatTek plates. The next day, cells were co-transfected 
with 100ng HA-tagged neurofascin-186 or E-cadherin plasmids and 80ng GFP-tagged 
chimeric ankyrin plasmids. 24 hours later, cells were fixed and processed for 
immunofluorescence as described above.  
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Co-immunoprecipitation 
6x106 293T cells were plated in 10cm dishes, and the next day cells were co-
transfected with 4µg of plasmid DNA encoding HA-tagged ANK repeat domain of 
ankyrin-B or ankyrin-G with 2µg of plasmid DNA encoding GFP-tagged B-linker. 48 
hours after transfection, cells were collected and lysed in lysis buffer (10mM sodium 
phosphate, 2mM NaEDTA, 0.32M sucrose and protease inhibitors (10µg/ml AEBSF, 
30µg/ml benzamidine, 10µg/ml pepstatin, and 10µg/ml leupeptin), pH=7.4) by passage 
through a 27G needle. Cell lysates were then centrifuged at 105×g for 30 minutes, the 
supernatant were collected and incubated with protein-G dynabeads preloaded with 
anti-GFP antibody. Immunoprecipitation samples were then analyzed by SDS-PAGE 
and western blotting.  
Hippocampal neuronal cultures and transfection 
Neurons and medium were prepared as described (Baranes et al., 1998). Briefly, 
hippocampi of P0 mouse pups were isolated, treated with trypsin and then gently 
triturated through a glass pipette with a fire-polished tip. The dissociated cells were 
plated onto poly-D-lysine and laminin coated MatTek dishes in Neurobasal-A medium 
containing 10% fetal bovine serum, B27 supplement, 2mM glutamine and 
Penicillin/Streptomycin. On the following day, the medium was replaced with fresh 
serum-free Neurobasal-A medium containing B27, glutamine and Ara-C. Cultured 
hippocampal neurons at day 5 were transfected with 50ng chimeric ankyrin plasmids 
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following standard protocol. 48 hours after transfection, cells were fixed in 4% PFA with 
4% sucrose, and processed for immunostaining as described above. 
Quantification and statistical analysis 
The immunofluorescence intensities of plasma membrane or cytoplasmic 
staining were measured using image J. The intensity ratios were calculated and analyzed 
using Graphpad Prism6. Student’s t-tests or one way ANOVA with Tukey's post-hoc 
tests were performed for hypothesis testing.  
 
2.3 Results 
2.3.1 Ankyrin-B is excluded from the lateral plasma membrane in 
Human Bronchial Epithelial Cells 
Cultured epithelial cells require ankyrin-G for biogenesis of their lateral 
membranes (Kizhatil and Bennett, 2004).  Ankyrin-G in turn requires interaction with 
βII-spectrin for its function in lateral membrane biosynthesis (Kizhatil et al., 2007b). 
Ankyrin-B recruits beta-2 spectrin to an intracellular compartment in neonatal 
cardiomyocytes (Mohler et al., 2004e), but ankyrin-B has not been studied in epithelial 
cells. Therefore, we used human bronchial epithelial (HBE) cells to compare the 
localization of ankyrin-G and ankyrin-B.    
We first determined the expression and localization of endogenous ankyrin-B 
and ankyrin-G in HBE cells. An antibody against the C-terminal domain of ankyrin-B 
detected multiple spliced isoforms, including the 220kDa isoform and a major 55kDa 
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isoform (Figure 4B). Immunofluorescence showed no ankyrin-B-immunoreactivity on 
the plasma membrane and instead revealed intracellular vesicles of unknown identity 
(Figure 4A). Three major ankyrin-G isoforms (one at 210kDa, two at 120kDa) are 
expressed in HBE cells (Figure 4B), and are mainly concentrated on the plasma 
membrane, consistent with previous findings (Kizhatil and Bennett, 2004) (Figure 4A). 
We next compared the localization of transfected 220kDa ankyrin-B-GFP and 190kDa 
ankyrin-G-GFP in HBE cells. Figure 4C is a scheme showing the structural details of 
ankyrin proteins, where ankyrin-B domains are highlighted in red and ankyrin-G 
domains are highlighted in green. 220kDa ankyrin-B-GFP is excluded from the plasma 
membrane where it is associated with vesicles in a similar pattern as endogenous 
ankyrin-B, while the 190kDa ankyrin-G predominantly localizes to the lateral membrane 
(Figure 4D, E).  
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Figure 4: Ankyrin-B is excluded from the lateral membrane of HBE cells 
(A), immunofluorescence showing total endogenous AnkB and AnkG in polarized HBE 
cells. Scale bar, 10µm. (B), immunoblot of total HBE cell lysate showing various AnkB 
and AnkG isoforms. (C), schematic representation of the canonical 220kDa AnkB (red) 
and 190kDa AnkG (green) polypeptides. (D), immunofluorescence showing transiently-
expressed, GFP-tagged AnkB and AnkG (green, GFP staining; blue, DAPI staining) in 
polarized HBE cells. Scale bar, 10µm. (E), quantification of the immunofluorescence 
intensity ratio of plasma membrane vs. cytosolic GFP staining. (Student’s t-test, n=23-25, 
* indicates p<0.05). 
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2.3.2 An ANK repeat-ZU5 linker determines lateral membrane 
exclusion of ankyrin-B 
In order to explore the molecular mechanism for the dramatic difference between 
plasma membrane localization of ankyrin-B and ankyrin-G, we examined which domain 
is required for plasma membrane localization using B/G chimeras.  We first used the 
previously generated ankyrin-B/G chimeric proteins containing all 8 combinations of 
membrane-binding, spectrin-binding, and C-terminal domains (Mohler et al., 2002b). 
Surprisingly, the C terminal region, which was reported to regulate the activity of 
ankyrin-B in neonatal cardiomyocytes (Mohler et al., 2002b), is not required for plasma 
membrane localization of ankyrin-B or ankyrin-G (BBG, GGB, Figure 5A, B and C). 
Instead, we found that the central spectrin-binding domain determines the specificity of 
ankyrin localization. Ankyrin-B containing the ankyrin-G spectrin-binding domain 
(BGB, Figure 5A, B and C), efficiently targets to the lateral membrane. Similarly, 
ankyrin-G containing the ankyrin-B spectrin-binding domain shows more intracellular 
localization (GBG, Figure 5A, B and C), even though it did not become completely 
intracellular. 
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Figure 5: The linker-ZU52-UPA module of ankyrin proteins regulates their 
subcellular localization. 
(A), schematic representation of the AnkB/G chimeric proteins, red represents AnkB 
counterparts while green represents AnkG counterparts. (B), immunofluorescence 
showing transiently-expressed, GFP tagged AnkB/G chimeric proteins (green, GFP 
staining; blue, DAPI staining) in polarized HBE cells. Scale bar, 10µm. (C), quantification 
of the immunofluorescence intensity ratio of plasma membrane vs. cytosolic GFP 
staining (One way ANOVA followed by Tukey’s post-hoc test, n=27-35, * indicates 
p<0.05) 
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The spectrin-binding domain consists of a linker peptide, two ZU5 domains, and 
a UPA domain.  The beta spectrin-binding site has been mapped to the first ZU5 domain 
(Kizhatil et al., 2007b; Mohler et al., 2004b). In order to further explore the structural 
requirement for ankyrin localization in HBE cells, we made a second generation of 
ankyrin-B/G chimeric constructs, in which we sequentially exchanged their linker 
peptides, ZU5 domains, and UPA domains. The sequence boundaries of each region 
were determined by the structure of the ZU52-UPA super-domain module of ankyrin-B 
(Wang et al., 2012). We then compared the cellular localization of chimeras transfected 
into HBE cells. Interestingly, neither the ZU5 domains nor the UPA domain were 
required for localization of ankyrin-B or ankyrin-G, since the chimeric proteins (B/ZU5G, 
B/UPAG, G/ZU5B, G/UPAB) behaved the same as their wild type counterparts (Figure 6A, 
B and C).  However, exchange of the linker peptides (hereby referred to as the B-linker 
and G-linker for ankyrin-B and -G respectively) between ankyrin-B and ankyrin-G 
resulted in dramatic alteration of cellular localization. Ankyrin-B, containing the G-
linker (B/LG) gained lateral membrane localization, while ankyrin-G containing the B-
linker (G/LB) showed increased intracellular staining (Figure 6A, B and C). The residual 
membrane staining of G/LB may indicate that B-linker is not sufficient to block all the 
potential protein interactions with ankyrin-G, or the lipid modification described in the 
next chapter. 
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Figure 6: An ANK repeat-ZU5 linker contains the information regulating 
AnkB or AnkG subcellular localization. 
(A), schematic representation of the second generation AnkB/G chimeric proteins, red 
represents AnkB counterparts while green represents AnkG counterparts. (B), 
immunofluorescence showing transiently-expressed, GFP-tagged 2nd AnkB/G chimeric 
proteins in polarized HBE cells. Scale bar, 10µm. (C), quantification of the 
immunofluorescence intensity ratio of plasma membrane vs. cytosolic GFP staining. 
(One way ANOVA followed by Tukey’s post-hoc test, n=30-37, * indicates p<0.05). 
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2.3.3 The B-linker acts through an autoinhibitory mechanism 
Since ankyrin-B targets to the plasma membrane when its linker region was 
replaced with the G-linker, we initially hypothesized that the G-linker itself 
independently associates with the plasma membrane. To test this hypothesis, GFP-
tagged G-linker was expressed in HBE cells. However, the G-linker alone showed no 
membrane localization (Figure 7A). We next generated truncated constructs only 
including the ANK repeat domain and the linker region (Figure 7B). Surprisingly, the 
ANK repeat domain of either ankyrin-B or ankyrin-G was sufficient for lateral 
membrane targeting (ANKRB, ANKRG), and this membrane localization was not affected 
by addition of the G-linker (ANKRB/LG, ANKRG/LG) (Figure 7C and D). However, fusion 
of the B-linker to the C terminus of the ANK repeat domain efficiently blocked the 
lateral membrane binding activity of the ANK repeat domains of both ankyrin-B and 
ankyrin-G (ANKRB/LB, ANKRG/LB, Figure 7C and D). 
Given the fact that B-linker inhibits the lateral membrane targeting of the ANK 
repeat domain, the B-linker may directly interact with ANK repeats. To test this 
hypothesis, we performed a co-immunoprecipitation assay, in which GFP-tagged B-
linker was co-expressed with HA-tagged ANK repeat domain of ankyrin-B or -G. After 
immunoprecipitating GFP-B-linker, we detected robust HA immunoreactivity, which 
indicated a strong interaction between the B-linker and the ANK repeat domain (Figure 
7E). Interestingly, an atomic structure of the C-terminal twelve ankyrin repeats of 
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ankyrin-R solved by Michaely and colleagues showed that the ankyrin repeat solenoid 
contains an extended groove which associates with the endogenous C-terminal peptide 
corresponding to the B-linker (Figure 7F) (Michaely et al., 2002). This model suggests an 
autoinhibitory mechanism where an unstructured B-linker polypeptide represses the 
activity of ANK repeat domain through association with the ANK repeat groove thus 
competing with membrane partners.  
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Figure 7: The ANK repeat-ZU5 linker regulates AnkB localization through 
autoinhibition. 
(A), the linker region of AnkG (G-linker) was tagged with GFP, and transiently 
expressed in HBE cells. Cells were fixed and stained against GFP to visualize G-linker 
localization. Scale bar, 10µm. (B), schematic representation of the truncated AnkB/G 
chimeric proteins, red represents AnkB counterparts while green represents AnkG 
counterparts. (C), immunofluorescence showing transiently-expressed, GFP-tagged 
truncated AnkB/G chimeric proteins. Scale bar, 10µm. (D), quantification of the 
immunofluorescence intensity ratio of plasma membrane vs. cytosolic GFP staining 
(One way ANOVA followed by Tukey’s post-hoc test, n=33-36, * indicates p<0.05). (E), 
co-immunoprecipitation of B-linker and the ANK repeat domain. HA-tagged ANK 
repeat domain of AnkB (HA-ANKRB) or AnkG (HA- ANKRG) was co-expressed with 
GFP-tagged B-linker (or GFP only, as a negative control) in 293T cells. Samples were 
then immunoprecipitated with anti-GFP antibody and blotted with anti-HA antibody. 
(F), structure of the human AnkR C-terminal 12 ankyrin repeats with a following 
peptide. Image was generated using CCP4MG software. The surface of the ankyrin 
repeats was colored by temperature factor, and the peptide was colored red. 
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2.3.4 The B-linker prevents interaction of ankyrin-B with E-cadherin 
and neurofascin-186 
Ankyrin-G is the native partner for neurofascin-186 and binds to E-cadherin with 
a much higher affinity than ankyrin-B (Davis et al., 1996; Kizhatil et al., 2007a; Scotland 
et al., 1998). Therefore, we were interested in testing whether the B-linker functions by 
regulating the interaction of ankyrin-B with E-cadherin or neurofascin-186. We 
addressed this question using a previously reported cellular recruitment assay where co-
expression of ankyrin-G with a membrane partner in HEK 293 cells results in 
recruitment of ankyrin-G from the cytoplasm to the plasma membrane (Zhang et al., 
1998). Ankyrin-B, when co-expressed with neurofascin-186 or E-cadherin, which both 
target to the plasma membrane in HEK293 cells, remained in the cytoplasm, indicating 
no interaction between ankyrin-B and neurofascin-186 or E-cadherin (Figure 8A and B). 
However, the chimeric ankyrin-B with the G-linker (B/LG) was efficiently recruited to the 
plasma membrane by both neurofascin-186 and E-cadherin (Figure 8A and B). These 
results implied that the B-linker suppressed the binding activity of ankyrin-B with 
neurofascin-186 and E-cadherin, probably through autoinhibition, as noted above.  
In contrast to its effects on ankyrin-B, the B-linker, when substituted for G-linker, 
did not completely block the recruitment of ankyrin-G by neurofascin-186 or E-cadherin 
(Figure 8C and D).  This result is consistent with the cellular localization results where B-
linker only partially prevents ankyrin-G from targeting to the lateral membrane in HBE 
cells (Figure 6B and C). One explanation for the different sensitivities of ankyrin-B and -
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G may be that B-linker requires specific regions in the ANK repeat domain of ankyrin-B 
for an efficient intramolecular interaction and repression. Consistent with this 
interpretation, the co-immunoprecipitation assay shows greater binding between B-
linker and the ANK repeat domain of ankyrin-B than of ankyrin-G (Figure 7E).  
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Figure 8: The B-linker inhibits the interaction between AnkB and E-cadherin 
and neurofascin-186. 
(A,B), AnkB-GFP or B/LG-GFP, or (C,D), AnkG-GFP or G/LB -GFP were co-expressed 
with HA-tagged neurofascin-186 (NF-HA) or Ecadherin (Ecad-HA) in HEK293 cells. 
Cells were then fixed and co-stained with anti-GFP (green) and anti-HA (red). Scale 
bars, 10µm. (E), quantification of the immunofluorescence intensity ratio of plasma 
membrane vs. cytosolic GFP staining (One way ANOVA followed by Tukey’s post-hoc 
test, n=17-24, * indicates p<0.05) 
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2.3.5 Multiple sites in the B-linker are required for its inhibitory 
function. 
To identify critical regions required for the autoinhibition activity of the B-linker, 
we first truncated the C-terminal half (residues 891-960) of the B-linker, and found that it 
still maintained its inhibitory activity (data not shown). Then we performed NAAIRS-
scanning mutagenesis on the N-terminal portion (residue 848-890) of the B-linker 
(Marsilio et al., 1991). The NAAIRS (Asp-Ala-Ala-Ile-Arg-Ser) hexapeptide was 
identified in diverse secondary structures (Wilson et al., 1985). This peptide thus is able 
to adopt a flexible conformation based upon the local protein structural context, and has 
been widely used for efficient scanning mutagenesis by replacing six amino acids at a 
time, without perturbing overall protein folding (Armbruster et al., 2001; Banik et al., 
2002; Lonergan et al., 1998; Mosher et al., 2006; Sellers et al., 1998). 
We identified three regions (amino acids 848-853, 878-883 and 885-890) within 
the B-linker that are required for lateral membrane exclusion of ankyrin-B. When those 
amino acids were mutated into NAAIRS, transiently expressed ankyrin-B-GFP 
predominantly localized on the lateral membrane in polarized HBE cells (Figure 9). 
Considering our co-immunoprecipitation result showing that the B-linker interacts with 
ANK repeat domain (Figure 7E), this finding implies that the B-linker requires multiple 
contact sites for full interaction and repression of interactions.  
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Figure 9: Multiple sites are required for the inhibitory activity of the B-linker. 
(A), every six amino acids were mutated into NAAIRS to scan through B-linker region. 
(B), immunofluorescence showing transiently-expressed, GFP-tagged AnkB mutants. 
Scale bar, 10µm. (C), quantification of the immunofluorescence intensity ratio of plasma 
membrane vs. cytosolic GFP staining. (One way ANOVA followed by Tukey’s post-hoc 
test, n=32-39, * indicates p<0.05). 
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2.3.6 The B-linker prevents membrane localization of ankyrin-B in 
cultured hippocampal neurons 
We next investigated whether the B-linker autoinhibition mechanism extends to 
neurons. We transfected wildtype 220 kDa ankyrin-B-GFP, 190 kDa ankyrin-G-GFP, and 
their linker chimeras into cultured hippocampal neurons, and compared their 
membrane localization in soma and primary dendrites. We were unable to resolve the 
plasma membrane from cytoplasm in axons due to their small size. However, consistent 
with results in HBE cells, we found that 190kDa ankyrin-G-GFP was able to target to the 
plasma membrane of soma and primary dendrites (Figure 10A, AnkG panel, and 10B), 
whereas 220kDa ankyrin-B predominantly localized in the cytoplasm in these cells 
(Figure 10A, AnkB panel, and 10B). However, ankyrin-G with the B-linker showed 
increased cytoplasmic staining (Figure 10A, G/LB panel, and 10B), while ankyrin-B with 
the G-linker conversely exhibited a robust membrane staining (Figure 10A, B/LG panel, 
and 10B).  
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Figure 10: The B-linker regulates ankyrin protein localization in the same way 
in neurons as in HBE cells. 
(A), immunofluorescence showing transiently-expressed, GFP-tagged 2nd generation 
AnkB/G chimeric proteins (see Figure 4) in hippocampal neurons. The first column show 
the profile of entire transfected neurons, scale bar, 100µm. The cell body (shown in the 
second column, scale bar, 5µm) was boxed in while, while the primary dendrite (shown 
in the third column, scale bar, 2µm) was boxed in red. (B), quantification of the 
immunofluorescence intensity ratio of plasma membrane vs. cytosolic GFP staining. 
(One way ANOVA followed by Tukey’s post-hoc test, n=10, * indicates p<0.05). 
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2.3.7 The active region of the B-linker evolved from a single highly 
divergent exon  
The similar role of B-linker in regulating plasma membrane localization in both 
HBE cells and hippocampal neurons suggests that the autoinhibition mechanism may 
contribute to functional differences between ankyrin family members. The three 
vertebrate ankyrins evolved from a single ankyrin gene present in the urochordate C. 
intestinalis ((Cai and Zhang, 2006), Figure 11A). Surprisingly, the critical region of B-
linker (Figure 9A) required for restricting membrane localization is encoded by a single 
exon in all three vertebrate ankyrins (Figure 11B). The B-linker exon is highly conserved 
within the Ank2 family across multiple species from humans to fish (H.sapiens, 
M.musculus, Xenopus and D.rerio, Figure 11B), especially in the regions identified to be 
critical for its inhibitory function (highlighted in red, Figure 11B). On the other hand, the 
linker exons are divergent among Ank1, Ank2, and Ank3 (H. sapiens Ank1, Ank2 and 
Ank3, Figure 11B), although conserved core elements indicate a common evolutionary 
origin (highlighted in yellow, Figure 11B).  
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Figure 11: The B-linker region is encoded by a single exon evolutionarily-
conserved in the ankyrin-B lineage. 
(A), a phylogenetic tree showing the evolutionary lineage of ankyrin proteins. (B), 
sequence alignment of the linker region in AnkB across multiple species and other 
ankyrin isoforms. Regions highlighted in red represent the critical regions for the 
linker’s inhibitory activity, regions highlighted in yellow represent conservation back to 
ancient ankyrin molecules in Drosophila. 
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2.4 Discussion 
Ankyrin-B is primarily associated with an intracellular compartment(s) while 
ankyrin-G localizes to plasma membranes in epithelial cells (Figure 4) as well as 
cardiomyocytes (Mohler et al., 2004a; Mohler et al., 2004e).  Here, we identify an 
ankyrin-B-specific linker peptide connecting the ANK repeat domain to the ZU52-UPA 
module that inhibits binding of ankyrin-B to membrane protein partners E-cadherin and 
neurofascin-186, and prevents association of ankyrin-B with epithelial lateral 
membranes as well as neuronal plasma membranes. The active region of the B-linker is 
encoded by a small exon that is highly divergent between different ankyrin family 
members but conserved in the ankyrin-B lineage. We show that the ankyrin-B linker can 
suppress activity of the ANK repeat domain through an intramolecular interaction, 
likely with a groove on the surface of the ANK repeat solenoid, thereby regulating the 
affinities between ankyrin-B and its binding partners. Scanning mutagenesis revealed 
three regions in the ankyrin-B linker that are required for its full autoinhibition. These 
results provide a simple evolutionary explanation for how ankyrin-B and -G have 
acquired striking differences in their plasma membrane association while maintaining 
overall high levels of sequence similarity. 
Deficiency of ankyrin-B causes a constellation of traits termed as “ankyrin-B 
syndrome” (Healy et al., 2010; Mohler et al., 2007a; Mohler et al., 2007b; Mohler et al., 
2004d). Previous research have identified multiple human genetic ankyrin-B variants 
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(E1425G, L1622I, T1626N, R1788W, E1813K) (Healy et al., 2010; Mohler et al., 2007b; 
Mohler et al., 2004c; Mohler et al., 2003) which are associated with this syndrome. 
Interestingly, a search of the Exome Variant Server (http://evs.gs.washington.edu/EVS/) 
revealed a human genetic variant in this linker region of ankyrin-B (NM_020977.3). This 
variant causes a Glutamine (aa 879) to Arginine mutation, which happens to locate in 
one of the three critical regions of B-linker that we identified through scanning 
mutagenesis (Figure 9). Therefore, it will be interesting to test whether this mutation 
causes any cellular or physiological defects in future experiments. Additionally, a study 
conducted by Cunha and the colleagues revealed multiple new exons in the ANK2 gene, 
and one of those exons is immediately 5’ to the B-linker exon (Cunha et al., 2008). This 
new exon encodes a short peptide, which can potentially alter the relative position 
between the ANK repeat domain and the B-linker. Similar alternative exons were also 
identified 5’ to the G-linker exon (Peters et al., 1995), which may affect membrane 
protein interactions of ankyrin-G polypeptide. 
Here we show that endogenous ankyrin-G localizes to the plasma membrane 
while ankyrin-B exists in some intracellular vesicles with unknown identity in HBE cells. 
However membrane association may be cell type specific, since in some cases both 
ankyrin-B and ankyrin-G localize to the plasma membrane, although in different 
subdomains. For example, in myelinated neurons, ankyrin-G targets to the nodes of 
Ranvier while ankyrin-B localizes to the paranode (Galiano et al., 2012). Another 
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example is the cardiac T-tubules membrane where ankyrin-B localizes together with 
Na/K ATPase, Na/Ca exchanger, and InsP3 receptor (Mohler et al., 2005), while ankyrin-
G localizes to both intercalated disc and T-tubules, and is required for targeting of 
Nav1.5channels (Lowe et al., 2008). These specific localization patterns may be achieved 
through ankyrin-B and -G interactions unaffected by the B-linker peptide, and likely 
involve additional proteins.  
Ankyrins recognize their membrane partners through natively unstructured 
peptides in their cytoplasmic domains (Table 1) (Bennett and Healy, 2009).  A structure 
of the C-terminal half of the ankyrin-R ANK repeat domain revealed a groove-like 
surface, which provides a potential binding site for unstructured peptides (Michaely et 
al., 2002).  The linker we identified here may function as a native competitor or regulator 
for determining binding affinities with different partners. To further confirm this 
hypothesis, it will be important in the future to determine atomic structures of ANK 
repeats of ankyrin-B with membrane partners and with the B-linker.  
Ankyrins and their partner spectrin have from their initial discovery exhibited 
association with both plasma membranes and intracellular organelles (Beck et al., 1994; 
Bennett et al., 1982; Levine and Willard, 1981; Lin et al., 1994). Our discovery of a 
mechanism for preventing association of ankyrin-B with plasma membranes through 
intramolecular competition for membrane binding partners provides a molecular clue as 
to how closely related ankyrins can direct spectrin to both cytoplasmic compartments 
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and the plasma membrane. Given that ankyrin-B and ankyrin-G originated from a single 
ancestral ankyrin, it is possible that pre-chordate ankyrin had both intracellular and 
plasma membrane-related functions. The identity of the ankyrin-B-associated 
intracellular structures in cardiomyocytes (Mohler et al., 2004e) or HBE cells (Figure 4A) 
remains unknown. Therefore, it will be intriguing to identify the composition and 
function of ankyrin-B-positive organelles and their cellular functions.   
Table 1: Diversity of ankyrin-binding motifs. 
 
(From Bennett and Healy, 2009) 
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Chapter 3. Cysteine 70 of Ankyrin-G is S-palmitoylated 
and Required for Function of Ankyrin-G in Membrane 
Domain Assembly 
3.1 Introduction 
In the last Chapter, we identified a molecular diversity that explains how 
ankyrin-B is excluded from the plasma membrane of epithelial cells and neurons. 
However, it is still unclear how ankyrin-G localizes to the epithelial lateral membrane 
and other specialized membrane domains. Multiple protein domains are required to 
direct AnkG to the AIS of dorsal root ganglion neurons and lateral membranes of 
cultured epithelial cells (Kizhatil and Bennett, 2004; Zhang and Bennett, 1998). 
Elimination of the AnkG binding partners, β4-spectrin or neurofascin, does not prevent 
localization of AnkG at the AIS (Boiko et al., 2007; Dzhashiashvili et al., 2007; Hedstrom 
et al., 2007). Recent work has shown that ankyrin-B is critical to confine AnkG to the AIS, 
though the mechanism for axonal localization remains unclear (Galiano et al., 2012). In 
epithelial cells, a DAR999AAA mutant AnkG, which specifically loses interaction with 
β2-spectrin, still efficiently localizes to the lateral membrane, even though this mutant 
AnkG lacks activity in membrane biogenesis (Kizhatil et al., 2007b).  Therefore, 
additional features mediated by interactions with unidentified proteins or membrane 
phospholipids may contribute to targeting of AnkG to specialized membrane domains.  
Covalent modification of proteins with lipids can contribute to micro-patterning 
of plasma membranes (Levental et al., 2010). Interestingly, ankyrin-R (AnkR) purified 
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from erythrocyte membranes exhibited hydrophobicity intermediate between a cytosolic 
protein and an integral protein (Bennett and Stenbuck, 1980). Moreover, AnkR is 
palmitoylated in a reversible fashion (Staufenbiel, 1987). In this chapter, we report that 
AnkG is S-palmitoylated at a cysteine conserved among all three ankyrin family 
members and located in their membrane-binding domains. We also find that the same 
cysteine, possibly due to its S-palmitoylation, is required for targeting as well as the 
biological functions of AnkG in epithelial cells and neurons.  
 
3.2 Methods and Materials 
Reagents, plasmids and antibodies 
N-Ethylmaleimide and hydroxylamine were from Sigma, EZ-Linker Biotin-
BMCC from Thermo, activated Thiol Sepharose 4B from GE Healthcare, Dynabeads with 
protein-G and Lipofectamine 2000 transfection reagent were from Invitrogen, 
QuikChange II XL Site-Directed Mutagenesis Kit from Agilent Technologies, palmitic 
Acid, [9,10-3H] from PerkinElmer. Rat wild-type 190kDa AnkG cDNA was previously 
described (Kizhatil and Bennett, 2004). Rabbit polyclonal antibody targeting the C-
terminal domain of AnkG, and rabbit polyclonal antibody against β2-spectrin were 
previously described (Kizhatil et al., 2007b), Mouse monoclonal antibodies against 
human E-cadherin and ZO-1 were from Invitrogen, mouse monoclonal anti-sodium 
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channel pan antibody was from Sigma, and rabbit polyclonal antibody against biotin 
was from Abcam.  
MDCK stable cell lines 
The ViraPower Lentiviral Expression System based on the pLenti6/V5-DEST 
Gateway Vector from Invitrogen was used to generate stable MDCK cell lines 
expressing wild-type or C70A AnkG-GFP. For lentivirus generation, 293T cells were 
grown in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% fetal 
bovine serum. 15 million cells were plated in 100mm dishes and transfected the next day 
with 16μg cDNA (4μg pMDLg/pRRE, 4μg pRSV-Rev, 4μg pMD2.G, and 4μg transfer 
plasmid) using Lipofectamine 2000 following the manufacturer’s protocol. 48 hours 
later, 25 ml culture medium were collected and centrifuged at 25000rpm for 2 hours to 
collect the virus. Half a million MDCK cells were plated in a 6-well plate and infected 
with the virus for 16 hours. Blasticidin S was used to select infected cells and establish a 
stable cell line. 
Calcium switch assay 
MDCK cells were maintained in DMEM supplemented with 10% FBS until they 
formed a polarized monolayer. Cells were then trypsinized, and 2x106 cells were plated 
on 14mm coverslip inserts of MatTek plates in calcium-free Minimum Essential Medium 
supplemented with 5% dialyzed low calcium FBS. 16 hours later, cells were washed with 
PBS to remove unattached cells, and then fed with normal growth medium.  Cells were 
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fixed and processed for immunofluorescence to visualize protein localization at multiple 
time points.  
Membrane recruitment assay 
This assay was previously reported (Zhang and Bennett, 1998). Briefly described, 
1x105 HEK293 cells were plated in 14mm insert, collagen-coated MatTek plates. The next 
day, cells were co-transfected with 100ng HA-tagged neurofascin or E-cadherin cDNA 
and 80ng GFP-tagged 190kDa AnkG cDNA using Lipofectamine 2000. 24 hours later, 
cells were fixed and processed for immunofluorescence as described below.  
Biotin switch assay 
The biotin switch assay was previously described for testing protein S-acylation 
(Drisdel et al., 2006). Since endogenous AnkG is resistant to Triton X-100 extraction we 
developed a protocol for solubilizing AnkG from MDCK cells in a state compatible with 
immuno-precipitation. A polarized MDCK monolayer in 150mm dish was washed and 
suspended in ice-cold PBS buffer with protease inhibitors; cells were then collected by 
centrifugation at 1000 x g for 5 minutes. The cell pellet was homogenized in lysis buffer 
(10mM sodium phosphate, 2mM NaEDTA, 0.32M sucrose, 50mM N-Ethylmaleimide 
and protease inhibitors (10µg/ml AEBSF, 30µg/ml benzamidine, 10µg/ml pepstatin, and 
10µg/ml leupeptin), pH=7.4) using a 27G needle, and incubated at 4oC for 6 hours to pre-
block free sulfhydryl groups. SDS was then added to the lysates at a final concentration 
of 1% (w/v) and mixed well immediately. Lysates were sonicated for 30 seconds on ice 
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followed by centrifugation at 100,000xg for 30min. Triton X-100 was then added to a 
final concentration of 1%, (v/v), then mixed well and incubated on ice for 30 minutes 
followed by rotation at 4oC for another 30 minutes to quench SDS. 60 μl of Dynabeads 
preloaded with 10μg AnkG antibody were then incubated with the lysates overnight 
rotating at 4oC. The beads were washed 3 times with cold wash buffer (10mM sodium 
phosphate, 2mM NaEDTA, and protease inhibitors, pH=7.4), and then incubated with 
hydrolysis-labeling buffer (1M hydroxylamine, 80μM biotin-BMCC, 10mM sodium 
phosphate, 2mM NaEDTA, and protease inhibitors, pH 7. As a control, 1M Tris-HCl was 
substituted for hydroxylamine) at room temperature for 2 hours. Beads were then 
washed 3 times with wash buffer and incubated with 5X loading buffer (5% SDS, 20% 
sucrose, 40mM Tris-HCl, 150mM NaCl, 2mM NaEDTA, 200mM DTT with bromophenol 
blue) at 70oC for 15 minutes to elute proteins.  Samples were analyzed by SDS-PAGE 
and western blotting. A biotin antibody was used to detect S-acylation.  
Mass spectrometry 
HEK293 cells transfected with WT AnkG-GFP were homogenized in lysis buffer 
(10mM sodium phosphate, 2mM NaEDTA, 0.32M sucrose, 50 mM N-Ethylmaleimide 
and protease inhibitors (10µg/ml AEBSF, 30µg/ml benzamidine, 10µg/ml pepstatin, and 
10µg/ml leupeptin), pH=7.4) and incubated at 4oC for 6 hours to pre-block free 
sulfhydryl groups. Triton X-100 was then added at 1% final concentration, and lysates 
were sonicated for 20 seconds. Dynabeads preloaded with GFP antibody (GFP antibody 
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was blocked with NEM) were then added to immunoprecipitate AnkG-GFP overnight.  
The following day, the beads were washed 3 times and incubated with elution buffer 
(1% SDS, 10mM sodium phosphate, 2mM NaEDTA, 0.32M sucrose) at 50oC for 5 
minutes to selectively release AnkG-GFP. Eluted samples were divided into two equal 
portions: one treated with 1M hydroxylamine the other with 1M Tris-HCl (as a control) 
at neutral pH with the presence of activated thiol sepharose 4B. After two-hour 
incubation at 24°C, sepharose beads were washed with 20mM ammonium bicarbonate 3 
times and digested in 0.1% Rapigest. After trypsin digestion, the beads were incubated 
with 20 mM DTT at 24°C for 45 minutes to elute cysteine-containing peptides. Eluted 
samples were alkylated with 40 mM iodoacetamide and analyzed by LC-MS/MS. 
[3H]-palmitic acid labeling 
8×106 stable MDCK cells of WT or C70A AnkG-GFP were plated on 100mm 
dishes and grown in 37oC, 5% CO2 overnight. The next day, cells were rinsed with PBS 
buffer and incubated with 5ml serum-free medium for 4 hours, and then the medium 
was replaced with 5ml of fresh DMEM containing 100μCi/ml [3H]-palmitic acid. 
Following a 4-hour incubation, AnkG-GFP was immunoisolated using the protocol 
previously described, and divided into two equal portions: one treated with 1M 
hydroxylamine, the other treated with 1M Tris-HCl at room temperature for 2 hours. 
Proteins were then eluted, separated by SDS-PAGE and transferred to a nitrocellulose 
membrane, which was then exposed for 6 weeks in -80oC to detect tritium radioactivity. 
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Immunostaining and fluorescence recovery after photobleaching 
MDCK cells on MatTek plates were first washed with cold PBS and fixed with 
4% paraformaldehyde at room temperature for 15 minutes, and then cells were 
permeabilized with 0.2% Triton X-100 at room temperature for 10 minutes. Following a 
30-minute blocking in PBS buffer containing 2% bovine serum albumin, cells were 
incubated with primary antibody in 4oC overnight. Cells were next washed with PBS 
buffer three times and then incubated with fluorescence-conjugated secondary 
antibodies (AlexaFluor 488, 568 or 663, Molecular Probes) at room temperature for 2 
hours. Fluorescent antibody labeling was visualized using a Zeiss LSM 510 laser 
scanning microscope. Images from figure 11 and 17 were collected using the 63X NA 1.4 
objective lens, and XZ planes were reconstructed from Z stacks with optical sections of 
0.5µm. Images from figure 14 and 16 were collected using a 100X NA 1.45 objective lens, 
and XZ planes were reconstructed from Z stacks with optical sections of 0.37µm. 
Volocity 3D image analysis software was used to measure the fluorescence intensity of 
plasma membrane and cytoplasm. Data were analyzed using Graphpad Prism5. For 
fluorescence recovery after photobleaching (FRAP) measurements, MDCK cells grown 
on MatTek plates were transfected with 300ng WT, C70A, DAR999AAA or 
C70A/DAR999AAA double mutation AnkG-GFP plasmids. 24 hours later, cells were 
analyzed using a Zeiss LSM 780 laser scanning confocal system. The selected membrane 
region was bleached for 5 seconds, and the fluorescence recovery was monitored for the 
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following 500 seconds. An unbleached region was also monitored during the 
measurements, and was used to normalize the FRAP data. Graphpad Prism5 was used 
to analyze the data by fitting them to the one-phase association 
equation .  
Doxycycline-inducible shRNA cell lines and rescue experiments 
The Tet-pLKO-puro vector was originally obtained from Addgene (Plasmid 
21915). We replaced the puromycin-resistance gene with mCherry to allow isolation of 
transfected cells by fluorescence activated cell sorting (FACS), while the IRES region was 
replaced with the Foot & Mouth Disease Virus 2A peptide 
(GSGATNFSLLKQAGDVEENPGP) to facilitate higher expression levels of mCherry. 
Oligos encoding a shRNA hairpin targeting canine AnkG in the ankyrin repeats domain 
(gctagaagtagctaatctcct) were cloned into Tet-pLKO-2A-mCherry, with hairpin targeting 
luciferase gene (ggagatcgaatcttaatgtgc) as a negative control. Lentivirus was generated 
using the second generation packaging system from Addgene (psPAX2 and pMD2.G) 
following the recommended protocol. Two days after MDCK cells were infected, cells 
were trypsinized and fractionated by FACS to establish a stable cell line. To evaluate 
AnkG knockdown efficiency, stable cells were induced by 5μg/ml doxycycline for 24 
and 48 hours. Total RNA was extracted following standard protocol and applied for real 
time quantitative PCR using Power SYBR Green Master Mix from Life Technology. For 
rescue experiments, cells were pre-induced for 12 hours using 5μg/ml doxycycline, and 
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re-plated on 14mm insert MatTek plates with the presence of doxycycline at a density of 
1600/mm2. 6 hours later, cells were transfected with 80ng WT or C70A AnkG-GFP using 
Lipofectamine 2000. Cells were supplemented with fresh medium 4 hours post-
transfection and fixed for immunofluorescence after 36 hours.   
Hippocampal neuronal cultures 
Hippocampi were dissected from neonatal C57bl/6 mice (P0-P1) and incubated in 
2mg/mL papain in Hibernate A with 100µg/mL DNase at 37°C for 20 minutes. 
Hippocampi were washed twice in plating medium (Neurobasal A plus 2% B-27 
supplement, 2mM Glutamax, and 10% horse serum) and triturated first with a P200 
pipette tip and then with a fire-polished Pasteur pipette until dissociated. Cells were 
resuspended in plating medium and plated in poly-L-lysine-coated MatTek plates for 3-
4 hours. Media was gently aspirated and replaced with growth medium (Neurobasal A 
plus 2% B-27 supplement and 2mM Glutamax) for 4-5 days. Transfections were carried 
out with Lipofectamine 2000. In one tube, 1µg total cDNA was mixed with 100µL 
Neurobasal A, and in a second tube, 3µL Lipofectamine 2000 was mixed with 100µL 
Neurobasal A.  After 15 minutes tubes were mixed. Growth medium was removed from 
neurons and set aside, and transfection mixture was added to cells. After 1 hour at 37°C 
the transfection mix was aspirated and cells were fed with original growth medium 
supplemented with 5µM cytosine arabinoside. After 48 hours (7 DIV), cells were fixed 
with 4% paraformaldehyde for 15 minutes at room temperature and ice-cold methanol 
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for 7 minutes at -20°C and processed for immunostaining. For quantification, confocal Z-
stack images were collapsed, and the fluorescence intensities from the first 60μm portion 
of axons and dendrites were measured using ImageJ software. The intensity ratios of 
axon to dendrite were quantified and analyzed using Graphpad Prism5. 
 
3.3 Results 
3.3.1 AnkG remains on the plasma membrane in MDCK cells grown in 
low calcium  
MDCK cells are well known to require extracellular calcium to maintain 
transepithelial resistance and apical-basal polarity (Martinez-Palomo et al., 1980).  
Adherens junction proteins (E-cadherin), tight junction proteins (zonula occludens-1 
(ZO-1)), desmosomal proteins (desmoplakin), and components of the spectrin-based 
membrane skeleton all depend on extracellular calcium for their localization at lateral 
membrane domains of MDCK cells (Gumbiner et al., 1988; Kaiser et al., 1989; Mattey and 
Garrod, 1986; Siliciano and Goodenough, 1988).  Here we determined effects of low 
calcium on localization of AnkG and its binding partners, E-cadherin and β2-spectrin. 
MDCK cells grown in low-calcium medium lacked cell-cell contacts and exhibited a 
spherical morphology (Figure 12A, B). As previously reported, E-cadherin is 
intracellular in unpolarized MDCK cells, and accumulates at the region of cell-cell 
contact only after addition of calcium (Busche et al., 2010; Gumbiner et al., 1988). β2-
spectrin also exhibits a similar pattern and associates with the plasma membrane only 
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following addition of calcium ((Nelson and Veshnock, 1987); Figure 12B).  However, we 
were surprised to observe a substantial fraction of AnkG that remained associated with 
the plasma membrane in low calcium and in the absence of cell-cell contacts (Figure 
12A, B). Following elevation of calcium, AnkG re-organized and concentrated at the 
lateral membrane to achieve polarized localization (Figure 12A, B).  As far as we are 
aware, AnkG is the only lateral membrane-associated protein identified so far that 
remains on the plasma membrane in MDCK cells following depletion of calcium. 
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Figure 12: AnkG remains membrane-associated in MDCK cells following 
calcium switch.   
(A and B), fully-polarized MDCK cells (polarized) were trypsinized and re-plated in Ca2+ 
free medium with 5% FBS overnight to reach a steady state. Cells were then either fixed 
(-Ca2+) or allowed 24 hours to recover in normal growth medium (+Ca2+) then fixed, and 
processed for immunofluorescence to stain against AnkG, β2-spectrin, E-cadherin and 
ZO-1. A, the XZ planes showing AnkG staining in MDCK cells following calcium switch 
described above. (B), the XY planes showing immunostaining of AnkG, β2-spectrin, E-
cadherin and ZO-1 (a marker of tight junction) in MDCK cells following calcium switch. 
(Scale bars, 10μm, images are representative of at least three independent repeated 
experiments). 
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3.3.2 AnkG is S-palmitoylated at cysteine 70 
The finding that AnkG associates with the plasma membrane in non-polarized 
MDCK cells in the absence of β2-spectrin and E-cadherin suggested the possibility of a 
protein-independent mode of membrane interaction though lipidation.  S-acylation 
plays critical roles in membrane interactions, intracellular sorting, protein stability and 
signaling (Salaun et al., 2010).  It is pertinent in this regard that AnkR was reported to 
undergo palmitoylation, although amino acid site(s) were not identified (Staufenbiel, 
1988). We therefore explored possible S-acylation of AnkG in MDCK cells using a biotin-
switch assay (Drisdel et al., 2006). In this assay, proteins with free sulfhydryl groups 
were first blocked by N-ethylmaleimide (NEM), and then treated with hydroxylamine 
(or Tris as a negative control), which selectively cleaves  thioester bonds and releases 
new sulfhydryl groups for labeling using sulfhydryl-reactive biotinylation reagent 
(BMCC-Biotin). We found that 210kDa AnkG was S-acylated in MDCK cells (Figure 
13A).  Two smaller AnkG polypeptides with molecular weights of 100 and 120 kDa, 
which lack ankyrin repeats (Peters et al., 1995), were not S-acylated (Figure 13A).  
We next identified the principal S-acylated cysteine(s) of AnkG by mutagenesis. 
Considering that only full-length AnkG is S-acylated, we created cysteine to alanine 
mutants of all of cysteines in the membrane-binding domain (C70A, C315A, C357A, 
C385A, C416A, and C746A). These AnkG mutants were expressed in HEK293 cells, and 
processed for the biotin switch assay to detect protein S-acylation. As shown in Fig 13B, 
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WT AnkG as well as C315A, C357A, C385A, C416A, C746A mutants are all S-acylated in 
HEK293 cells, demonstrating that this modification is not limited to epithelial cells. 
However, the C70A mutation completely abolished the specific biotin signal (Figure 
13B), 
In separate experiments we employed mass spectrometry as an independent 
approach to identify S-acylated peptides in AnkG.  We isolated S-acylated AnkG by first 
blocking free SH groups in cells with NEM followed by removal of thioester groups 
with hydroxylamine as described above for the biotin switch assay.  We then isolated S-
acylated AnkG using activated thiol sepharose 4B (Forrester et al., 2011).  Following 
proteolysis, the S-acylated peptide(s) were eluted with dithiothreitol and then alkylated 
with iodoacetamide. Using liquid chromatography and mass spectrometry we identified 
a single AnkG peptide, KNGVDVNICNQNGLNALHLASKE, which contains C70, 
confirming that cysteine 70 was indeed S-acylated (Figure 13C). Figure 13C shows the 
selected ion chromatograms of the identified peptide from both control (-NH2OH) and 
experimental (+NH2OH) samples. 
Protein S-acylation can occur by modification with multiple fatty acids (Jennings 
and Linder, 2012). We therefore next tested whether AnkG S-acylation is mediated by 
palmitic acid. MDCK stable cells expressing WT or C70A AnkG-GFP were metabolically 
labeled with tritiated palmitic acid, followed by immunoisolation of AnkG-GFP.  We 
found that palmitic acid was incorporated into wild type AnkG-GFP, but not the C70A 
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mutant, and that palmitoylation was reversed by hydroxylamine but not by Tris-HCl 
(Figure 13D).  These results provide direct evidence that palmitic acid is coupled to 
cysteine 70 of AnkG through a thioester bond. 
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Figure 13: AnkG is S-palmitoylated at Cysteine 70. 
(A), The blot shows that only the ~200kDa isoform, which has ankyrin repeats, is S-
acylated. (B), The blot shows that C70A completely abolishes AnkG S-acylation. (C), MS 
identified an S-acylated AnkG peptide KNGVDVNICNQNGLNALHLASKE containing 
cysteine70, Figure 2C is a mass chromatogram of the selected AnkG peptide. (D), stable 
MDCK cell lines of WT or C70A AnkG-GFP were labeled with 100μCi/ml [3H]-palmitic 
acids. AnkG was then immunoprecipitated and analyzed by SDS-PAGE. The blot shows 
that radioactive palmitic acids can be incorporated into WT AnkG but not C70A in a 
hydroxylamine-sensitive way. 
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C70 is located in a loop of the first ankyrin repeat in the membrane-binding domain 
of AnkG (Figure 14A).  Interestingly, C70 is conserved among all three human ankyrin 
members as well as all vertebrate ankyrins. Interestingly, Drosophila ankyrin isoform 1 
also has a cysteine at the comparable position, while the single C. elegans ankyrin and 
Drosophila ankyrin isoform 2 both contain a serine instead of cysteine (Figure 14B).  
These results suggest strong evolutionary pressure and a conserved function(s) shared 
between the three vertebrate ankyrins and one of the Drosophila ankyrin genes. 
 
 
Figure 14: The conservation of Cysteine70 and its position in predicted ankyrin 
repeats structure 
(A), a predicted structure of ankyrin repeats shows that Cysteine 70 locates in the loop 
connecting the first two repeats, highlighted in red. (B), cysteine70 is conserved among 
three human ankyrin members, and also conserved in AnkG across different species. 
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3.3.3 AnkG requires C70 for membrane association in MDCK under 
low calcium conditions 
We next explored the role of cysteine 70 in targeting of AnkG to the plasma 
membrane of MDCK cells grown in low calcium where other known ankyrin-G protein 
partners are absent (Figure 12).  We evaluated the localization of WT or C70A AnkG-
GFP in MDCK cells grown in low calcium medium by measuring the fluorescence 
intensity ratios of membrane to cytosolic staining.  A majority of WT AnkG-GFP remains 
on the plasma membrane, as observed with native AnkG (Figure 12A). In contrast the 
C70A mutant was mainly distributed in the cytoplasm (Figure 15A, 4D).  WT and C70A 
AnkG-GFP show average intensity ratios between plasma membrane and cytoplasm of 
8.3±0.3 and 2.7±0.2 respectively, (p<0.001). This observation indicates that C70 is 
required for targeting AnkG to the plasma membrane in the absence of E-cadherin and 
β2-spectrin. Interestingly, WT AnkG-GFP also associates with internal structures that are 
currently uncharacterized. 
One interpretation of loss of C70A AnkG association with plasma membranes of 
unpolarized MDCK cells (Figure 15A) is that C70 is required for stable folding or 
protein-protein interactions. We therefore examined membrane localization of C70A 
AnkG in polarized MDCK cells, which display normal localization of AnkG binding 
partners (Figure 12B). In contrast to unpolarized MDCK cells, WT and C70A AnkG 
associate equivalently with the lateral membrane in polarized MDCK cells (Figure 15B, 
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4D; WT and C70A AnkG-GFP show indistinguishable average intensity ratios between 
plasma membrane and cytoplasm  of 10±0.5 and 8.9±0.5 respectively,  p=0.1248).  
In order to compare effects of C70A mutation with a loss of spectrin-binding 
mutation we utilized a DAR999AAA mutant AnkG that lacks spectrin-binding activity 
(Kizhatil et al., 2007b). We compared the plasma membrane targeting of WT, C70A, 
DAR999AAA and C70A/DAR999AAA double mutated AnkG expressed by transient 
transfection of MDCK cells. Both the DAR999AAA mutant and C70A/DAR999AAA 
double AnkG mutant exhibited plasma membrane localization.  However, more of the 
double mutant remained cytosolic than with either mutation alone (Figure 15C, 15E).  
WT, C70A, DAR999AAA and C70A/DAR999AAA double mutated AnkG show average 
intensity ratios between plasma membrane and cytoplasm of 8.5±0.4, 8.1±0.5, 7.8±0.5 and 
5.4±0.3 respectively ( p<0.001).  
To evaluate the possibility that C70A mutation interferes with AnkG binding to 
known membrane-spanning proteins, we directly evaluated ability of C70A mutant 
AnkG-GFP to interact with E-cadherin and neurofascin using a membrane-recruitment 
assay in 293 cells. This assay takes advantages of the fact that WT AnkG, when 
expressed at high levels, exists in the cytoplasm, but can be recruited to the plasma 
membrane if co-expressed with a membrane partner. Detailed information of this assay 
can be found in previous publications (Kizhatil et al., 2007a; Zhang and Bennett, 1998). 
WT and C70A/DAR999AAA double mutant AnkG both were cytosolic when over-
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expressed in 293 cells, but were equivalently recruited to the plasma membrane when 
co-transfected with either E-cadherin or neurofascin (Figure 16). C70A mutation thus 
has no effect on association of AnkG with at least two of its known protein partners. 
These results taken together are consistent with a role of palmitoylation of C70 in 
membrane targeting of ankyrin-G to the membrane of unpolarized MDCK cells (Figure 
15A). 
 67 
 
Figure 15: C70A mutation prevents AnkG retention in MDCK cells grown in 
low calcium. 
(A, B), stable MDCK cells expressing WT or C70A AnkG-GFP were grown in low 
calcium medium or normal medium, then fixed and immunostained against GFP. (C), 
WT, C70A, DAR999AAA (DAR) and DAR999AAA, C70A double mutant (C70A, DAR) 
AnkG-GFP cDNA were transfected into MDCK cells, Scale bars, 10µm for A, B and C. 
(D), Quantitative results of the fluorescence intensity ratio of plasma membrane vs. 
cytoplasmic staining in AnkG stable MDCK cell lines. (p<0.001 for ANOVA, n=26-31 
from two independent experiments). (E), Quantitative results of the fluorescence 
intensity ratio of plasma membrane vs. cytoplasmic staining of WT, C70A, DAR999AAA 
(DAR) and DAR999AAA, C70A double mutant (C70A, DAR) (p<0.001 for ANOVA, 
n=26-28 from three independent experiments). * indicates p<0.05. 
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Figure 16: C70 mutation does not affect AnkG interactions with E-cadherin or 
neurofascin. 
The membrane recruitment assay was used to monitor AnkG interactions with the 
interacting partners, E-Cadherin and Neurofascin. 80ng WT AnkG-GFP (A) or 
C70A/DAR999AAA AnkG-GFP (B) was transfected into HEK293 cells with or without 
(control) 100ng binding partner (V5-E-Cadherin or HA-Neurofascin). Cells were then 
fixed and double stained with anti-HA or -V5 (red) and anti-GFP (green) antibodies 
(scale bar, 10 µm). 
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3.3.4 Effect of C70A and DAR999AAA mutations on AnkG membrane 
dynamics 
It is known that palmitoylation can alter membrane protein dynamics and 
intracellular trafficking (Henis et al., 2006). Here, we used Fluorescence recovery after 
photobleaching (FRAP) to examine whether C70A and DAR999AAA mutations affect 
mobility of GFP-tagged 190 kDa AnkG within the lateral membrane of polarized MDCK 
cells. WT AnkG exhibited rapid recovery to about 40 percent of its pre-bleach intensity 
in the first 100 seconds following photobleaching.  However, WT AnkG exhibited little 
further recovery in the remaining 400 seconds, demonstrating a substantial immobile 
fraction of around 60 percent in the time scale of these measurements. In order to 
exclude the possibility that the partial recovery is an artifact resulting from total 
fluorescence loss, we analyzed our data by normalizing to an unbleached region (see 
experimental procedures for detail). We found that C70A mutation showed no 
significant increase in the mobile fraction or the initial rate of AnkG recovery within 5 
minutes (Figure 17A, B). However, loss of β2-spectrin interaction through the 
DAR999AAA mutation further increased the mobile fraction by more than 30%, 
indicating that AnkG is restricted by association with β-2 spectrin (Figure 17A, B).  The 
double mutant C70A/DAR999AAA AnkG showed no further increase in recovery 
compared to DAR999AAA mutation alone (Fig. 17A, B).  These FRAP data demonstrate 
that a substantial fraction of lateral membrane-associated AnkG is immobile over a 5 
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minute measurement, and that loss of interaction with β2-spectrin but not C70A 
mutation increases the mobile fraction of AnkG.  
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Figure 17: Effects of C70A mutation on AnkG dynamics at the lateral 
membrane 
(A), 300ng WT, C70A , DAR999AAA and C70A/ DAR999AAA double mutant AnkG-
GFP were transfected into MDCK cells. Fluorescence recovery after photobleaching 
(FRAP) was performed using LSM780 confocal microscope. The representative graphs 
show the fluorescence recovery within 5 minutes, yellow boxes indicate the regions 
bleached. B, quantitative results of N=10 repetitive measurements. The normalized 
fluorescence intensities were plotted against time and regressed against the one phase 
exponential equation , using Graphpad Prism5 (scale bar, 10µm).   
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3.3.5 C70A mutation abolishes AnkG function in lateral membrane 
biosynthesis 
AnkG collaborates with β2-spectrin in biogenesis of the lateral membrane in 
human bronchial epithelial cells (Kizhatil and Bennett, 2004; Kizhatil et al., 2007b). We 
evaluated effects of the C70A mutation on this AnkG function by knocking down 
endogenous AnkG in MDCK cells followed by rescue with GFP-tagged wild-type or 
mutant AnkG. We generated a doxycyclin-inducible AnkG shRNA MDCK stable cell 
line with a hairpin sequence targeting the ankyrin repeat domain. The targeting vector 
included the fluorescent protein mCherry which allowed isolation of infected cells by 
fluorescence activated cell sorting (FACS). RT-PCR  and immunoblotting showed that 48 
hour induction by doxycyclin diminished 210 kDa AnkG by more than 90% at both 
mRNA and protein levels without affecting the 100 and 120 kDa isoforms (Figure 18A).  
We observed that when AnkG is silenced by 90 percent, lateral membrane height is 
reduced from 10 microns to 3 microns (Figure 18B, C) (Kizhatil and Bennett, 2004). 
When cells depleted of endogenous AnkG were transfected with WT 190 kDa AnkG-
GFP, the lateral membrane was restored to its normal height, as previously reported 
(Kizhatil and Bennett, 2004).  However, expression of C70A 190 kDa AnkG failed to 
rescue lateral membrane height, and resulted in further intracellular accumulation of 
AnkG-GFP (Figure 18B). Of note, we found that rescue of lateral membrane height was 
dependent on expression of the rescue plasmid in adjacent cells, since cells that shared a 
cell-cell contact with a non-transfected cell demonstrated much lower cell heights.  
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Figure 18: C70A mutation abolishes AnkG function in lateral membrane 
biosynthesis. 
(A), doxycycline-inducible AnkG-shRNA MDCK cell line was generated using an 
engineered Tet-pLKO-mCherry vector. Two days doxycycline induction could 
selectively knock down 90% ~200kDa AnkG. (Blot is representative of at least three 
independent experiments). (B), XZ planes of lateral membrane under different 
conditions (green, AnkG; white, ZO-1, scale bar, 10µm). AnkG knockdown cells show 
defect in lateral membrane height compared to luciferase-shRNA cells. WT AnkG, but 
not C70A mutant is able to restore the height of lateral membrane. (C), quantitative 
results of the height of lateral membrane. The height was defined as the distance 
between the bottom of ZO-1 staining and the end of lateral membrane. Mean lateral 
membrane height was 9.8±0.3µm for Luciferase shRNA, 3.4±0.4µm for AnkG shRNA, 
9.1±0.6µm for WT-AnkG rescue, and 4.1±0.5µm for rescue with C70A AnkG-GFP. 
Conditions were compared using one-way ANOVA followed by a Tukey Post-hoc test 
(p<0.001 for ANOVA, n=24-30 per condition). * indicates p<0.05. 
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3.3.6 C70A mutation abolishes function of 270kDa AnkG at the axon 
initial segment  
270/480kDa AnkG concentrates at the AIS of neurons throughout the peripheral 
and central nervous system and recruits β4-spectrin and neurofascin (Jenkins and 
Bennett, 2001; Kordeli et al., 1995; Zhou et al., 1998). None of the known binding 
partners for AnkG are sufficient for its localization to the AIS (Hedstrom et al., 2007; 
Zhang and Bennett, 1998). We determined whether C70 plays a role in targeting of 
270kDa AnkG to the AIS of cultured hippocampal neurons using a similar knockdown 
and replacement strategy as used in MDCK cells. By transfecting cells at 4-5 days in 
vitro, we are able to rescue AnkG expression during AIS formation to test the function of 
the mutant proteins. C70A 270kDa AnkG-GFP concentrated normally at the AIS in 
hippocampal neurons containing endogenous AnkG and intact AIS (Figure 20). 
However, if endogenous AnkG was depleted by shRNA, C70A AnkG was unable to 
cluster at the AIS region, and instead distributed evenly in the soma, dendrites and axon 
of transfected neurons (Figure 19A, B). Similarly, interaction with spectrin is also critical 
for formation of the initial segment, since DAR999AAA was also unable to cluster at the 
AIS (Figure 19A, B). Moreover, C70A 270kDa AnkG also lost ability to cluster 
neurofascin and sodium channels to the AIS (Figure 19D, E, F).  This loss of ability to 
recruit neurofascin to the AIS is not a result of a loss of neurofascin binding since the 
AnkG double mutant (C70A/DAR999AAA) still interacts with neurofascin in the 
membrane recruitment assay in 293 cells (Figure 16).  These results are consistent with a 
 75 
requirement for palmitoylation for function of AnkG at the AIS as well as epithelial 
lateral membranes. 
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Figure 19: C70A mutation abolishes 270 kDa AnkG clustering and function at 
axon initial segments in hippocampal neurons. 
(A, D), anti-GFP staining for 270kDa AnkG-GFP shown in green, mCherry marking 
transfected neurons shown in red and the axonal marker neurofilament shown in white 
(scale bar 50 µm). Brackets mark the axon initial segment, which is shown at higher 
magnification below each image (scale bar, 10 µm). (B), quantification of fluorescence 
intensity along the axons. (C), quantification of the anti-GFP fluorescence intensity ratio 
of axons to dendrites (n=3, * indicates p<0.05). (E, F) quantification of the anti-
endogenous neurofascin or pan sodium channel fluorescence intensity ratio of axons to 
dendrites in cells depleted of endogenous 270kDa AnkG and rescued with mock, WT, 
C70A or DAR999AAA AnkG-GFP (n=3-4, * indicates p<0.05). 
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Figure 20: C70A 270kDa AnkG-GFP localizes at axon initial segments in wild 
type hippocampal neurons. 
Hippocampal neurons were transfected with C70A 270kD AnkG-GFP, and fixed at day 
7. (A), anti-GFP staining for C70A 270kD AnkG-GFP shown in green, anti-neurofascin 
shown in red (scale bar 100um). (B), measurements of fluorescent intensity along the 
axons.  
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3.4 Discussion 
Here we demonstrate that AnkG is S-palmitoylated at cysteine 70 in MDCK cells, 
and that C70A mutation abolishes activity of AnkG in biogenesis of epithelial lateral 
membranes and assembly of the AIS in neurons. We also find that C70A mutation 
prevents association of AnkG with the plasma membrane of unpolarized MDCK cells.  
The C70A mutation is unlikely to result in loss of folding of AnkG since this residue is 
located in a predicted solvent-exposed loop of an ankyrin repeat (Figure 14A).  
Moreover, C70A mutation has no effect on interaction of AnkG with polarized MDCK 
cell lateral membranes or on interaction with E-cadherin or neurofascin.  Effects of C70A 
mutation therefore are consistent with requirement of S-palmitoylation for function of 
AnkG at epithelial lateral membranes and the AIS.  However, it is important to note that 
we cannot exclude other interpretations such as requirement of cysteine 70 for 
interaction with unidentified proteins. 
A critical step in developing the palmitoylation hypothesis will be to identify 
which of the 24 palmitoyl-transferases are responsible for modification of AnkG. These 
enzymes exhibit specific expression and localization patterns and determine protein 
subcellular targeting, protein stability and membrane micropatterning (Aicart-Ramos et 
al., 2011; Greaves and Chamberlain, 2010). C70 is conserved among three ankyrin 
isoforms and across vertebrate species as well as one of the Drosophila ankyrin genes 
(Figure 14B). Therefore, it will be important to evaluate palmitoylation of other ankyrin 
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members and to determine if there is a conserved palmitoylation-dependent targeting 
mechanism shared by the ankyrin family. 
FRAP measurements of WT AnkG-GFP motility on the lateral membrane in 
MDCK cells surprisingly shows a limited mobile fraction, which can be increased by 
30% upon loss of β2-spectrin interaction but not palmitoylation (Figure 17A, B).  The 
increased recovery with loss of spectrin binding is unlikely to result from plasma 
membrane-cytoplasm protein exchange, since WT AnkG-GFP reaches a steady plateau 
at only 40% fractional recovery. Our findings, for the first time, suggest the existence of 
membrane subdomains or compartments which may coordinate AnkG, β2-spectrin and 
probably other proteins. Those domains could play important roles in limiting AnkG 
dynamics on the lateral membrane. Even though the C70A mutation shows no effect on 
AnkG mobility, palmitoylation could be involved in organizing those subdomains.  
Interestingly, it has been reported that palmitoylated proteins are targeted to “lipid 
rafts” membrane subdomains (Delint-Ramirez et al., 2011; Fragoso et al., 2003; Linder 
and Deschenes, 2007). Furthermore, neurofascin, an AnkG binding partner, is 
palmitoylated at a site in the transmembrane domain conserved among the L1CAM 
family (Ren and Bennett, 1998).  It will be of interest to study how the doubly 
palmitoylated AnkG-neurofascin complexes alter the properties of membrane domains 
in neurons.  It also will be important in future experiments to directly visualize the 
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distribution of AnkG and other palmitoylated proteins at those membrane domains 
using high-resolution 3D microscopy. 
A striking finding that stimulated our discovery of S-palmitoylation of AnkG 
was the retention of AnkG at the plasma membrane of unpolarized MDCK cells grown 
in low calcium (Figure 12A).  AnkG is the only lateral membrane-associated protein that 
we are aware of that persists under low calcium conditions, and this behavior depends 
on C70 (Figure 15A, B). Residual AnkG is not associated with its partners β2-spectrin or 
E-cadherin, which are located in the cytoplasm, and may function as a template during 
reassembly of these proteins on the lateral membrane following restoration of calcium.  
It is tempting to speculate that residual AnkG remains membrane-associated through its 
C70-palmitate modification. In this case, lipid-based patterning of AnkG and other 
palmitoylated proteins may play important roles in determining lateral membrane 
identity.  
Interestingly, in Chapter 2 we found that fusion of the B-linker to the ANK 
repeat domain of ankyrin-G or ankyrin-B reduces their lateral membrane targeting. One 
explanation may be that B-linker interferes with S-palmitoylation, since protein S-
palmitoylation is mediated by a group of palmitoyltransferases, which can transiently 
associate with their substrates and transfer palmitic acids to target cysteine(s).  Another 
possibility is that palmitoylation follows association of ANK repeats with membrane 
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proteins. In this case, the B-linker prevents ANK repeat domains from binding to plasma 
membrane compartments where they are subsequently palmitoylated. 
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Chapter 4. Ankyrin-G Palmitoylation and βII-spectrin 
Binding to Phosphoinositides Drive Lateral Membrane 
Assembly 
4.1 Introduction 
A common organizational principle shared by the spectrin-ankyrin-based plasma 
membrane domains, as presented in reviews and cartoons, is straightforward: 
membrane-spanning proteins, including cell adhesion proteins capable of responding to 
extracellular cues as well as membrane transporters, are “anchored” within the fluid 
bilayer by association with ankyrin, which in turn is coupled to an extended spectrin-
actin network that is tightly associated with the plasma membrane. However, these 
protein-based models, while descriptive of steady state protein composition, do not 
provide an explanation for how membrane domains are actually assembled and 
precisely localized in cells.        
In Chapter 3, we found that ankyrin-G is S-palmitoylated at a conserved cysteine 
70, which is required for its function in assembling membrane domains, suggesting the 
essential roles of lipids in membrane domain assembly. Indeed, membrane lipids and 
lipid modifications play important roles in determining plasma membrane identity. For 
example, phosphoinositide lipids are increasingly recognized as critical determinants of 
plasma membrane organization in addition to their roles in intracellular organelles 
(Hammond et al., 2012; Johnson et al., 2012; Martin-Belmonte et al., 2007; Nakatsu et al., 
2012; Shewan et al., 2011). In addition, the aspartate-histidine-histidine-cysteine (DHHC) 
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family of 23 protein palmitoyltransferases, first discovered in yeast, now are known to 
function in vertebrates in targeting and trafficking of membrane proteins (Bartels et al., 
1999; Fukata et al., 2004; Fukata and Fukata, 2010; Greaves and Chamberlain, 2011; Roth 
et al., 2002). Beta-spectrins contain a pleckstrin homology domain with preference for 
phosphatidylinositol 4, 5-bisphosphate (PI(4,5)P2) (Das et al., 2008; Trave et al., 1995). 
Moreover, as described in the last chapter, different from any known polarized lateral 
membrane proteins, ankyrin-G remains on the plasma membrane of unpolarized MDCK 
cells through the palmitoylated cysteine 70 (Figure 11 and 15A), suggesting ankyrin-G as 
a candidate to function as a template to assemble lateral membranes. Together, these 
considerations suggest the membrane lipid environment and in particular 
phosphoinositides and protein palmitoylation, are likely to work in concert with 
ankyrin- and spectrin-based protein interactions in establishing and/or regulating 
membrane domains. 
In this Chapter, we identifies DHHC 5 and 8 as the only DHHC family members 
localized to the lateral membrane of MDCK cells and the two palmitoyltransferases 
responsible for palmitoylation and targeting of ankyrin-G. We also find that βII-spectrin 
requires binding to both ankyrin-G as well as phosphoinositide lipids in order to localize 
and function at lateral membranes. βII-spectrin thus operates as a co-incidence detector 
that ensures high spatial fidelity in its polarized targeting to the lateral membrane. 
Together these findings demonstrate a critical requirement of palmitoylation and 
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phosphoinositide recognition in addition to protein-protein interactions for precise 
assembly of ankyrin-G and βII-spectrin at the lateral membrane of epithelial cells. 
 
4.2 Methods and Materials  
Plasmids 
The 23 HA tagged mouse DHHC constructs were a kind gift from Dr. Masaki 
Fukata (National Institute for Physiological Sciences, Japan). DHHC5 was subcloned 
into peGFP-C1 vector using SacII and BamHI cut sites; DHHC8 was subcloned into 
peGFP-C1 vector using SalI and BamHI cut sites; DHHC14 was subcloned into peGFP-
N1 using HindIII and EcoRI cut sites. The wild type ankyrin-G-GFP and mutants C70A 
and DAR999AAA were previously described (Kizhatil et al., 2007b). The human βII-
spectrin cDNA was subcloned into peGFP-C3 vector using HindIII and SacII cut sites, 
the mutations Y1874A and K2207Q were introduced by mutagenesis. For βII-spectrin 
purification, a prescission protease site (LEVLFQGP) was introduced between the GFP 
and start codon. The pleckstrin homology domain of human βII-spectrin (PH domain: 
amino acids 2200-2305) was subcloned into peGFP-N1 using XhoI and SacII cut sites.  
Reagents and antibodies 
Palmitic Acid, [9,10-3H(N)] (PerkinElmer); N-Ethylmaleimide and 
hydroxylamine (Sigma); EZ-Link BMCC-Biotin, 1-Biotinamido-4-[4 -´
(maleimidomethyl)cyclohexanecarboxamido]butane (Thermo Scientific); Dynabeads 
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with protein-G and Lipofectamine 2000 transfection reagent (Invitrogen); QuikChange II 
XL Site-Directed Mutagenesis Kit (Agilent Technologies). Mouse α-HA monoclonal 
antibody (Santa Cruz); rabbit α-GFP polyclonal antibody (lab generated); chicken α-GFP 
polyclonal antibody, rat α-E-cadherin monoclonal antibody (Abcam); rabbit α-ankyrin-
G polyclonal antibody (lab generated using the C terminal domain as epitope); rabbit α-
biotin polyclonal antibody, rabbit α-DHHC5 polyclonal antibody, rabbit α-DHHC8 
polyclonal antibody (Abcam); mouse α-GAPDH monoclonal antibody (sigma); mouse α-
ZO-1 monoclonal antibody (Invitrogen). 
Metabolic radiolabeling 
This assay was performed following the protocol previously described with a 
few modifications (Fukata et al., 2006). In brief, 106 HEK293T cells were plated in the 6-
well plates and transfected with 2μg HA-DHHC plasmids plus 3μg ankyrin-G-GFP 
plasmids. 20 hours after transfection, the cells were incubated with DMEM 
supplemented with 5% dialyzed FBS for 1 hour, then [3H]palmitic acid was added to the 
final concentration of 200μCi/ml. After 4 hours incubation, the cells were washed with 
PBS and lysed directly using 0.5ml SDS-PAGE buffer (62.5mM Tris–HCl pH 6.8, 10% 
glycerol, 2% SDS, 0.001% bromophenol blue and 10mM DTT) and heated for 5 minutes 
at 70oC. The proteins were separated in 3.5%-17.5% gradient polyacrylamide gels. For 
western blotting, samples were transferred onto nitrocellulose membrane and probed 
with α-GFP, or α-HA antibody. For autoradiography, the gels were treated with amplify 
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fluorographic reagent, dried using cellophane membrane and exposed to X-ray film at -
80oC. 
Generation of doxycycline-inducible shRNA MDCK cell lines 
The original pLKO-Tet-on lentiviral vector (Addgene) was modified by 
replacement of the puromycin resistant gene with fluorescent TagBFP, and the IRES 
(internal ribosome entry site) with P2A peptide (GSGATNFSLLKQAGDVEENPGP), 
which mediates co-translational cleavage. After cloning the shRNA hairpin targeting 
genes of interest to the vector, lentivirus was generated following standard protocol 
(Wiederschain et al., 2009). On the day of infection, 0.5-1×106 MDCK cells were mixed 
with virus and 8μg/ml polybrene and plated in 6-well dishes. 16 hours later, the cells 
were extensively washed to remove viral particles and then grown in DMEM, 10% FBS. 
The next day, cells were trypsinized and sorted for the brightest TagBFP population 
(~1%), which can be maintained as a stable cell line. Hairpins used to target genes of 
interest: luciferase control (ggagatcgaatcttaatgtgc); dog ankyrin-G 
(gctagaagtagctaatctcct); dog βII-spectrin (ggtgctattactatctcaaga); dog DHHC5 
(gtgtcagatgggcagataact); dog DHHC8 (acctgtccaggaccatcatgg); dog DHHC5/8 
(tgggtgaacaactgtatcg). 
rtPCR  
To examine the native transcription of DHHC5 and DHHC8 in MDCK cells, total 
RNA was isolated using standard TRIzol-based protocol, and cDNA was generated 
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using SuperScript®  III First-Strand Synthesis System (Life technology). Primers used for 
gene amplification:  dog GAPDH (F: ggtgatgctggtgctgagtatgttg; R: 
agtggaagcagggatgatgttctgg); dog DHHC5 (F: ggaggatgaagacaaggaagatgac; R: 
gctacagggatgaagaataagccag); dog DHHC8 (F: gatgaggacgaggataaggaggac; R: 
gatgacagggatgaagaagaggc). 
Acyl-biotin exchange assay 
This assay was described in the last chapter. Briefly, Luc-, DHHC5-, DHHC8- or 
DHHC5/8-shRNA cells were induced by 4μg/ml doxycycline for 3 days and then 
homogenized in the presence of 50mM N-Ethylmaleimide. 1% SDS was added to the 
lysates to increase ankyrin-G solubility. After sonication and centrifugation, Triton X-100 
was added to a final concentration of 1% (v/v) to quench SDS. 60 μl of dynabeads 
preloaded with 10μg α-ankyrin-G antibody were then incubated with the lysates 
overnight. The beads were then washed and incubated with hydrolysis-labeling buffer 
(1M hydroxylamine/Tris as a control, 80μM biotin-BMCC, 10mM sodium phosphate, 
2mM NaEDTA, pH=7) at room temperature for 2 hours. Beads were then washed and 
incubated with  loading buffer (2% SDS, 10% glycerol, 40mM Tris-HCl, 150mM NaCl, 
2mM NaEDTA, 200mM DTT with bromophenol blue). Samples were analyzed by SDS-
PAGE and probed by immunoblotting with α-ankyrin-G or α-biotin antibodies. The 
total cell lysates were also collected and analyzed to confirm the knockdown efficiency 
of DHHC5 and 8. 
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Transfection and Immunofluorescence 
To examine the subcellular localization of the 23 DHHC palmitoyltransferases, 
1×105 MDCK cells were plated in the insert of MatTek plates. The next day, cells were 
transfected with 80ng plasmids encoding HA- or GFP-DHHC using Lipofectamine. 48 
hours later, the cells were fixed by 4% paraformaldehyde for 15 minutes, permeabilized 
by 0.4% Triton-X100 for 10 minutes, blocked by 5% BSA, and incubated with primary 
antibody overnight at 4oC. Alexa Fluor 488, 568 were used for secondary antibody. To 
study the localization of ankyrin-G after silencing DHHC5, DHHC8 or DHHC5/8, cells 
were induced by 4μg/ml doxycycline for one day and then re-plated on MatTek plates in 
the presence of doxycycline for another 2 days before fixation. Parallel samples were 
collected for western blotting to study ankyrin-G levels.  
Calcium switch assay and lateral membrane re-assembly 
The calcium switch assay was described in the last chapter. Here we used this 
assay to study lateral membrane re-assembly. Luc-, Ankyrin-G- or DHHC5/8-shRNA 
cells were induced by 4 μg/ml doxycycline for 3 days, then trypsinized and plated in 
calcium-depleted medium (DMEM, 5% dialyzed FBS, 4 μg/ml doxycycline, 106 cells in 
MatTek plates). The next day, washed the plates slightly to remove un-attached cells and 
then switched to regular medium (DMEM, 10% FBS, 4 μg/ml doxycycline). Cells were 
then fixed at different time points (2 hours, 4 hours, 8 hours, 16 hours and 24 hours). To 
examine the localization of transfected GFP-DHHC5 and 8 in unpolarized MDCK cells, 
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100ng DNA was transfected into MDCK cells following standard protocol. 6 hours later, 
the cells were trypsinized and re-plated in calcium-depleted medium and kept for 24 
hours before fixation. 
Lateral membrane rescue 
107 Ankyrin-G-shRNA or βII-spectrin-shRNA cells were induced in 10cm dishes 
in the presence of 4 μg/ml doxycycline for 16 hours. Then 1.5×105 pre-induced cells were 
re-plated in MatTek plates. 8 hours later, cells were washed and transfected them with 
100ng rescue plasmids (GFP, Ankyrin-G-GFP or GFP-βII-spectrin) using the standard 
protocol. Cells were maintained in 4 μg/ml doxycycline and fixed 48 hours after 
transfection. 
Microscopy 
Imaging for fixed samples was performed at room temperature using a Zeiss 
LSM780 confocal microscope with either a 63×, NA 1.40 or 100×, NA 1.45 objective lens. 
Secondary antibodies were conjugated with Alexa fluor 488, 568 or 647. XZ planes were 
reconstructed from Z stacks with optical sections of 250nm using ZEN 2012 software. 
For live imaging, the incubation chamber was maintained at 37oC, 5% CO2, and cells 
were maintained in growth medium (DMEM, 10% FBS). For 3D deconvolution 
microscopy, images were collected at room temperature using the 100×, NA 1.45 
objective lens with optical sections of 250nm, and subjected to 3D deconvolution in 
Volocity 3D Image Analysis Software (PerkinElmer) with a point spread function (Axial 
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Spacing In Z: 0.25 µm, Lateral Spacing In X-Y: 0.0277 µm, Medium Ref. Index: 1.52, 
Numerical Aperture: 1.45, Detector Pinhole Size: 1 Airy unit(s)). 
Expression and purification of βII-spectrin: 
βII-spectrin was cloned into peGFP-C3 along with a prescission protease site 
(LEVLFQGP) between the GFP and ATG of βII-spectrin. Mutations were made into the 
βII-spectrin sequence using site-directed mutagenesis (Stratagene). WT-βII-spectrin and 
mutants were transfected into 293T17 cells in 10 cm dishes using lipofectamine 
(Invitrogen). After 36 hours lysates were produced from each transfection and GFP-βII-
spectrin was isolated using a rabbit anti-GFP antibody and pulled down using protein-G 
dynabeads (Invitrogen). After extensive washing using high salt and TritonX-100, βII-
spectrin was released from dynabeads using prescission protease enzyme (GE Life 
Sciences).  
Ankyrin-G-βII-spectrin binding assay 
His-tagged ankyrin-G expressed in S9 cells was purified as previously described 
(Kizhatil et al., 2007a). GFP-βII-spectrin WT and GFP-βII-spectrin Y1874A expressed and 
purified from HEK293 cells were immobilized using antibody against GFP on protein-G 
dynabeads and increasing concentrations of ankyrin-G-His were added to a final 
reaction volume of 200μl in binding buffer (10 mM sodium phosphate, 75 mM NaCl, 
1mM DTT, 1mM EDTA, 5% sucrose and 4% BSA, pH 7.3). Bound and free ankyrin-G-
His were separated by pelleting beads through a 20% sucrose cushion. The amount of 
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bound ankyrin-G-His was determined through immunoblotting with α-His antibody 
followed by phosphor image analysis. Data points were generated after normalization 
for βII-spectrin levels and nonspecific binding of ankyrin-G.  
Fluorescence recovery after photobleaching 
300ng plasmids encoding GFP-βII-spectrin WT or Y1874A were transfected into 
βII-spectrin-silenced MDCK cells as described above. The GFP signals were collected 
every 5 seconds for a 3-minute period, at each time point three regions were monitored: 
region 1 is the photobleached membrane area; region 2 is a membrane area of an 
adjacent transfected cell, which can be used to control the signal variability; region 3 is a 
non-transfected cell region, which is used to correct the background noise. The signal 
from region 1 was double-normalized to that from region 2 and 3, and then fitted to the 
exponential equation . 
Phosphatidylinositol binding assay  
We purchased phosphatidylinositol labeled liposomes that contained a biotin tag 
from Echelon Biosciences. Liposomes for PIP2(3,4), PIP2(4,5), PIP3(3,4,5) and 
PIPN(control) were used at 10 μM concentration and incubated with purified βII-
spectrin WT and βII-spectrin K2207Q in interaction buffer (50 mM Tris, 100 mM NaCl, 
1mM DTT, 5% sucrose and 3% fatty-acid free BSA, pH 7.4). Bound βII-spectrin was 
separated from free βII-spectrin through pull down of liposomes using streptavidin-
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labeled dynabeads. Levels of protein binding were determined by immunoblotting 
using α-βII-spectrin antibody and quantified through phosphor imager. 
Data analysis 
ImageJ was used to measure the fluorescence intensity of confocal microscopy 
images, and a typhoon-9200 phosphor imager and Imagequant software were used to 
quantify the intensity of western blots. Student’s t-test was used to analyze two-group 
comparison, and one-way ANOVA followed by Tukey’s tests were used to perform 
multiple group comparison. The tests were performed using GraphPad Prism 5 
software.  
 
4.3 Results 
4.3.1 DHHC5 and 8 are the physiological ankyrin-G palmitoyl-
transferases in MDCK cells. 
We previously demonstrated that cysteine 70 of ankyrin-G is palmitoylated, and 
is required for ankyrin-G function in formation of epithelial lateral membranes of 
MDCK cells as well as axon initial segments of hippocampal neurons (He et al., 2012). 
We next sought to identify the palmitoyltransferase(s) responsible for modifying 
ankyrin-G. A screening assay using metabolic labeling with tritiated-palmitate in cells 
co-transfected with substrate and individual member of the DHHC family of 23 
palmitoyltransferases has been widely used to determine enzyme specificity 
(Fernandez-Hernando et al., 2006; Fukata et al., 2004; Fukata et al., 2006; Iwanaga et al., 
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2009; Tsutsumi et al., 2009). Using this assay in HEK 293T cells, we observed a dramatic 
increase of palmitoylation of ankyrin-G-GFP when co-expressed with either DHHC5 or 
DHHC8, but not with the other 21 DHHC family members (Figure 21A). 
A phylogenetic comparison of the 23 mouse DHHC proteins shows that DHHC5 
and DHHC8 are closely related (Figure 21B). DHHC5 and DHHC8 use GRIP1b as a 
substrate in neurons and play critical roles in regulating AMPA-R trafficking (Thomas et 
al., 2012). Additionally, DHHC5 also directly palmitoylates flotillin-2 and is required for 
flotillin-2 oligomerization (Li et al., 2012). However, no study has characterized the 
biological functions of DHHC5 and 8 palmitoyltransferases in epithelial cells.  
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Figure 21: Ankyrin-G is palmitoylated by palmitoyltransferases DHHC5 and 
DHHC8. 
(A) DHHC5 and DHHC8 increase the palmitoylation level of ankyrin-G. Ankyrin-G-
GFP was co-transfected into HEK293 cells with each of the 23 HA-DHHC. After 
metabolic labeling with [3H]-palmitic acid, cells were lysed and analyzed by SDS-PAGE. 
(Top) the expression level of ankyrin-G-GFP probed by α-GFP antibody; (middle) 
autoradiograph showing the extent of protein labeling in cell extracts; (bottom) the 
expression level of the co-transfected HA-DHHC probed by α-HA antibody. (B) The 
phylogenetic tree of the 23 mouse DHHC shows that DHHC5 and DHHC8 are closely 
related. 
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We next asked where DHHC5 and 8 are localized in MDCK cells, and whether 
these particular palmitoyltransferases exhibit a distinct pattern compared to the other 21 
DHHC family members. Tagged DHHC proteins exhibit specific localization patterns in 
non-polarized HEK 293T cells (Ohno et al., 2006). However, the localization of DHHC 
proteins in epithelial cells has not been reported. 20 of the HA-DHHC constructs 
transfected into MDCK cells localized to intracellular compartments, most likely the 
Golgi/ER network as previously described (Ohno et al., 2006). However, DHHC5, 
DHHC8 and DHHC14 predominantly localized to the plasma membrane when viewed 
in XY sections (Figure 22A). The plasma membrane localization of DHHC8 and 
DHHC14 in MDCK cells was unexpected since these proteins are primarily intracellular 
in HEK 293T cells (Ohno et al., 2006). 3D confocal imaging in MDCK cells revealed that 
DHHC5 and DHHC8 are polarized and confined to the lateral membrane together with 
ankyrin-G (Figure 22B, 22C). DHHC14, in contrast to DHHC 5 and 8, localizes equally to 
both lateral and apical membranes (Figure 22D). DHHC5 and 8 thus are the only family 
members that co-localize with ankyrin-G on the lateral membranes of MDCK cells. 
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Figure 22: DHHC5 and DHHC8 colocalize with ankyrin-G at lateral 
membranes of MDCK cells. 
(A) HA-DHHC family members target to different membrane structures. HA-DHHC 1-
23 were expressed separately in MDCK cells, and visualized by immunofluorescence 
(red, α-HA; blue, DAPI). HA-DHHC5, 8 and 14 are primarily localized to the plasma 
membrane, while the others exist in intracellular compartments. Scale bar, 10 μm. (B, C 
and D) GFP tagged DHHC5, 8 and 14 were transfected into MDCK cells, after achieving 
complete polarization, the cells were fixed for immunofluorescence (green, α-GFP; red, 
α-ankyrin-G), the XZ planes were reconstructed from confocal Z-stacks. Scale bar, 10μm. 
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A critical test of whether ankyrin-G is a physiological substrate for DHHC5 and 8 
was to determine if knockdown of these enzymes resulted in loss of ankyrin-G 
palmitoylation. We first confirmed that both DHHC5 and DHHC8 are natively 
transcribed in cultured MDCK cells using RT-PCR (Figure 23A). Then we developed a 
cell-sorting strategy for generating doxycycline-inducible shRNA stable cell lines in 
order to study effects of knockdown of DHHC 5 and 8, either separately or together. We 
modified the single lentiviral vector Tet-inducible shRNA system (pLKO-Tet-On) 
(Wiederschain et al., 2009) in two ways: 1. The puromycin resistance gene was replaced 
with DNA encoding the fluorescent protein TagBFP (excite 402; emit 457) to allow 
fluorescent cell sorting without interfering with other fluorescent tags such as GFP or 
mCherry;  2. The internal ribosome entry site (IRES) was replaced with a 2A “self-
splicing” peptide linker to ensure that stimulation of shRNA expression also efficiently 
stimulated expression of TagBFP (Figure 23B). Through cell sorting, we were able to 
select a small population of MDCK cells with similar high levels of shRNA expression 
(Figure 23C). 
DHHC5 and DHHC8 genes of Canis lupus familiaris share identical genomic 
sequences in multiple regions, which allow individual knockdown as well as selection of 
a single hairpin simultaneously targeting both genes in MDCK cells. An acyl-biotin 
exchange assay was used to assess ankyrin-G palmitoylation (Drisdel et al., 2006). Single 
knockdown of either DHHC5 or DHHC8 had no effect on palmitoylation of ankyrin-G 
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(Figure 23D, E, F and J). However, silencing both DHHC5 and DHHC8 markedly 
reduced ankyrin-G palmitoylation (Figure 23G, H, I and J). In summary, DHHC 5 and 8 
are the physiological palmitoyltransferases responsible for palmitoylating ankyrin-G in 
MDCK cells based on their unique behavior compared to the other 21 DHHC family 
members in palmitoylating ankyrin-G in heterologous cells, their co-localization with 
ankyrin-G at the lateral membranes of MDCK cells, as well as loss of ankyrin-G 
palmitoylation following their knockdown in MDCK cells.   
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Figure 23: DHHC5 and DHHC8 exhibit functional redundancy in 
palmitoylation of ankyrin-G. 
(A) The rtPCR shows that both DHHC5 and 8 are natively transcribed in MDCK cells. (B 
and C) The cell sorting based strategy for making inducible shRNA cell lines. (D, E and 
F) Single knockdown of DHHC5 or DHHC8 shows no reduction of ankyrin-G 
palmitoylation. Endogenous ankyrin-G was immunoprecipitated and analyzed using 
acyl biotin exchange assay (D). The silencing efficiency of DHHC5 (E) or DHHC8 (F) 
was also verified. Luc is a control cell line which targets the luciferase gene. (G, H and I) 
Double knockdown of DHHC 5 and 8 causes significant reduction of ankyrin-G 
palmitoylation. (J) Quantification of the normalized ankyrin-G palmitoylation level, 
mean±SEM. Results were analyzed using one-way ANOVA and Tukey’s tests, p<0.001, 
n=3-5. 
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4.3.2 DHHC5/8 double knockdown phenocopies loss of ankyrin-G in 
MDCK cells 
We next examined effects of knockdown of DHHC5 and 8 on subcellular 
localization of endogenous ankyrin-G and on cell height. In the DHHC5/8 double 
knockdown cells, ankyrin-G staining spread from the plasma membrane to the cytosol, 
in contrast to the single knockdown or control cells where ankyrin-G was confined to the 
lateral membrane (Figure 24A and 24D). Residual ankyrin-G staining remaining on the 
lateral membrane may result from residual palmitoylation which was only 90 percent 
complete, and/or interaction with E-cadherin and/or βII-spectrin. In addition, 110 and 
120 kDa cross-reacting polypeptides (Figure 24B) likely resulting from alternative 
splicing lack ANK repeats and are not subject to palmitoylation (He et al., 2012; Hoock et 
al., 1997; Peters et al., 1995). The loss of membrane staining was not caused by reduction 
of ankyrin-G expression level based on immunoblots of control and DHHC5/8 double 
knockdown cells (Figure 24B and C). Interestingly, the DHHC5/8 double knockdown 
cell monolayer exhibited a markedly reduced lateral membrane height (Figure 24A, the 
XZ plane; 24E), thus phenocopying loss of ankyrin-G (Kizhatil and Bennett, 2004; 
Kizhatil et al., 2007b). This result is consistent with previous findings that ankyrin-G 
requires its palmitoylated cysteine 70 to restore the lateral membrane in ankyrin-G-
depleted MDCK cells (He et al., 2012). 
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Figure 24: Double knockdown of DHHC5 and 8 in MDCK cells causes 
disassociation of ankyrin-G from the plasma membrane and reduces lateral 
membrane height. 
(A) The inducible shRNA cell lines were treated with doxycycline to knockdown 
indicated genes, and then fixed for immunofluorescence (green, α-ankyrin-G; white, α-
ZO-1). The profiles represent the α-ankyrin-G fluorescence intensities across the regions 
of interest indicated by the white arrows. Scale bar, 10μm. (B) Representative western 
blot showing ankyrin-G levels after silencing DHHC5 and 8. (C) Quantification of the 
normalized ankyrin-G level in DHHC5/8-silenced cells, mean±SEM, student’s t-test, 
p=0.8, n=4. (D) Quantification of the α-ankyrin-G fluorescence intensity ratio of plasma 
membrane to cytosol. Results were analyzed using one-way ANOVA and Tukey’s tests, 
p<0.001, n=47-53. (E) Quantification of the lateral membrane height. Results were 
analyzed using one-way ANOVA and Tukey’s tests, p<0.001, n=47-53. 
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MDCK cells require millimolar concentrations of calcium to achieve apical-
basolateral polarity, and reversibly lose their polarity when transferred to a low calcium 
medium (Martinez-Palomo et al., 1980). We previously reported that ankyrin-G remains 
on the plasma membrane in un-polarized MDCK cells exposed to low calcium, while its 
binding partners E-cadherin and βII-spectrin re-locate to intracellular sites (Figure 25A. 
(He et al., 2012)). In contrast, C70A ankyrin-G mutant, which is resistant to 
palmitoylation, also exhibited loss of plasma membrane staining in un-polarized MDCK 
cells (He et al., 2012). Under the same low calcium condition, DHHC5 and DHHC8 
remain localized to the plasma membrane together with ankyrin-G (Figure 25B). 
Moreover, double knockdown of DHHC5 and 8 abolished the plasma membrane 
localization of ankyrin-G in un-polarized MDCK cells (Figure 25C). These results 
together with loss of membrane association by the C70A ankyrin-G mutant demonstrate 
that palmitoylation of ankyrin-G by DHHC5/8 drives its association with the plasma 
membrane in un-polarized MDCK cells.  
We next compared effects of knockdown of either DHHC5/8 or 210 kDa ankyrin-
G on lateral membrane re-assembly following restoration of calcium. Control cells (Luc-
shRNA) experienced rapid biosynthesis of the lateral membrane, and grew from about 2 
to 8 microns in height within 24 hours. In contrast, cells depleted of either 210 kDa 
ankyrin-G or DHHC5/8 failed to restore lateral membrane height and grew from 2 to 
only 3 microns over the same period (Figure 25D and E) (see Figure 26 for extent of 210 
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kDa ankyrin-G knockdown). However, loss of 210 kDa ankyrin-G or DHHC5/8 did not 
affect the establishment of cell polarity, indicated by unaltered tight junction staining for 
ZO-1 and lateral membrane staining for E-cadherin (Figure 25D). Cells depleted of either 
ankyrin-G or DHHC5/8 still maintained a residual lateral membrane of about 3μm. The 
remaining lateral membrane may result from incomplete knockdown as detectable 
levels of ankyrin-G as well as DHHC5/8 persist in shRNA-expressing cells (Figure 23, 
26). Alternatively, the residual height of 2-3 microns may represent lateral membrane 
that is independent of the ankyrin-G-DHHC5/8 pathway. 
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Figure 25: DHHC5/8 and ankyrin-G are required for lateral membrane re-
assembly following calcium switch. 
(A) Ankyrin-G persists on the plasma membrane in unpolarized MDCK cells. Polarized 
MDCK cells (Polarized) were trypsinized and grown in Ca2+-depleted medium for 24 
hours before fixation (-Ca2+), or switched back to regular medium for another 24 hours 
(+Ca2+). Samples were stained against Ankyrin-G, ZO-1, E-cadherin or βII-spectrin. 
Scale bar, 10μm. (B) GFP-DHHC5 and 8 colocalize with ankyrin-G in unpolarized 
MDCK cells (green, α-GFP; red, α-ankyrin-G), scale bar, 10μm. (C) DHHC5/8-silenced 
cells or control cells (Luc-shRNA) were plated in Ca2+-depleted medium, and fixed to 
stain against endogenous ankyrin-G, scale bar, 10μm. (D) DHHC5/8 or ankyrin-G-
silenced cells fail to re-assemble the lateral membrane following calcium switch. Luc-
shRNA, Ankyrin-G-shRNA and DHHC5/8-shRNA cells were induced by doxycycline to 
knockdown indicated genes, and then plated in Ca2+-depleted medium. 24 hours later, 
cells were switched back to regular medium and fixed at different time points, 2 hours, 4 
hours, 8 hours, 16 hours and 24 hours (green, α-E-cadherin; white, α-ZO-1), scale bar, 
10μm. (E) Quantification of the lateral membrane heights, mean±SEM, n=17-31. 
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4.3.3 βII-spectrin requires both ankyrin-G and phosphoinositides for 
lateral membrane targeting 
Results so far demonstrate that palmitoylation of ankyrin-G by DHHC5/8 is 
required for targeting ankyrin-G to the lateral membrane as well as for re-assembly of 
the lateral membrane following restoration of calcium to un-polarized MDCK cells. We 
next addressed the role of ankyrin-G in targeting βII-spectrin to the lateral membrane. 
βII-spectrin potentially can associate with plasma membranes either through its ankyrin-
binding site (Davis et al., 2009; Ipsaro et al., 2009), and/or through a pleckstrin homology 
(PH) domain that preferentially binds to PI(4,5)P2 (Das et al., 2006; Das et al., 2008; 
Hyvonen et al., 1995; Wang et al., 1996; Wang and Shaw, 1995). Analysis of epistatic 
relationships between β-spectrin and the two ankyrin genes in Drosophila indicate cell 
type-specific variations in utilization of PH domains and ankyrin-binding activities (Das 
et al., 2006; Das et al., 2008; Garbe et al., 2007; Mazock et al., 2010). We therefore wanted 
to determine how βII-spectrin assembles on the lateral membrane in MDCK cells.   
We faced technical challenges in imaging endogenous βII-spectrin and ankyrin-G 
polypeptides. βII-spectrin antibodies prepared from two different sets of rabbits 
recognized a large portion of intracellular structures and reacted weakly with the lateral 
membrane. We do not believe these antibodies accurately represent the localization of 
endogenous βII-spectrin for the following reasons. GFP-tagged βII-spectrin, which is 
biologically active since it rescues the loss of lateral membrane height in βII-spectrin 
knockdown cells, localizes almost entirely to the lateral membrane in cells depleted of 
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native βII-spectrin (not shown), whether viewed by live imaging  or in fixed cells using 
antibodies against GFP (Figure 27). Antibodies against ankyrin-G recognize a major 210 
kDa polypeptide as well as 110 and 120 kDa polypeptides that are likely alternatively 
spliced variants lacking ANK repeats (Figure 26) (Peters et al., 1995; Hoock et al., 1997). 
110 and 120 kDa polypeptides were not depleted by shRNA directed against the ANK 
repeat region (Figure 26). In order to avoid problems with βII-spectrin antibodies and 
complications due to multiple ankyrin-G alternative spliced variants, we therefore 
adopted the strategy of knockdown of endogenous 210 kDa ankyrin-G or βII-spectrin 
and replacement with GFP-tagged proteins as described next. 
We addressed the contributions of spectrin-ankyrin and spectrin-
phosphoinositide interactions in MDCK cells by evaluating mutations of ankyrin-G that 
abolish its binding to βII-spectrin, and mutations of βII-spectrin that abolish either its 
binding to either ankyrin or to phosphoinositides. In each set of experiments, native 210 
kDa ankyrin-G or βII-spectrin were knocked down and replaced with either GFP-tagged 
wildtype or mutated proteins. GFP-tagged proteins were visualized either using the 
same antibody against GFP, or by live imaging of native GFP fluorescence. This 
approach circumvented the problems with antibodies against βII-spectrin as well as 
complications due to alternatively spliced variants of ankyrin-G noted above. We 
utilized the same approach of doxycycline-inducible knockdown as employed with 
DHHC5 and 8 (see above; (Figure 23)) to achieve inducible loss of 80-90 percent of native 
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210 kDa ankyrin-G or βII-spectrin (Figures 26, 27). Cells induced for shRNA expression 
were subsequently transfected within 24 hours with GFP-tagged 190 kDa ankyrin-G or 
βII-spectrin (Methods). 190 kDa ankyrin-G and the native 210 kDa ankyrin-G differ in 
that 210 kDa ankyrin-G contains additional residues in the C-terminal regulatory 
domain (WeiChou Tseng and Vann Bennett, unpublished data). However, 190 and 210 
kD ankyrin-G do not exhibit any difference in localization or ability to restore the lateral 
membrane in MDCK cells. 
DAR999AAA mutation of ankyrin-G at surface residues of its ZU5N domain 
abolishes its binding to spectrin without affecting ankyrin-G expression levels (Ipsaro et 
al., 2009; Ipsaro and Mondragon, 2010; Kizhatil et al., 2007b). DAR999AAA ankyrin-G 
lost activity in restoring the lateral membrane in ankyrin-G-silenced cells (Kizhatil et al., 
2007b) (Figure 26A and 26B). However, DAR999AAA ankyrin-G still maintained its 
polarized localization at the residual lateral membrane, presumably due to 
palmitoylation and/or interaction with E-cadherin (Figure 26B).  Ankyrin-G thus does 
not require βII-spectrin for targeting to the lateral membrane.  
Mutation of a highly conserved tyrosine located in a surface-exposed loop within 
the 15th repeat of β-spectrins disrupts their interaction with ankyrins (Ipsaro et al., 2009; 
Ipsaro and Mondragon, 2010; Kizhatil et al., 2007b) (Figure 25f). We confirmed that the 
Y1874A mutation increased the dissociation constant of βII-spectrin for ankyrin-G from 
10-20nM to greater than 200nM, and thus reduced the affinity by at least 8 fold (Figure 
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26F and G). Y1874A βII-spectrin associated equally with both apical and lateral 
membranes and thus completely lost polarity (Figure 26C and D). Y1874A βII-spectrin 
also failed to restore the lateral membrane height (Figure 26C and D). The non-polarized 
plasma membrane association of Y1874A βII-spectrin is likely due to its PH domain, 
since the βII-spectrin PH domain fused to GFP also associates generically with all 
plasma membrane surfaces (Figure 27D).  
We performed fluorescence recovery after photobleaching (FRAP) experiments 
to examine whether loss of ankyrin-G interaction affects higher-order assembly of βII-
spectrin into stabilized structures. Indeed, the Y1874A GFP-βII-spectrin exhibited a 
marked increase in dynamics on the lateral membrane compared to the WT GFP-βII-
spectrin (Figure 26H), affecting both the extent of recovery (55% for WT, 86% for 
Y1874A) and half-time required for recovery (36s for WT, 17s for Y1874A). These results 
indicate that βII-spectrin depends on ankyrin-G for its localization and function in 
MDCK cells.   
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Figure 26: Ankyrin-G determines the polarized recruitment of βII-spectrin to 
the lateral membrane. 
(A) ankyrin-G knockdown efficiency. (B) Ankyrin-G-silenced cells were rescued by GFP, 
WT Ankyrin-G-GFP or DAR999AAA Ankyrin-G-GFP (green, α-GFP; white, α-ZO-1). 
Scale bar, 10μm. (C) βII-spectrin knockdown efficiency. (D) ΒII-spectrin-silenced cells 
were rescued by GFP, GFP-βII-spectrin WT or GFP-βII-spectrin Y1874A (green, α-GFP; 
white, α-ZO-1). Scale bar, 10μm. (E) GFP-βII-spectrin construct with precision protease 
site. (F) βII-spectrin’s ankyrin-binding domain, residue Y1874 is highlighted in yellow. 
(G) The protein binding curve of ankyrin-G with WT βII-spectrin or the Y1874A mutant. 
(H) The fluorescence recovery after photobleaching (FRAP) showing the dynamics of 
GFP tagged WT βII-spectrin or the Y1874A mutant on the lateral membrane, n=8-11. 
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We also confirmed the finding that in MDCK cells βII-spectrin requires ankyrin-
G to be polarized at the lateral membrane by examining endogenous proteins. In βII-
spectrin knockdown cell, ankyrin-G still localized at the lateral membrane, though the 
height was significantly reduced. However, in ankyrin-G knockdown cells, βII-spectrin 
was mislocalized to the apical surface (Figure 27).  
 
Figure 27: Knockdown of ankyrin-G causes apical mislocalization of βII-
spectrin. 
 
We next addressed the role of phosphoinositide recognition by the PH domain of 
βII-spectrin. Basic residues in the pleckstrin homology domain of β-spectrin required for 
binding to inositol (1,4,5) P3 have been identified using NMR and other methods 
(Hyvonen et al., 1995; Rameh et al., 1997). Moreover, mutation of a basic PH domain 
residue eliminated binding of Drosophila β-spectrin to PI(4,5)P2 (Das et al., 2008). We 
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confirmed that K2207Q mutation in the PH domain of βII-spectrin abolished binding 
affinity for phosphoinositides based on loss of interaction with lipid strips and 
liposomes containing various phosphoinositide lipids (Figure 28C). WT βII-spectrin also 
associated weakly with PI(3,4)P2 and PI(3,4,5)P3 in addition to PI(4,5)P2, but these 
interactions were also eliminated by the K2207Q mutation. 
The K2207Q βII-spectrin mutant exhibited a striking loss of association with the 
plasma membrane and remained intracellular (Figure 28E). The K2207Q βII-spectrin 
mutant also failed to restore the lateral membrane height (Figure 28E and F). This 
complete loss of plasma membrane targeting by K2207Q βII-spectrin that still retains 
ankyrin-G binding site is not consistent with a simple linear assembly pathway. Instead, 
βII-spectrin association with ankyrin-G on the lateral membrane is somehow coupled to 
interactions of its PH domain with phosphoinositide lipids. The dual requirement of βII-
spectrin for both ankyrin and phosphoinositide lipids may explain some of the 
complexity noted in earlier analysis of relationships between ankyrins and spectrin in 
Drosophila (Das et al., 2008).   
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Figure 28: βII-spectrin targets to the plasma membrane through its pleckstrin 
homology domain by binding to PI (4,5)P2. 
(A) The schematic diagram of GFP-βII-spectrin K2207Q. (B) The atomic structure of the 
pleckstrin homology domain (PHD), the key residue required for phosphoinositides 
binding is highlighted in yellow. (C) The blots and quantification show the binding 
affinity of isolated WT βII-spectrin or K2207Q mutant to different phosphatidylinositol 
labeled liposomes (PI(3,4)P2, PI(4,5)P2, PI(3,4,5)P3 and PIPN(control)). (D) The 
pleckstrin homology domain (PHD) of βII-spectrin is sufficient to target to the plasma 
membrane. (Top) the XZ plane, (bottom) the XY plane. Scale bar, 10μm. (E) GFP-βII-
spectrin K2207Q fails to target to the plasma membrane or restore the lateral membrane. 
ΒII-spectrin-silenced cells were rescued by GFP-βII-spectrin WT or GFP-βII-spectrin 
K2207Q (green, α-GFP; white, α-ZO-1), (top) the XZ plane, (bottom) the XY plane. Scale 
bar, 10μm. (F) Quantification of lateral membrane heights rescued by WT, Y1874A or 
K2207Q GFP-βII-spectrin. Results were analyzed using one-way ANOVA and Tukey’s 
tests, p<0.001, n=27-35. 
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4.3.4 DHHC5/8, ankyrin-G, and βII-spectrin co-localize in micron-scale 
membrane subdomains 
We next examined the spatial relationships between DHHC5/8, ankyrin-G, and 
βII-spectrin in the lateral plasma membrane using 3D deconvolution to improve 
resolution of confocal microscopy (Biggs, 2010; Santangelo et al., 2009; Sibarita, 2005). To 
evaluate DHHC5/8 and native ankyrin-G at steady state, MDCK cells were transfected 
with GFP-DHHC5 or 8, fixed, and co-stained with antibodies against GFP and ankyrin-
G. After 3D restoration and deconvolution of a selected lateral membrane region, we 
observed subdomains containing DHHC5/8 or ankyrin-G that ranged in size from 0.5-2 
square microns (Figure 29A, top two panels).  A substantial population of DHHC5 and 8 
are co-patterned into ankyrin-G-positive microdomains based on Pearson coefficients of 
0.7 for DHHC5/ankyrin-G, and 0.6 for DHHC8/ankyrin-G (Figure 29A and B). For 
evaluating the co-localization between ankyrin-G and βII-spectrin, we replaced 
endogenous βII-spectrin with either WT or Y1874A mutant GFP-βII-spectrin. WT βII-
spectrin was also co-patterned into ankyrin-G positive microdomains (Figure 29A, the 
third panel). This co-localization with ankyrin-G required ankyrin-spectrin interaction 
since the Y1874A βII-spectrin mutant/ankyrin-G exhibited a markedly reduced Pearson 
coefficient of 0.3 compared to 0.8 for WT βII-spectrin/ankyrin-G (Figure 29A bottom two 
panels and 29B). However, this Y1874A βII-spectrin mutant is still patterned into 
microdomains, probably through its PH domain or other unidentified protein 
interactions. 
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Figure 29: DHHC5/8 and βII-spectrin co-localize with ankyrin-G in 
microdomains. 
(A) A region of interest highlighted in white box was cropped from the lateral 
membrane, and reconstructed using 3D deconvolution in Volocity Image Analysis 
Software. Green, α-GFP; red α-ankyrin-G, the unit of the 3D grid is 1um long, scale bar, 
10um. (B) Quantification of the co-localization indicated by pearson coefficient. Student 
t-test was performed for the comparison between WT and Y1874A βII-spectrin, *p<0.01, 
n=4-7. 
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The finding that DHHC5/8 and βII-spectrin are co-patterned with ankyrin-G into 
highly organized microdomains suggests a model where ankyrin-G is locally 
palmitoylated at the lateral membrane, and in turn drives the polarized recruitment of 
βII-spectrin-phosphoinositide complexes (Figure 30). Loss of ankyrin-G/βII-spectrin 
binding activity results in loss of ankyrin-G/βII-spectrin co-patterning in those 
microdomains and failure to restore the epithelial lateral membrane. Thus recruitment of 
βII-spectrin to ankyrin-G microdomains is essential for its downstream functions in 
building lateral membranes. The mechanism for polarized targeting of DHHC5/8, which 
determines the location of ankyrin-G, will be the subject of future investigation. 
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Figure 30: A DHHC5/8-ankyrin-G-βII-spectrin functional network is required 
to build lateral membranes of polarized MDCK cells.   
The schematic view summarizes roles of DHHC5/8, ankyrin-G and βII-spectrin in 
assembling the lateral membrane of columnar epithelial cells. ○1 DHHC5/8 are localized 
to the lateral membrane, ○2 where they palmitoylate ankyrin-G. βII-spectrin requires co-
incidence detection of ○3 ankyrin-G and ○3` PI(4,5)P2 to ensure its precise lateral 
membrane localization. Loss of any of the components or the functional relationship 
results in reduced lateral membrane height. 
 
 
 
 
 
 
 
 
 117 
4.4 Discussion 
A core challenge for contemporary biology is to understand how individual 
molecular partnerships translate into the complex spatial and temporal organization that 
distinguishes living cells. This is a particularly important issue for ankyrin- and spectrin- 
based plasma membrane domains whose function critically depends on precise cellular 
localization of ankyrin-G and beta-2 spectrin. This study identifies two critical inputs 
from lipids that together provide a rationale for how ankyrin-G and βII-spectrin 
selectively localize on lateral membranes of MDCK epithelial cells (Figure 30). These 
experiments began with the observation that ankyrin-G is S-palmitoylated at a single 
conserved cysteine that is required for ankyrin-G function in assembling lateral 
membranes and axon initial segments (He et al., 2012). Here, we identified DHHC 
palmitoyltransferases 5 and 8 as the DHHC family members required for ankyrin-G 
palmitoylation as well as its localization at the lateral membranes of polarized MDCK 
cells. We also found that βII-spectrin functions as a co-incidence detector that requires 
recognition of both palmitoylated ankyrin-G and phosphoinositide lipids as a 
prerequisite for its localization to the lateral membrane (Figure 29 and 30). DHHC5/8 
and phosphoinositides thus ensure that ankyrin-G and βII-spectrin localize only on 
lateral plasma membranes and not in the cytosol or on other membrane surfaces. Loss of 
either DHHC5/8, or interactions between ankyrin-G and βII-spectrin, or βII-spectrin 
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recognition of phosphoinositide lipids all result in failure to build the lateral membrane, 
which underscores the functional importance of this pathway.   
Our findings establish DHHC5 and 8 as critical determinants of polarity for 
ankyrin-G and βII-spectrin in MDCK cells. However, the mechanisms responsible for 
polarized localization of DHHC 5 and 8 themselves at the lateral membrane remain to be 
elucidated. Both proteins are distinguished from other DHHC family members by an 
extended cytoplasmic domain (Thomas et al., 2012). However, substitution of the C-
terminal domain of DHHC14 for that of DHHC5 does not abolish lateral membrane 
targeting of DHHC5 (Figure 31). Thus important localization information resides in the 
N-terminal halves of DHHC5 and 8.  
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Figure 31: Replacing the C-terminal domain of DHHC5 with that of DHHC14 
does not abrogate its polarized localization. 
cDNA encoding the C-terminal domain of DHHC14 (amino acids 285-489) was fused to 
cDNA encoding the N-terminal portion of DHHC5 (amino acids 1-219), and then 
subcloned into peGFP-C1 vector. Chimeric plasmids were transfected into MDCK cells, 
followed by immunofluorescence using α-GFP (green) and α-ZO-1 (white) antibody. (A) 
XY plane, (B) XZ plane, scale bar, 10um. 
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In initial efforts to learn more about the generality of findings in MDCK cells, we 
examined localization of DHHC5/8 and ankyrin-G in neurons, human bronchial 
epithelial (HBE) cells, and the LLC-PK1 line of epithelial cells (Hull et al., 1976). HBE 
cells resemble MDCK cells in the polarized lateral membrane localization of DHHC5 
and 8 with endogenous ankyrin-G (Figure 32B). In contrast, DHHC5 and 8 localize 
uniformly along neuronal plasma membranes when transfected into cultured 
hippocampal neurons, and do not exhibit enrichment at axon initial segments where 
ankyrin-G is concentrated (Figure 33, 34). DHHC5 and 8 also exhibit a non-polarized 
localization on both apical and lateral plasma membrane surfaces in LLC-PK1 cells 
(Figure 32C). Surprisingly, we find that LLC-PK1 cells lack the canonical 210 kDa 
ankyrin-G and instead express a 110 kDa cross-reacting polypeptide, likely a spliced 
variant lacking ANK repeats that is uniformly associated with all plasma membrane 
surfaces (Figure 32A and C). LLC-PK1 cells also differ from MDCK cells in lacking the 
AP1b clathrin adaptor (Ohno et al., 1999) as well as having a cuboidal rather than 
columnar morphology (Figure 32C). Based on this limited set of examples we conclude 
that the DHHC5/8-ankyrin-G-βII-spectrin pathway resolved here in MDCK cells may be 
a specialized feature of columnar epithelial cells. 
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Figure 32: DHHC5/8 and ankyrin-G show polarized localization in columnar 
epithelial cells (HBE) but not cuboidal epithelial cells (LLC-PK1). 
(A) Total cell lysates from cultured MDCK, HBE and LLC-PK1 cells were analyzed by 
SDS-PAGE and western blotting using α-ankyrin-G antibody. (B) GFP-DHHC5 or 8 
were transfected into HBE cells and visualized by immunofluorescence, green, α-GFP; 
red, α-ankyrin-G, scale bar, 10μm. (C) GFP-DHHC5 or 8 were transfected into LLC-PK1 
cells and visualized by immunofluorescence, green, α-GFP; red, α-ankyrin-G, scale bar, 
10μm. 
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Figure 33: DHHC5 uniformly localize to all neuronal plasma membranes. 
GFP-DHHC5 was transfected into cultured hippocampal neurons, and visualized by 
immunofluorescence. (A) Maximum intensity projection of a transfected neuron, GFP 
signal was pseudo-colored in white, scale bar, 10μm. (B, C and D) Magnified images to 
show a single XY plane across the middle of the cell body, axon and primary dendrite 
highlighted in red, yellow and cyan boxes respectively in (A), green, α-GFP; red, α-
ankyrin-G; blue, α-MAP2, scale bar, 5μm. 
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Figure 34: DHHC8 uniformly localize to all neuronal plasma membranes. 
GFP-DHHC8 was transfected into cultured hippocampal neurons, and visualized by 
immunofluorescence. (A) Maximum intensity projection of a transfected neuron, GFP 
signal was pseudo-colored in white, scale bar, 10μm. (B, C and D) Magnified images to 
show a single XY plane across the middle of the cell body, axon and primary dendrite 
highlighted in red, yellow and cyan boxes respectively in (A), green, α-GFP; red, α-
ankyrin-G; blue, α-MAP2, scale bar, 5μm. 
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The finding that βII-spectrin requires both ankyrin-G and phosphoinositides to 
associate with the lateral membrane was unexpected given the high affinity of the 
ankyrin-G-βII-spectrin interaction (Figure 26). Moreover, β-spectrin in erythrocytes lacks 
a PH domain due to alternative splicing but is tightly bound to the plasma membrane 
through ankyrin (Bennett and Stenbuck, 1979; Byers and Branton, 1985; Winkelmann et 
al., 1990b). These considerations suggest the possibility of a phosphoinositide-dependent 
relief of autoinhibition of ankyrin-binding, as occurs with Talin and beta-integrins 
(Goksoy et al., 2008). Another puzzle is that βII-spectrin preferentially binds to PI(4,5)P2 
which is enriched in the apical domain, while PI(3,4,5)P3, confers basolateral membrane  
identity, at least  in some epithelial cell models (Martin-Belmonte et al., 2007; Shewan et 
al., 2011). Nevertheless, the βII-spectrin PH domain, whether it associates with PI(4,5)P2 
or PI(3,4,5)P3, imposes a dual requirement for phosphoinositides in addition to ankyrin-
binding that prevents association of β-spectrins with ankyrin at sites other than the 
plasma membrane. PI(4,5)P2 lipids interact with many effectors including cytoskeletal 
proteins such as Talin and Arp2/3 as well as small GTPases, and also have several 
biosynthetic routes (Di Paolo and De Camilli, 2006; Kwiatkowska, 2010). It will be 
important in future work to resolve other components of the βII-spectrin-dependent 
membrane microenvironment where PI(4,5)P2 and DHHC5/8 palmitoyltransferases co-
reside. 
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A critical tool that we developed for this study was a method to generate 
inducible shRNA-mediated knockdown of protein expression in an entire population of 
MDCK cells. This permitted evaluation of the roles of ankyrin-G and βII-spectrin in 
assembling lateral membranes, without interference by other cellular defects, including 
impaired cytokinesis, caused by loss of ankyrin-G or βII-spectrin (Hu et al., 1995). By 
using this system, we were able to knockdown ankyrin-G or βII-spectrin after cells 
reached confluence, where mitosis is less frequent. Previous research using a transient 
siRNA strategy that resulted in a nearly complete loss of ankyrin-G in HBE cells led to a 
complete loss of the lateral membrane domain and intracellular accumulation of E-
cadherin (Kizhatil and Bennett, 2004; Kizhatil et al., 2007a; Kizhatil et al., 2007b). 
However, we did not observe these phenotypes in MDCK cells with 80-90 percent 
knockdown achieved with the inducible system. The intracellular accumulation of E-
cadherin in these experiments likely was secondary to loss of lateral membranes rather 
than a failure of post-Golgi transport as originally proposed (Kizhatil et al., 2007a). 
An unexpected discovery from our recent studies was that ankyrin-G persists on 
the plasma membrane together with DHHC5/8 in unpolarized MDCK cells grown in 
low calcium (Figure 25A, He et al,. 2012). Ankyrin-G so far is the only lateral membrane-
localized proteins as we are aware of with this property (Gumbiner et al., 1988; He et al., 
2012; Kaiser et al., 1989; Mattey and Garrod, 1986). Re-addition of calcium to calcium-
depleted cells results in rapid re-establishment of cell polarity and re-assembly of the 
 126 
lateral membrane. Using this calcium switch assay, we demonstrated that ankyrin-G and 
DHHC5/8 are not only required for the maintenance of lateral membranes but also for de 
novo biosynthesis of the lateral membrane following re-addition of calcium (Figure 25D 
and E). These results suggest that palmitoylated ankyrin-G functions as a core organizer 
during the assembly of lateral membranes. It remains to be determined whether 
ankyrin-G affects the biosynthesis and the maintenance of lateral membranes through 
identical pathways. The calcium switch assay also raises interesting questions whether 
the re-establishment of apical and lateral membranes is achieved through delivery of 
newly synthesized membrane components, or through re-arrangements of pre-existing 
plasma membrane, and how the DHHC5/8/ankyrin-G/βII-spectrin network is 
incorporated into this process. Therefore future experiments using live imaging to 
capture the real time distribution of the palmitoyltransferases DHHC5/8, ankyrin-G and 
βII-spectrin during the re-polarization process may help to address these questions. 
While DHHC5/8, ankyrin-G and βII-spectrin are required for columnar 
morphology of MDCK cells and operate in the same pathway, the mechanism of action 
of these proteins in expanding the lateral membrane remains to be determined. One 
possibility is that a lateral membrane-associated spectrin-based actin skeleton provides 
mechanical support for epithelial monolayers by coupling to membrane-spanning cell 
adhesion molecules such as E-cadherin, which is an ankyrin-G partner (Kizhatil et al., 
2007b; Nelson et al., 1990a; Nelson et al., 1990b). Another possibility is that an ankyrin-
 127 
G-spectrin-actin skeleton promotes cell height by enhancing cell-cell contacts through 
retention of E-cadherin and prevention of its endocytosis. In support of this idea, E-
cadherin polarity in MDCK cells depends on a motif in its cytoplasmic domain that 
contains both ankyrin-binding activity as well as embedded di-leucine residues required 
to engage clathrin endocytosis (Jenkins et al., 2013). E-cadherin likely can associate with 
either ankyrin-G or clathrin adaptors but not both at the same time, and thus is 
restricted to the lateral membrane by the ankyrin-spectrin skeleton. A surprising 
conclusion of our study is that E-cadherin interaction with ankyrin-G is not sufficient to 
recruit ankyrin-G to the lateral membrane, which also requires palmitoylation in 
addition to its protein interactions. However, once ankyrin-G concentrates at the lateral 
membrane it may be able to prevent participation of E-cadherin in endocytosis through 
competition for binding to the polarity motif. Interestingly, inhibition of endocytosis of 
the cell adhesion molecule Fas 2 has been proposed as a mechanism for regulating cell 
height in Drosophila epithelia (Gomez et al., 2012).   
We have observed for the first time that ankyrin-G and βII-spectrin are 
concentrated in microdomains ranging from 0.5 to 2 square microns in the MDCK cell 
lateral membrane (Figure 29), which is inconsistent with the conventional view of a 
uniform ankyrin/spectrin lattice as observed in  the plasma membrane of erythrocytes 
(Baines, 2010; Bennett and Baines, 2001; Liu et al., 1987). We believe that microdomains 
are not an artifact of cell fixation or deconvolution software, since we observe similar 
 128 
micro-patterning using live imaging with GFP-ankyrin-G and GFP-βII-spectrin as with 
fixed cells (Figure 35).  In contrast, imaging with a lipid probe reveals uniform label 
(Figure 35). Moreover, the protein interaction-dependent co-localization between 
ankyrin-G and βII-spectrin demonstrates specificity in co-segregation of these proteins 
(Figure 29). The ankyrin-G- and βII-spectrin microdomains revealed by 3D 
deconvolution microscopy in our study are distinguishable from the membrane “lipid 
rafts” which normally are much smaller (Lingwood and Simons, 2010; Simons and Gerl, 
2010). Segregation of functionally related proteins into microdomains can provide a 
platform for proteins that interact with moderate affinity and require high local 
concentration to achieve complexes. The fact that DHHC5/8 colocalize with ankyrin-G in 
these microdomains suggests localized palmitoylation of ankyrin-G. It will be 
interesting in future experiments to study the real time dynamics of those microdomains 
during lateral membrane assembly and their relationship to the clathrin-dependent 
endocytosis machinery. 
In summary, we have identified functional interactions connecting 
palmitoyltransferases DHHC5/8 with their substrate ankyrin-G, ankyrin-G with its 
partner βII-spectrin, and βII-spectrin with phosphoinositide lipids that are required to 
build lateral membranes of MDCK epithelial cells. Given the rapidly reversible nature of 
palmitoylation (Fukata et al., 2013; Martin et al., 2012; Rocks et al., 2010), as well as 
PI(4,5)P2 synthesis and degradation (Di Paolo and De Camilli, 2006; Shewan et al., 2011), 
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these new  findings suggest that the ankyrin-G/βII-spectrin-based membrane skeleton is 
much more dynamic and subject to regulation than previously appreciated. Moreover, 
the regulatory network properties of this set of interactions in terms of positive and 
negative feedback and co-incidence circuitry are important areas for future 
investigation. Finally, our findings reinforce an emerging view of plasma membrane 
identity determination by a combinatorial code based on highly dynamic protein and 
lipid variables rather than “hard-wired” stable protein assemblies.  
 
Figure 35: 3D deconvolution of live imaging reveals micro-patterning of GFP-
tagged ankyrin-G and βII-spectrin but not lipophilic probes. 
(A and B) Endogenous ankyrin-G or βII-spectrin was silenced and replaced with GFP-
tagged ankyrin-G or βII-spectrin, native GFP signals were collected from live cells, a 
shared lateral membrane region was selected and processed for 3D deconvolution, grid 
unit, 1μm. (C) Live cells were labeled with lipophilic probes (CellMask Orange) and 
imaged for 3D deconvolution, grid unit, 1μm. 
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Chapter 5. The Spectrin-Ankyrin Network Assembles 
Epithelial Lateral Membrane by Opposing Clathrin-
Mediated Endocytosis 
5.1 Introduction 
The previous chapters have provided a mechanism for targeting the spectrin-
ankyrin network to those plasma membrane domains, however it is still unclear how 
this network mechanistically assembles the membrane domains after it is precisely 
localized. The area of plasma membrane is controlled by the equilibrium between 
addition and removal of membrane components. Previous work proposed that the 
spectrin-ankyrin network may be involved in direct transport of new membrane 
components to the epithelial lateral membrane (Kizhatil et al., 2007a). However, no 
direct experimental evidence has been observed to support this idea, and at steady state 
the spectrin-ankyrin network is predominantly localized at the lateral membrane. 
A recent study showed that ankyrin-G binds to the cytoplasmic domain of E-
cadherin at the same region recognized by the clathrin adaptors (Jenkins et al., 2013). 
This finding suggests a role of ankyrin-G in regulating the removal of membrane 
components through clathrin-mediated endocytosis. In this chapter, we provide 
experimental evidence to demonstrate that the spectrin-ankyrin network plays a role in 
inhibiting clathrin-mediated endocytosis from the epithelial lateral membrane. 
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5.2 Methods and Materials 
Double Stable cell lines 
 The ankyrin-G/Clathrin double stable cell line was generated using the improved 
pLKO-Tet-on lentivector discussed above. Hairpin sequence targeting canis ankyrin-G 
(gctagaagtagctaatctcct) was first cloned into the pLKO-mCherry vector and used to 
make the ankyrin-G shRNA stable cell line, then the hairpin sequence targeting canis 
clathrin heavy chain (aatggatctctttgaatacgg) was cloned into pLKO-tagBFP vector and 
used to transduce the ankyrin-G shRNA stable cells, which were then sorted for 
mCherry and tagBFP double positive cells. 
Dynasore treatment 
 Luciferase shRNA control cells, ankyrin-G shRNA  cells or beta II spectrin 
shRNA cells were first induced by 4ug/ml doxycycline for 48 hours to knockdown genes 
of interest, then 5X105 cells were replated on the 14mm insert of MatTek plates with or 
without 60uM dynasore for 24 hours. The next day, cells were fixed and stained for E-
cadherin to mark the lateral membrane. 
Transferrin uptake 
 Stable cell lines expressing WT ankyrin-binding domain or YA mutated ankyrin-
binding domain tagged to the destabilization domain were generated in a way similar to 
the shRNA stable cell lines. Cells were then induced by Shield-1 to stimulate the rapid 
expression of ankyrin-binding domain, and labeled with fluorescein isothiocyanate 
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(FITC)-transferrin from the basolateral surface using filter-grown MDCK cells to 
measure internalization. 
Lipophilic labeling 
 Cells were grown in the 14mm insert of MatTek plates, and induced to 
knockdown genes of interest. The CellMask™ Plasma Membrane dye was then added to 
the medium at 1:1000 dilution, and allow it to incubate with 45 minutes. Then wash the 
cells with PBS for 3 times, and then add regular medium and applied for live imaging 
using the LSM 780 confocal microscopy. 
 
5.3 Results 
5.3.1 Inhibition of clathrin-mediated endocytosis restores lateral 
membrane in ankyrin-G depleted MDCK cells. 
According to our hypothesis that the spectrin-ankyrin network protects the 
lateral membrane from being internalized by clathrin-mediated endocytosis, we should 
observe a restoration of lateral membranes if we inhibit clathrin-mediated endocytosis in 
ankyrin-G depleted cells. In order to test this, we made shRNA stable cell line which 
achieved double knockdown of both ankyrin-G and clathrin heavy chain. The 
knockdown efficiency was verified by western blot (Figure 36A, 91% for ankyrin-G, 84% 
for clathrin heavy chain), then we measured the height of the lateral membrane by 
staining endogenous E-cadherin after knocking down both proteins. Loss of clathrin-
heavy chain alone resulted in partial mislocalization of E-cadherin (Figure 36B), which is 
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consistent with previous studies (Deborde et al., 2008; Jenkins et al., 2013). Surprisingly, 
cells lacking both ankyrin-G and clathrin heavy chain regained their lateral membrane 
up to the wild type level (Figure 36B and C).  
 
Figure 36: Double knockdown of ankyrin-G and CHC restores MDCK 
epithelial lateral membranes.  
(A) Knockdown efficiency of ankyrin-G and clathrin heavy chain (CHC) in the double 
shRNA stable cell line. (B) XZ plane of the polarized cell monolayer, green, anti-E-
cadherin staining. (C) Quantification of the height of lateral membranes, * indicates 
p<0.05. 
 
 
Alternatively, we also inhibited endocytosis by using a small inhibitor, dynasore, 
which blocks all the dynamin-dependent endocytosis (Macia et al., 2006). Similarly, 
dynasore treatment in cells depleted of ankyrin-G or beta II spectrin also restored the 
lateral membrane in MDCK cells (Figure 37A and B). These findings are consistent with 
our hypothesis that the spectrin-ankyrin network plays a role in inhibiting clathrin-
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mediated endocytosis, therefore protecting proteins or lipids from being internalized at 
the lateral membrane by clathrin. 
 
Figure 37: Dynasore treatment restores the lateral membrane in ankyrin-G or 
beta II spectrin knockdown cells. 
(A) XZ plane of the polarized cell monolayer, green, anti-E-cadherin staining. (B) 
Quantification of the height of lateral membranes, * indicates p<0.05. 
 
5.3.2 Disruption of spectrin-ankyrin interaction increases clathrin-
mediated uptake of transferrin 
Next, we decided to directly examine how the spectrin-ankyrin network affects 
clathrin-mediated endocytosis. We used an inducible protein expression system 
previously developed (Banaszynski et al., 2006) to express the ankyrin-binding domain 
of beta II spectrin. This fragment can disrupt the interaction between ankyrin-G and beta 
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II spectrin (Hu et al., 1995), thus functions as a dominant negative mutant (Figure 38A ). 
As a control, a tyrosine residue in the peptide critical for ankyrin binding was mutated 
to alanine (Davis et al., 2009; Ipsaro and Mondragon, 2010).  
We used Fluorescein isothiocyanate (FITC) conjugated transferrin as a marker to 
evaluate clathrin-mediated endocytosis. After rapid induction of the expression of 
ankyrin-binding domain (WT ABD) but not the control (YA ABD), we observed a 
significant increase of transferrin uptake (Figure 38B and C.). This finding further 
supports our hypothesis that the spectrin-ankyrin network inhibits clathrin-mediated 
endocytosis. 
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Figure 38: Disruption of spectrin-ankyrin interaction increases clathrin-
mediated uptake of transferrin. 
(A) Binding curve of the Y1874A mutated beta II spectrin with ankyrin-G and the 
schematic view of the inducible expression system. (B) Compacted view of Z stacks,  
FITC-conjugated transferrin (green) was introduced to the cells from the basolateral 
surface of filter-grown MDCK cells, dsRed marking cells that are expressing ankyrin-
binding domain, scale bar, 10um. (C) Quantification of transferrin level, *** indicates 
p<0.05. (Experiments performed by Dr. Paul Jenkins) 
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5.3.3 Knockdown of ankyrin-G causes massive intracellular 
accumulation of membrane components. 
To further evaluate the role of ankyrin-G in opposing clathrin-mediated 
endocytosis, we then decided to label plasma membrane using fluorescent lipophilic 
molecules and study the cellular distribution of the labeled membrane components. The 
cells that were treated with dynasore or induced to knockdown clathrin heavy chain 
showed significantly reduced intracellular membrane components compared to control 
cells (Figure 39A). Surprisingly, the ankyrin-G knockdown cells exhibited a dramatic 
increase of intracellular membrane components (Figure 39A). To further confirm this 
accumulation was due to increased activities of endocytosis, we treated the ankyrin-G 
knockdown cells with dynasore to inhibit dynamin-dependent endocytosis, the cells did 
not only show an increased lateral membrane height as described above, but also 
showed markedly reduced intracellular membrane accumulation (Figure 39A). 
Additionally, even though the lipophilic molecules were incorporated into the 
cells from the apical surface, the control cells actually showed a more robust labeling at 
the lateral membrane than the apical membrane, suggesting that at steady state there is 
more rapid internalization from the apical than from the basolateral membranes (Figure 
39B). This difference may be largely contributed by endocytosis, because when the cells 
were treated with dynasore or induced to knockdown clathrin heavy chain, they 
showed evenly labeled apical and lateral membranes.  Together these experimental data 
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demonstrated that ankyrin-G plays an essential role in inhibiting clathrin-mediated 
endocytosis. 
 
Figure 39: Knockdown of ankyrin-G causes massive intracellular accumulation 
of membrane components. 
(A) Stable MDCK cells were induced to knockdown ankyrin-G or CHC, and then labeled 
with fluorescent lipophilic dye from the apical surface. Red, cell mask orange dye, scale 
bar, 10um. (B), XZ plane of the polarized MDCK monolayer, scale bar, 10um. 
 
5.4 Discussion 
It has been well recognized that the spectrin-ankyrin network is essential for 
epithelial cells to establish and maintain their lateral membranes (Kizhatil and Bennett, 
2004; Kizhatil et al., 2007a; Kizhatil et al., 2007b). However, the molecular mechanisms 
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underlying this process are unknown. Here, we identify a mechanism of the spectrin-
ankyrin network in assembling epithelial lateral membranes. Instead of being involved 
in direct membrane delivery, the spectrin-ankyrin network functions as molecular 
machinery to inhibit clathrin-mediate endocytosis thus protects critical lateral 
membrane proteins and lipids from being internalized. This spatial and temporary 
regulation of clathrin-mediate endocytosis may function as a general principal for 
polarized cells to establish and maintain their specialized membrane domains (Figure 
40). 
 
Figure 40: Model of the spectrin-ankyrin networking opposing clathrin-
mediated endocytosis. 
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Membrane components can be internalized from both apical and lateral 
membranes (Barroso and Sztul, 1994; Thompson et al., 2007; von Bonsdorff et al., 1985; 
Wang et al., 2000). Here we showed that the spectrin-ankyrin network localized at the 
lateral membrane is playing a role in regulating clathrin-mediate endocytosis to 
assemble and maintain this membrane domain. We would hypothesize the existence of a 
similar protein complex at the apical membrane that may regulate endocytosis to protect 
specific apical components from being internalized.  
We showed here that the spectrin-ankyrin network opposes clathrin-mediated 
endocytosis, but it is still unclear how this network achieves such inhibition. Based on 
our knowledge, there may be three different explanations. First, given the finding that 
ankyrin-G can bind to the cytoplasmic region of E-cadherin which is also recognized by 
clathrin adaptors (Jenkins et al., 2013), there may be a competitive mechanism between 
the ankyrin-based protein retention and clathrin-mediate removal. Therefore, it will be 
interesting in future work to verify whether other sorting signals recognized by clathrin 
adaptors can also bind to ankyrin-G directly or indirectly. Second, it was shown that 
clathrin-mediated endocytosis requires PI(4,5)P2 lipids which can recruit the clathrin 
adaptor AP2 to the plasma membrane and facilitate the formation of endocytic pits 
(Ford et al., 2001; Gaidarov and Keen, 1999; Motley et al., 2003; Padron et al., 2003; 
Rohde et al., 2002). Since beta II spectrin also binds to PI(4,5)P2 with the highest affinity 
as shown above, it may compete with the clathrin adaptor AP2 at the lateral membrane 
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for PI(4,5)P2, and  inhibit the formation of clathrin scaffolds. Third, it was shown that 
the spectrin-ankyrin network forms a lattice underlying the plasma membrane of 
erythrocytes (Liu et al., 1987), and the spectrin-actin filaments are also tightly packed 
into a meshwork that wrap around the circumference of neuronal axons (Xu et al., 2013). 
These findings also imply that the spectrin-ankyrin network may simply block the 
access of clathrin machinery to the lateral membrane by forming a highly organized 
meshwork. However, due to the technical limitation, it still remains challenging to 
visualize the detailed organization of the spectrin-ankyrin network at epithelial lateral 
membrane; otherwise it will provide critical information to understand its function. 
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Chapter 6. Future Directions and Conclusions 
6.1 Ankyrin and Phosphoinositide lipids 
The structure of the ZU5-UPA-Death domain supermodule of ankyrin-B reveals 
a binding pocket consisting of several positively-charged residues at the second ZU5 
domain (Wang et al., 2012). Those positively-charged residues are extremely conserved 
among the ankyrin families across different species (Figure 41A). This pocket provides 
an ideal binding site for lipids, indeed some preliminary data suggest a direct binding 
between ankyrin-G and phosphatidylinositol 3-phosphate (PI3P) (Figure 41B). To 
evaluate the functional significance of this binding pocket, we make point mutations to 
reverse the positively-charged residues into negatively-charged residues, and used this 
mutant to rescue the lateral membrane in epithelial cells, surprisingly this mutant losses 
its function to do so (Figure 41C). However, we have not been able to prove that this loss 
of function is attributed to loss of lipid binding. Therefore it will be very interesting in 
future experiments to measure the binding of this ankyrin-G mutant with PI3P lipids.  
Recently, phosphoinositide lipids are increasingly recognized as critical 
determinants of plasma membrane organization and identities (Hammond et al., 2012; 
Johnson et al., 2012; Martin-Belmonte et al., 2007; Nakatsu et al., 2012; Shewan et al., 
2011). Since ankyrin-G plays critical roles in assembling plasma membrane domains, this 
connection between ankyrin-G and phosphoinositide lipids may be of great biological 
significance in organizing membrane domains. It will be interesting to study how 
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phosphoinositide lipids affect ankyrin-G function through selective lipid depletion 
methods. 
 
Figure 41: The positively-charged pocket is required for ankyrin-G to restore 
the lateral membranes in MDCK cells. 
(A) From Want et al. 2012. (B) Liposome binding shows that ankyrin-G selectively binds 
to PI3P lipids (experiment was performed by Jonathan Davis). (C) The poly charge 
mutant failed to restore the lateral membrane in MDCK cells, green, anti-GFP, red, anti-
ZO-1, scale bar, 10um. * indicates p<0.05. 
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6.2 Non-canonical roles of ankyrin-G 
6.2.1 Ankyrin-G and cytokinesis 
In addition to the well-established function in organizing specialized membrane 
domains such as axon initial segments and the epithelial lateral membrane (Bennett and 
Healy, 2009; Bennett and Lorenzo, 2013), ankyrin-G and βII-spectrin are also involved in 
mitosis. Caco-2 intestinal epithelial cells, transfected with plasmids encoding the actin- 
or ankyrin-binding domain of βII-spectrin that functions as a dominant negative 
fragment, became multinucleated which is a sign of mitotic defects (Hu et al., 1995). 
Immunofluorescence using pan ankyrin antibodies revealed ankyrin analogues that 
were concentrated in the spindle pole during metaphase and were redistributed to the 
cleavage furrow in later stages of mitosis (Bennett and Davis, 1981), 
We tested how loss of ankyrin-G in MDCK cells affects cell division using our 
inducible shRNA cell line. First, we confirmed that knockdown of ankyrin-G resulted in 
multinucleation (Figure 42A and B). Then we did a growth curve to evaluate the overall 
influence of ankyrin-G on cell division. Surprisingly, loss of ankyrin-G in MDCK cells 
doubled the average cell cycle time (Figure 42C). We further showed that ankyrin-G 
functions specifically during the cytokinesis phase using live imaging, the control cells 
can complete the cytokinesis within a few minutes, whereas the ankyrin-G knockdown 
cells failed to complete this process even within a few hours.  
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Figure 42: Loss of ankyrin-G leads to delayed cytokinesis and multinucleation. 
(A) Ankyrin-G knockdown cells were stained with DAPI (blue) to visualize the nucleus, 
and NA K ATPase (green) for cell boundaries. (B) Quantification of the number of 
nucleus. (C) Growth curve of MDCK stable cells that are induced to knockdown 
ankyrin-G or luciferase as a control (number unit M: million).  
 
The molecular mechanism underlying this phenotype is not known, but it will be 
interesting to understand how ankyrin-G pays a role in cytokinesis. One of the initial 
experiments that we tried was to identify potential binding partners in MDCK cells that 
may function during cytokinesis. Interestingly, in our crosslinking and 
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immunoprecipitation assay, we identified the non-muscle myosin IIa as a potential 
binding partner of ankyrin-G (Table 2). It was shown that the non-muscle myosin II 
accumulates at the cleavage furrow and plays critical roles in cytokinesis and cell 
migration (Dean et al., 2005; Even-Ram et al., 2007; Straight et al., 2005; Yang et al., 2012). 
Therefore, it will be important to verify the interaction between ankyrin-G and non-
muscle myosin IIa, and examine whether this interaction plays any role in cytokinesis. 
Table 2: Mass spectrometry of ankyrin-G immunoprecipitation shows non-
muscle myosin IIa as a potential binding partner. 
 
 
6.2.2 Ankyrin-G and cell migration 
When we were characterizing ankyrin-G shRNA cell line, another striking 
phenotype we observed was that loss of ankyrin-G has a marked influence on cell 
motility. As demonstrated by wound healing assay and live imaging, the control cells 
can migrate up to 30 microns per hour, whereas the ankyrin-G knockdown cells showed 
significantly reduced motility (Figure 43). Interestingly, ankyrin-G knockdown does not 
 147 
only decrease the migration rate of MDCK cells, but also affect their collective migration 
pattern. Again, at this point we are not clear about the mechanism how ankyrin-G 
affects cell migration, and how this may affect development in vivo. 
 
Figure 43: Knockdown of ankyrin-G in MDCK cells results in slower cell 
mobility. 
shRNA stable cell lines were induced to knockdown ankyrin-G, or luciferase as a 
control, and then plated on MatTek plates. A wound was made across the monolayer, 
and live imaged for 12 hours, mCherry marking the shRNA expressing cells. 
 
 
6.3 Conclusions 
 Even though it has been known for a decade that ankyrin-G localizes to neuronal 
axon initial segments and epithelial lateral membranes (Kizhatil and Bennett, 2004; 
Kordeli et al., 1995), it was unclear how it targets to those specialized membrane 
domains. In this thesis, we characterized ankyrin-G palmitoylation and its significance 
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in determining ankyrin-G targeting to diverse plasma membrane domains. Our work 
has solved this long-standing puzzle. Moreover, when ankyrin was first isolated from 
red blood cells, it exhibited a high level of hydrophobicity as a peripheral membrane 
protein (Bennett and Stenbuck, 1980), over 30 years after the initial observation, our 
finding provided a molecular explanation of these biochemical properties. 
Following the identification of ankyrin-G palmitoylation, we also identified 
DHHC5 and DHHC8 as the physiological palmitoyl-transferases of ankyrin-G in MDCK 
cells. Those two palmitoyltransferases colocalize with ankyrin-G at the lateral membrane 
of columnar epithelial cells. The identification of DHHC5 and DHHC8 further improved 
our understanding about how ankyrin-G targeting and function is achieved through 
dynamic lipid modification. Another lipid input we identified that is critical for 
targeting beta II spectrin in MDCK cells is the phosphoinositide lipid. This co-incidence 
detection through protein-protein interaction and protein-lipid interaction further 
increases the complexity of the spectrin-ankyrin network, and may explain some of the 
discrepancies that were observed in different systems. Together, these findings 
expanded our vision about the spectrin-ankyrin network dynamics and how diverse 
lipid codes may be incorporated into this network to assemble membrane domains.  
A striking observation in this thesis is that the palmitoyltransferases, ankyrin-G 
and beta II spectrin are not only functionally related, but also spatially co-patterned on 
the epithelial lateral membrane. The existence of such micron scale domains that are 
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enriched in functionally-related proteins suggests a new mechanism to understand the 
plasma membrane organization and function, which cannot be fully explained by the 
“fluid mosaic” model.  
Along with the targeting mystery comes the function mystery. The requirement 
of ankyrin-G to assemble plasma membrane domains has been well-recognized for over 
a decade, but the molecular mechanism of how ankyrin-G is involved in this process 
was completely unknown (Bennett and Baines, 2001; Bennett and Healy, 2008; Bennett 
and Healy, 2009; Bennett and Lorenzo, 2013). Our work in this thesis, for the first time 
demonstrates the spectrin-ankyrin network maintains epithelial lateral membranes by 
opposing clathrin-mediated endocytosis. This finding does not only provide a 
mechanism for the spectrin-ankyrin-based plasma membrane domains, but also 
suggests a general principle for the cells to organize any plasma membrane domain: 
Instead of sorting and transporting proteins or lipid components to unique plasma 
membrane regions, the cells may simply utilize the protein transport pathways to 
deliver proteins evenly to all plasma membrane regions, and then selectively protect 
them from being internalized at specific regions to establish a specialized membrane 
domain.    
 
 
 150 
References 
Abdi, K.M., P.J. Mohler, J.Q. Davis, and V. Bennett. 2006. Isoform specificity of ankyrin-
B: a site in the divergent C-terminal domain is required for intramolecular 
association. The Journal of biological chemistry. 281:5741-5749. 
Agre, P., E.P. Orringer, D.H. Chui, and V. Bennett. 1981. A molecular defect in two 
families with hemolytic poikilocytic anemia: reduction of high affinity membrane 
binding sites for ankyrin. J. Clin. Invest. 68:1566-1576. 
Aicart-Ramos, C., R.A. Valero, and I. Rodriguez-Crespo. 2011. Protein palmitoylation 
and subcellular trafficking. Biochim. Biophys. Acta. 1808:2981-2994. 
Anderson, R.G., M.S. Brown, and J.L. Goldstein. 1977. Role of the coated endocytic 
vesicle in the uptake of receptor-bound low density lipoprotein in human 
fibroblasts. Cell. 10:351-364. 
Anderson, R.G., E. Vasile, R.J. Mello, M.S. Brown, and J.L. Goldstein. 1978. 
Immunocytochemical visualization of coated pits and vesicles in human 
fibroblasts: relation to low density lipoprotein receptor distribution. Cell. 15:919-
933. 
Armbruster, B.N., S.S. Banik, C. Guo, A.C. Smith, and C.M. Counter. 2001. N-terminal 
domains of the human telomerase catalytic subunit required for enzyme activity 
in vivo. Molecular and cellular biology. 21:7775-7786. 
Ayalon, G., J.Q. Davis, P.B. Scotland, and V. Bennett. 2008. An ankyrin-based 
mechanism for functional organization of dystrophin and dystroglycan. Cell. 
135:1189-1200. 
Ayalon, G., J.D. Hostettler, J. Hoffman, K. Kizhatil, J.Q. Davis, and V. Bennett. 2011. 
Ankyrin-B interactions with spectrin and dynactin-4 are required for dystrophin-
based protection of skeletal muscle from exercise injury. J. Biol. Chem. 286:7370-
7378. 
Baines, A.J. 2009. Evolution of spectrin function in cytoskeletal and membrane networks. 
Biochem. Soc. Trans. 37:796-803. 
Baines, A.J. 2010. The spectrin-ankyrin-4.1-adducin membrane skeleton: adapting 
eukaryotic cells to the demands of animal life. Protoplasma. 244:99-131. 
 151 
Banaszynski, L.A., L.C. Chen, L.A. Maynard-Smith, A.G. Ooi, and T.J. Wandless. 2006. A 
rapid, reversible, and tunable method to regulate protein function in living cells 
using synthetic small molecules. Cell. 126:995-1004. 
Banik, S.S., C. Guo, A.C. Smith, S.S. Margolis, D.A. Richardson, C.A. Tirado, and C.M. 
Counter. 2002. C-terminal regions of the human telomerase catalytic subunit 
essential for in vivo enzyme activity. Molecular and cellular biology. 22:6234-6246. 
Banuelos, S., M. Saraste, and K. Djinovic Carugo. 1998. Structural comparisons of 
calponin homology domains: implications for actin binding. Structure. 6:1419-
1431. 
Baranes, D., D. Lederfein, Y.Y. Huang, M. Chen, C.H. Bailey, and E.R. Kandel. 1998. 
Tissue plasminogen activator contributes to the late phase of LTP and to synaptic 
growth in the hippocampal mossy fiber pathway. Neuron. 21:813-825. 
Barroso, M., and E.S. Sztul. 1994. Basolateral to apical transcytosis in polarized cells is 
indirect and involves BFA and trimeric G protein sensitive passage through the 
apical endosome. J. Cell Biol. 124:83-100. 
Bartels, D.J., D.A. Mitchell, X. Dong, and R.J. Deschenes. 1999. Erf2, a novel gene product 
that affects the localization and palmitoylation of Ras2 in Saccharomyces 
cerevisiae. Mol. Cell. Biol. 19:6775-6787. 
Beck, K.A., J.A. Buchanan, V. Malhotra, and W.J. Nelson. 1994. Golgi spectrin: 
identification of an erythroid beta-spectrin homolog associated with the Golgi 
complex. The Journal of cell biology. 127:707-723. 
Bennett, V. 1978. Purification of an active proteolytic fragment of the membrane 
attachment site for human erythrocyte spectrin. J. Biol. Chem. 253:2292-2299. 
Bennett, V. 1979. Immunoreactive forms of human erythrocyte ankyrin are present in 
diverse cells and tissues. Nature. 281:597-599. 
Bennett, V. 1982. The molecular basis for membrane - cytoskeleton association in human 
erythrocytes. J. Cell. Biochem. 18:49-65. 
Bennett, V., and A.J. Baines. 2001. Spectrin and ankyrin-based pathways: metazoan 
inventions for integrating cells into tissues. Physiol. Rev. 81:1353-1392. 
 152 
Bennett, V., and J. Davis. 1981. Erythrocyte ankyrin: immunoreactive analogues are 
associated with mitotic structures in cultured cells and with microtubules in 
brain. Proc. Natl. Acad. Sci. U. S. A. 78:7550-7554. 
Bennett, V., J. Davis, and W.E. Fowler. 1982. Brain spectrin, a membrane-associated 
protein related in structure and function to erythrocyte spectrin. Nature. 299:126-
131. 
Bennett, V., and J. Healy. 2008. Organizing the fluid membrane bilayer: diseases linked 
to spectrin and ankyrin. Trends Mol. Med. 14:28-36. 
Bennett, V., and J. Healy. 2009. Membrane domains based on ankyrin and spectrin 
associated with cell-cell interactions. Cold Spring Harb Perspect Biol. 1:a003012. 
Bennett, V., and D.N. Lorenzo. 2013. Spectrin- and ankyrin-based membrane domains 
and the evolution of vertebrates. Current topics in membranes. 72:1-37. 
Bennett, V., and P.J. Stenbuck. 1979. Identification and partial purification of ankyrin, 
the high affinity membrane attachment site for human erythrocyte spectrin. J. 
Biol. Chem. 254:2533-2541. 
Bennett, V., and P.J. Stenbuck. 1980. Human erythrocyte ankyrin. Purification and 
properties. J. Biol. Chem. 255:2540-2548. 
Benz, E.J., Jr. 2010. Learning about genomics and disease from the anucleate human red 
blood cell. J. Clin. Invest. 120:4204-4206. 
Berchtold, D., and T.C. Walther. 2009. TORC2 plasma membrane localization is essential 
for cell viability and restricted to a distinct domain. Mol. Biol. Cell. 20:1565-1575. 
Berghs, S., D. Aggujaro, R. Dirkx, Jr., E. Maksimova, P. Stabach, J.M. Hermel, J.P. Zhang, 
W. Philbrick, V. Slepnev, T. Ort, and M. Solimena. 2000. betaIV spectrin, a new 
spectrin localized at axon initial segments and nodes of ranvier in the central and 
peripheral nervous system. J. Cell Biol. 151:985-1002. 
Biggs, D.S. 2010. 3D deconvolution microscopy. Current protocols in cytometry / editorial 
board, J. Paul Robinson, managing editor ... [et al.]. Chapter 12:Unit 12 19 11-20. 
Boiko, T., M. Vakulenko, H. Ewers, C.C. Yap, C. Norden, and B. Winckler. 2007. 
Ankyrin-dependent and -independent mechanisms orchestrate axonal 
compartmentalization of L1 family members neurofascin and L1/neuron-glia cell 
adhesion molecule. J Neurosci. 27:590-603. 
 153 
Bonifacino, J.S. 2014. Adaptor proteins involved in polarized sorting. J. Cell Biol. 204:7-17. 
Bonifacino, J.S., and J. Lippincott-Schwartz. 2003. Coat proteins: shaping membrane 
transport. Nat. Rev. Mol. Cell Biol. 4:409-414. 
Bonifacino, J.S., and L.M. Traub. 2003. Signals for sorting of transmembrane proteins to 
endosomes and lysosomes. Annu. Rev. Biochem. 72:395-447. 
Brameshuber, M., J. Weghuber, V. Ruprecht, I. Gombos, I. Horvath, L. Vigh, P. 
Eckerstorfer, E. Kiss, H. Stockinger, and G.J. Schutz. 2010. Imaging of mobile 
long-lived nanoplatforms in the live cell plasma membrane. J. Biol. Chem. 
285:41765-41771. 
Brown, D.A., and E. London. 1998. Functions of lipid rafts in biological membranes. 
Annu. Rev. Cell Dev. Biol. 14:111-136. 
Brown, D.A., and J.K. Rose. 1992. Sorting of GPI-anchored proteins to glycolipid-
enriched membrane subdomains during transport to the apical cell surface. Cell. 
68:533-544. 
Brown, M.S., and J.L. Goldstein. 1976. Analysis of a mutant strain of human fibroblasts 
with a defect in the internalization of receptor-bound low density lipoprotein. 
Cell. 9:663-674. 
Busche, S., E. Kremmer, and G. Posern. 2010. E-cadherin regulates MAL-SRF-mediated 
transcription in epithelial cells. J Cell Sci. 123:2803-2809. 
Byers, T.J., and D. Branton. 1985. Visualization of the protein associations in the 
erythrocyte membrane skeleton. Proc. Natl. Acad. Sci. U. S. A. 82:6153-6157. 
Cai, X., and Y. Zhang. 2006. Molecular evolution of the ankyrin gene family. Mol. Biol. 
Evol. 23:550-558. 
Casanova, J.E., G. Apodaca, and K.E. Mostov. 1991. An autonomous signal for 
basolateral sorting in the cytoplasmic domain of the polymeric immunoglobulin 
receptor. Cell. 66:65-75. 
Chan, W., E. Kordeli, and V. Bennett. 1993. 440-kD ankyrinB: structure of the major 
developmentally regulated domain and selective localization in unmyelinated 
axons. J. Cell Biol. 123:1463-1473. 
 154 
Clarkson, Y.L., E.M. Perkins, C. Cairncross, A.R. Lyndon, P. Skehel, and M. Jackson. 
2014. beta-III spectrin underpins ankyrin R function in Purkinje cell dendritic 
trees: protein complex critical for sodium channel activity is impaired by SCA5-
associated mutations. Hum. Mol. Genet. 
Cunha, S.R., S. Le Scouarnec, J.J. Schott, and P.J. Mohler. 2008. Exon organization and 
novel alternative splicing of the human ANK2 gene: implications for cardiac 
function and human cardiac disease. Journal of molecular and cellular cardiology. 
45:724-734. 
Das, A., C. Base, S. Dhulipala, and R.R. Dubreuil. 2006. Spectrin functions upstream of 
ankyrin in a spectrin cytoskeleton assembly pathway. J. Cell Biol. 175:325-335. 
Das, A., C. Base, D. Manna, W. Cho, and R.R. Dubreuil. 2008. Unexpected complexity in 
the mechanisms that target assembly of the spectrin cytoskeleton. J. Biol. Chem. 
283:12643-12653. 
Davis, J.Q., S. Lambert, and V. Bennett. 1996. Molecular composition of the node of 
Ranvier: identification of ankyrin-binding cell adhesion molecules neurofascin 
(mucin+/third FNIII domain-) and NrCAM at nodal axon segments. The Journal of 
cell biology. 135:1355-1367. 
Davis, L., K. Abdi, M. Machius, C. Brautigam, D.R. Tomchick, V. Bennett, and P. 
Michaely. 2009. Localization and structure of the ankyrin-binding site on beta2-
spectrin. J. Biol. Chem. 284:6982-6987. 
Davis, L.H., J.Q. Davis, and V. Bennett. 1992. Ankyrin regulation: an alternatively 
spliced segment of the regulatory domain functions as an intramolecular 
modulator. The Journal of biological chemistry. 267:18966-18972. 
Dean, S.O., S.L. Rogers, N. Stuurman, R.D. Vale, and J.A. Spudich. 2005. Distinct 
pathways control recruitment and maintenance of myosin II at the cleavage 
furrow during cytokinesis. Proc. Natl. Acad. Sci. U. S. A. 102:13473-13478. 
Deborde, S., E. Perret, D. Gravotta, A. Deora, S. Salvarezza, R. Schreiner, and E. 
Rodriguez-Boulan. 2008. Clathrin is a key regulator of basolateral polarity. 
Nature. 452:719-723. 
Delint-Ramirez, I., D. Willoughby, G.V. Hammond, L.J. Ayling, and D.M. Cooper. 2011. 
Palmitoylation targets AKAP79 protein to lipid rafts and promotes its regulation 
of calcium-sensitive adenylyl cyclase type 8. J Biol Chem. 286:32962-32975. 
 155 
Di Paolo, G., and P. De Camilli. 2006. Phosphoinositides in cell regulation and 
membrane dynamics. Nature. 443:651-657. 
Djinovic Carugo, K., S. Banuelos, and M. Saraste. 1997. Crystal structure of a calponin 
homology domain. Nat. Struct. Biol. 4:175-179. 
Drisdel, R.C., J.K. Alexander, A. Sayeed, and W.N. Green. 2006. Assays of protein 
palmitoylation. Methods. 40:127-134. 
Duffield, A., H. Folsch, I. Mellman, and M.J. Caplan. 2004. Sorting of H,K-ATPase beta-
subunit in MDCK and LLC-PK cells is independent of mu 1B adaptin expression. 
Traffic. 5:449-461. 
Dzhashiashvili, Y., Y. Zhang, J. Galinska, I. Lam, M. Grumet, and J.L. Salzer. 2007. Nodes 
of Ranvier and axon initial segments are ankyrin G-dependent domains that 
assemble by distinct mechanisms. J Cell Biol. 177:857-870. 
Edelman, E.J., Y. Maksimova, F. Duru, C. Altay, and P.G. Gallagher. 2007. A complex 
splicing defect associated with homozygous ankyrin-deficient hereditary 
spherocytosis. Blood. 109:5491-5493. 
Edidin, M. 2003. The state of lipid rafts: from model membranes to cells. Annu. Rev. 
Biophys. Biomol. Struct. 32:257-283. 
Even-Ram, S., A.D. Doyle, M.A. Conti, K. Matsumoto, R.S. Adelstein, and K.M. Yamada. 
2007. Myosin IIA regulates cell motility and actomyosin-microtubule crosstalk. 
Nat. Cell Biol. 9:299-309. 
Farias, G.G., L. Cuitino, X. Guo, X. Ren, M. Jarnik, R. Mattera, and J.S. Bonifacino. 2012. 
Signal-mediated, AP-1/clathrin-dependent sorting of transmembrane receptors to 
the somatodendritic domain of hippocampal neurons. Neuron. 75:810-823. 
Fernandez-Hernando, C., M. Fukata, P.N. Bernatchez, Y. Fukata, M.I. Lin, D.S. Bredt, 
and W.C. Sessa. 2006. Identification of Golgi-localized acyl transferases that 
palmitoylate and regulate endothelial nitric oxide synthase. J. Cell Biol. 174:369-
377. 
Folsch, H., H. Ohno, J.S. Bonifacino, and I. Mellman. 1999. A novel clathrin adaptor 
complex mediates basolateral targeting in polarized epithelial cells. Cell. 99:189-
198. 
 156 
Folsch, H., M. Pypaert, S. Maday, L. Pelletier, and I. Mellman. 2003. The AP-1A and AP-
1B clathrin adaptor complexes define biochemically and functionally distinct 
membrane domains. J. Cell Biol. 163:351-362. 
Ford, M.G., B.M. Pearse, M.K. Higgins, Y. Vallis, D.J. Owen, A. Gibson, C.R. Hopkins, 
P.R. Evans, and H.T. McMahon. 2001. Simultaneous binding of PtdIns(4,5)P2 and 
clathrin by AP180 in the nucleation of clathrin lattices on membranes. Science. 
291:1051-1055. 
Forrester, M.T., D.T. Hess, J.W. Thompson, R. Hultman, M.A. Moseley, J.S. Stamler, and 
P.J. Casey. 2011. Site-specific analysis of protein S-acylation by resin-assisted 
capture. J Lipid Res. 52:393-398. 
Fragoso, R., D. Ren, X. Zhang, M.W. Su, S.J. Burakoff, and Y.J. Jin. 2003. Lipid raft 
distribution of CD4 depends on its palmitoylation and association with Lck, and 
evidence for CD4-induced lipid raft aggregation as an additional mechanism to 
enhance CD3 signaling. J Immunol. 170:913-921. 
Fukata, M., Y. Fukata, H. Adesnik, R.A. Nicoll, and D.S. Bredt. 2004. Identification of 
PSD-95 palmitoylating enzymes. Neuron. 44:987-996. 
Fukata, Y., A. Dimitrov, G. Boncompain, O. Vielemeyer, F. Perez, and M. Fukata. 2013. 
Local palmitoylation cycles define activity-regulated postsynaptic subdomains. J. 
Cell Biol. 202:145-161. 
Fukata, Y., and M. Fukata. 2010. Protein palmitoylation in neuronal development and 
synaptic plasticity. Nat. Rev. Neurosci. 11:161-175. 
Fukata, Y., T. Iwanaga, and M. Fukata. 2006. Systematic screening for palmitoyl 
transferase activity of the DHHC protein family in mammalian cells. Methods. 
40:177-182. 
Gaidarov, I., and J.H. Keen. 1999. Phosphoinositide-AP-2 interactions required for 
targeting to plasma membrane clathrin-coated pits. J. Cell Biol. 146:755-764. 
Galiano, M.R., S. Jha, T.S. Ho, C. Zhang, Y. Ogawa, K.J. Chang, M.C. Stankewich, P.J. 
Mohler, and M.N. Rasband. 2012. A Distal Axonal Cytoskeleton Forms an Intra-
Axonal Boundary that Controls Axon Initial Segment Assembly. Cell. 149:1125-
1139. 
 157 
Gallagher, P.G., L.A. Steiner, R.I. Liem, A.N. Owen, A.P. Cline, N.E. Seidel, L.J. Garrett, 
and D.M. Bodine. 2010. Mutation of a barrier insulator in the human ankyrin-1 
gene is associated with hereditary spherocytosis. J. Clin. Invest. 120:4453-4465. 
Garbe, D.S., A. Das, R.R. Dubreuil, and G.J. Bashaw. 2007. beta-Spectrin functions 
independently of Ankyrin to regulate the establishment and maintenance of axon 
connections in the Drosophila embryonic CNS. Development. 134:273-284. 
Glenney, J.R., Jr., P. Glenney, and K. Weber. 1983. The spectrin-related molecule, TW-
260/240, cross-links the actin bundles of the microvillus rootlets in the brush 
borders of intestinal epithelial cells. J. Cell Biol. 96:1491-1496. 
Goksoy, E., Y.Q. Ma, X. Wang, X. Kong, D. Perera, E.F. Plow, and J. Qin. 2008. Structural 
basis for the autoinhibition of talin in regulating integrin activation. Mol. Cell. 
31:124-133. 
Goldstein, J.L., and M.S. Brown. 1977. The low-density lipoprotein pathway and its 
relation to atherosclerosis. Annu. Rev. Biochem. 46:897-930. 
Gomez, J.M., Y. Wang, and V. Riechmann. 2012. Tao controls epithelial morphogenesis 
by promoting Fasciclin 2 endocytosis. J. Cell Biol. 199:1131-1143. 
Gravotta, D., J.M. Carvajal-Gonzalez, R. Mattera, S. Deborde, J.R. Banfelder, J.S. 
Bonifacino, and E. Rodriguez-Boulan. 2012. The clathrin adaptor AP-1A mediates 
basolateral polarity. Dev. Cell. 22:811-823. 
Greaves, J., and L.H. Chamberlain. 2010. S-acylation by the DHHC protein family. 
Biochemical Society transactions. 38:522-524. 
Greaves, J., and L.H. Chamberlain. 2011. Differential palmitoylation regulates 
intracellular patterning of SNAP25. J. Cell Sci. 124:1351-1360. 
Grubb, M.S., and J. Burrone. 2010. Building and maintaining the axon initial segment. 
Curr. Opin. Neurobiol. 20:481-488. 
Gumbiner, B., B. Stevenson, and A. Grimaldi. 1988. The role of the cell adhesion 
molecule uvomorulin in the formation and maintenance of the epithelial 
junctional complex. J. Cell Biol. 107:1575-1587. 
Gundel, F., S. Eber, and A. Heep. 2011. A new ankyrin mutation (ANK1 EXON E9X) 
causing severe hereditary spherocytosis in the neonatal period. Ann. Hematol. 
90:231-232. 
 158 
Hall, T.G., and V. Bennett. 1987. Regulatory domains of erythrocyte ankyrin. The Journal 
of biological chemistry. 262:10537-10545. 
Hammond, G.R., M.J. Fischer, K.E. Anderson, J. Holdich, A. Koteci, T. Balla, and R.F. 
Irvine. 2012. PI4P and PI(4,5)P2 are essential but independent lipid determinants 
of membrane identity. Science. 337:727-730. 
Harris, T.J., and C.H. Siu. 2002. Reciprocal raft-receptor interactions and the assembly of 
adhesion complexes. Bioessays. 24:996-1003. 
Hase, K., F. Nakatsu, M. Ohmae, K. Sugihara, N. Shioda, D. Takahashi, Y. Obata, Y. 
Furusawa, Y. Fujimura, T. Yamashita, S. Fukuda, H. Okamoto, M. Asano, S. 
Yonemura, and H. Ohno. 2013. AP-1B-mediated protein sorting regulates 
polarity and proliferation of intestinal epithelial cells in mice. Gastroenterology. 
145:625-635. 
He, M., P. Jenkins, and V. Bennett. 2012. Cysteine 70 of ankyrin-G is S-palmitoylated and 
is required for function of ankyrin-G in membrane domain assembly. J. Biol. 
Chem. 287:43995-44005. 
Healy, J.A., K.R. Nilsson, H.E. Hohmeier, J. Berglund, J. Davis, J. Hoffman, M. Kohler, 
L.S. Li, P.O. Berggren, C.B. Newgard, and V. Bennett. 2010. Cholinergic 
augmentation of insulin release requires ankyrin-B. Science signaling. 3:ra19. 
Hedstrom, K.L., Y. Ogawa, and M.N. Rasband. 2008. AnkyrinG is required for 
maintenance of the axon initial segment and neuronal polarity. J. Cell Biol. 
183:635-640. 
Hedstrom, K.L., X. Xu, Y. Ogawa, R. Frischknecht, C.I. Seidenbecher, P. Shrager, and 
M.N. Rasband. 2007. Neurofascin assembles a specialized extracellular matrix at 
the axon initial segment. J. Cell Biol. 178:875-886. 
Heerklotz, H. 2002. Triton promotes domain formation in lipid raft mixtures. Biophys. J. 
83:2693-2701. 
Henis, Y.I., B. Rotblat, and Y. Kloog. 2006. FRAP beam-size analysis to measure 
palmitoylation-dependent membrane association dynamics and microdomain 
partitioning of Ras proteins. Methods. 40:183-190. 
Hirst, J., and M.S. Robinson. 1998. Clathrin and adaptors. Biochim. Biophys. Acta. 
1404:173-193. 
 159 
Hoock, T.C., L.L. Peters, and S.E. Lux. 1997. Isoforms of ankyrin-3 that lack the NH2-
terminal repeats associate with mouse macrophage lysosomes. J. Cell Biol. 
136:1059-1070. 
Hu, R.J., S. Moorthy, and V. Bennett. 1995. Expression of functional domains of beta G-
spectrin disrupts epithelial morphology in cultured cells. J. Cell Biol. 128:1069-
1080. 
Hu, R.J., M. Watanabe, and V. Bennett. 1992. Characterization of human brain cDNA 
encoding the general isoform of beta-spectrin. J. Biol. Chem. 267:18715-18722. 
Huang, H., P. Zhao, K. Arimatsu, K. Tabeta, K. Yamazaki, L. Krieg, E. Fu, T. Zhang, and 
X. Du. 2013. A deep intronic mutation in the ankyrin-1 gene causes diminished 
protein expression resulting in hemolytic anemia in mice. G3. 3:1687-1695. 
Hull, R.N., W.R. Cherry, and G.W. Weaver. 1976. The origin and characteristics of a pig 
kidney cell strain, LLC-PK. In Vitro. 12:670-677. 
Hund, T.J., O.M. Koval, J. Li, P.J. Wright, L. Qian, J.S. Snyder, H. Gudmundsson, C.F. 
Kline, N.P. Davidson, N. Cardona, M.N. Rasband, M.E. Anderson, and P.J. 
Mohler. 2010. A beta(IV)-spectrin/CaMKII signaling complex is essential for 
membrane excitability in mice. J. Clin. Invest. 120:3508-3519. 
Hunziker, W., C. Harter, K. Matter, and I. Mellman. 1991. Basolateral sorting in MDCK 
cells requires a distinct cytoplasmic domain determinant. Cell. 66:907-920. 
Hyvonen, M., M.J. Macias, M. Nilges, H. Oschkinat, M. Saraste, and M. Wilmanns. 1995. 
Structure of the binding site for inositol phosphates in a PH domain. EMBO J. 
14:4676-4685. 
Ipsaro, J.J., L. Huang, and A. Mondragon. 2009. Structures of the spectrin-ankyrin 
interaction binding domains. Blood. 113:5385-5393. 
Ipsaro, J.J., and A. Mondragon. 2010. Structural basis for spectrin recognition by ankyrin. 
Blood. 115:4093-4101. 
Iwanaga, T., R. Tsutsumi, J. Noritake, Y. Fukata, and M. Fukata. 2009. Dynamic protein 
palmitoylation in cellular signaling. Prog. Lipid Res. 48:117-127. 
Jenkins, P.M., C. Vasavda, J. Hostettler, J.Q. Davis, K. Abdi, and V. Bennett. 2013. E-
cadherin polarity is determined by a multifunction motif mediating lateral 
 160 
membrane retention through ankyrin-G and apical-lateral transcytosis through 
clathrin. J. Biol. Chem. 288:14018-14031. 
Jenkins, S.M., and V. Bennett. 2001. Ankyrin-G coordinates assembly of the spectrin-
based membrane skeleton, voltage-gated sodium channels, and L1 CAMs at 
Purkinje neuron initial segments. J. Cell Biol. 155:739-746. 
Jenkins, S.M., and V. Bennett. 2002. Developing nodes of Ranvier are defined by 
ankyrin-G clustering and are independent of paranodal axoglial adhesion. 
Proceedings of the National Academy of Sciences of the United States of America. 
99:2303-2308. 
Jennings, B.C., and M.E. Linder. 2012. DHHC protein S-acyltransferases use similar 
ping-pong kinetic mechanisms but display different acyl-CoA specificities. J. Biol. 
Chem. 287:7236-7245. 
Johnson, J.L., J.W. Erickson, and R.A. Cerione. 2012. C-terminal di-arginine motif of 
Cdc42 protein is essential for binding to phosphatidylinositol 4,5-bisphosphate-
containing membranes and inducing cellular transformation. J. Biol. Chem. 
287:5764-5774. 
Kaiser, H.W., E. O'Keefe, and V. Bennett. 1989. Adducin: Ca++-dependent association 
with sites of cell-cell contact. J. Cell Biol. 109:557-569. 
Kalthoff, C., J. Alves, C. Urbanke, R. Knorr, and E.J. Ungewickell. 2002a. Unusual 
structural organization of the endocytic proteins AP180 and epsin 1. J. Biol. Chem. 
277:8209-8216. 
Kalthoff, C., S. Groos, R. Kohl, S. Mahrhold, and E.J. Ungewickell. 2002b. Clint: a novel 
clathrin-binding ENTH-domain protein at the Golgi. Mol. Biol. Cell. 13:4060-4073. 
Kennedy, S.P., S.L. Warren, B.G. Forget, and J.S. Morrow. 1991. Ankyrin binds to the 
15th repetitive unit of erythroid and nonerythroid beta-spectrin. J. Cell Biol. 
115:267-277. 
Kirchhausen, T. 1999. Adaptors for clathrin-mediated traffic. Annu. Rev. Cell Dev. Biol. 
15:705-732. 
Kizhatil, K., S.A. Baker, V.Y. Arshavsky, and V. Bennett. 2009a. Ankyrin-G promotes 
cyclic nucleotide-gated channel transport to rod photoreceptor sensory cilia. 
Science. 323:1614-1617. 
 161 
Kizhatil, K., and V. Bennett. 2004. Lateral membrane biogenesis in human bronchial 
epithelial cells requires 190-kDa ankyrin-G. J Biol Chem. 279:16706-16714. 
Kizhatil, K., J.Q. Davis, L. Davis, J. Hoffman, B.L. Hogan, and V. Bennett. 2007a. 
Ankyrin-G is a molecular partner of E-cadherin in epithelial cells and early 
embryos. J Biol Chem. 282:26552-26561. 
Kizhatil, K., N.K. Sandhu, N.S. Peachey, and V. Bennett. 2009b. Ankyrin-B is required 
for coordinated expression of beta-2-spectrin, the Na/K-ATPase and the Na/Ca 
exchanger in the inner segment of rod photoreceptors. Exp. Eye Res. 88:57-64. 
Kizhatil, K., W. Yoon, P.J. Mohler, L.H. Davis, J.A. Hoffman, and V. Bennett. 2007b. 
Ankyrin-G and beta2-spectrin collaborate in biogenesis of lateral membrane of 
human bronchial epithelial cells. J. Biol. Chem. 282:2029-2037. 
Komada, M., and P. Soriano. 2002. [Beta]IV-spectrin regulates sodium channel clustering 
through ankyrin-G at axon initial segments and nodes of Ranvier. J. Cell Biol. 
156:337-348. 
Kordeli, E., J. Davis, B. Trapp, and V. Bennett. 1990. An isoform of ankyrin is localized at 
nodes of Ranvier in myelinated axons of central and peripheral nerves. J. Cell 
Biol. 110:1341-1352. 
Kordeli, E., S. Lambert, and V. Bennett. 1995. AnkyrinG. A new ankyrin gene with 
neural-specific isoforms localized at the axonal initial segment and node of 
Ranvier. J. Biol. Chem. 270:2352-2359. 
Koticha, D., P. Maurel, G. Zanazzi, N. Kane-Goldsmith, S. Basak, J. Babiarz, J. Salzer, and 
M. Grumet. 2006. Neurofascin interactions play a critical role in clustering 
sodium channels, ankyrin G and beta IV spectrin at peripheral nodes of Ranvier. 
Dev. Biol. 293:1-12. 
Kunimoto, M. 1995. A neuron-specific isoform of brain ankyrin, 440-kD ankyrinB, is 
targeted to the axons of rat cerebellar neurons. J. Cell Biol. 131:1821-1829. 
Kunimoto, M., E. Otto, and V. Bennett. 1991. A new 440-kD isoform is the major ankyrin 
in neonatal rat brain. J. Cell Biol. 115:1319-1331. 
Kusumi, A., I. Koyama-Honda, and K. Suzuki. 2004. Molecular dynamics and 
interactions for creation of stimulation-induced stabilized rafts from small 
unstable steady-state rafts. Traffic. 5:213-230. 
 162 
Kwiatkowska, K. 2010. One lipid, multiple functions: how various pools of PI(4,5)P(2) 
are created in the plasma membrane. Cell. Mol. Life Sci. 67:3927-3946. 
Legendre, K., S. Safieddine, P. Kussel-Andermann, C. Petit, and A. El-Amraoui. 2008. 
alphaII-betaV spectrin bridges the plasma membrane and cortical lattice in the 
lateral wall of the auditory outer hair cells. J. Cell Sci. 121:3347-3356. 
Lentz, B.R., D.A. Barrow, and M. Hoechli. 1980. Cholesterol-phosphatidylcholine 
interactions in multilamellar vesicles. Biochemistry (Mosc.). 19:1943-1954. 
Levental, I., M. Grzybek, and K. Simons. 2010. Greasing their way: lipid modifications 
determine protein association with membrane rafts. Biochemistry. 49:6305-6316. 
Levine, J., and M. Willard. 1981. Fodrin: axonally transported polypeptides associated 
with the internal periphery of many cells. The Journal of cell biology. 90:631-642. 
Li, Y., B.R. Martin, B.F. Cravatt, and S.L. Hofmann. 2012. DHHC5 protein palmitoylates 
flotillin-2 and is rapidly degraded on induction of neuronal differentiation in 
cultured cells. J. Biol. Chem. 287:523-530. 
Lim, J.A., H.J. Baek, M.S. Jang, E.K. Choi, Y.M. Lee, S.J. Lee, S.C. Lim, J.Y. Kim, T.H. Kim, 
H.S. Kim, L. Mishra, and S.S. Kim. 2014. Loss of beta2-spectrin prevents 
cardiomyocyte differentiation and heart development. Cardiovasc. Res. 101:39-47. 
Lin, H., L. Yue, and A.C. Spradling. 1994. The Drosophila fusome, a germline-specific 
organelle, contains membrane skeletal proteins and functions in cyst formation. 
Development. 120:947-956. 
Linder, M.E., and R.J. Deschenes. 2007. Palmitoylation: policing protein stability and 
traffic. Nat Rev Mol Cell Biol. 8:74-84. 
Lingwood, D., and K. Simons. 2010. Lipid rafts as a membrane-organizing principle. 
Science. 327:46-50. 
Lise, S., Y. Clarkson, E. Perkins, A. Kwasniewska, E. Sadighi Akha, R.P. Schnekenberg, 
D. Suminaite, J. Hope, I. Baker, L. Gregory, A. Green, C. Allan, S. Lamble, S. 
Jayawant, G. Quaghebeur, M.Z. Cader, S. Hughes, R.J. Armstrong, A. Kanapin, 
A. Rimmer, G. Lunter, I. Mathieson, J.B. Cazier, D. Buck, J.C. Taylor, D. Bentley, 
G. McVean, P. Donnelly, S.J. Knight, M. Jackson, J. Ragoussis, and A.H. Nemeth. 
2012. Recessive mutations in SPTBN2 implicate beta-III spectrin in both cognitive 
and motor development. PLoS Genet. 8:e1003074. 
 163 
Liu, S.C., L.H. Derick, and J. Palek. 1987. Visualization of the hexagonal lattice in the 
erythrocyte membrane skeleton. J. Cell Biol. 104:527-536. 
Lonergan, K.M., O. Iliopoulos, M. Ohh, T. Kamura, R.C. Conaway, J.W. Conaway, and 
W.G. Kaelin, Jr. 1998. Regulation of hypoxia-inducible mRNAs by the von 
Hippel-Lindau tumor suppressor protein requires binding to complexes 
containing elongins B/C and Cul2. Molecular and cellular biology. 18:732-741. 
Lowe, J.S., O. Palygin, N. Bhasin, T.J. Hund, P.A. Boyden, E. Shibata, M.E. Anderson, 
and P.J. Mohler. 2008. Voltage-gated Nav channel targeting in the heart requires 
an ankyrin-G dependent cellular pathway. J. Cell Biol. 180:173-186. 
Macia, E., M. Ehrlich, R. Massol, E. Boucrot, C. Brunner, and T. Kirchhausen. 2006. 
Dynasore, a cell-permeable inhibitor of dynamin. Dev. Cell. 10:839-850. 
Macias, M.J., A. Musacchio, H. Ponstingl, M. Nilges, M. Saraste, and H. Oschkinat. 1994. 
Structure of the pleckstrin homology domain from beta-spectrin. Nature. 369:675-
677. 
Marsilio, E., S.H. Cheng, B. Schaffhausen, E. Paucha, and D.M. Livingston. 1991. The T/t 
common region of simian virus 40 large T antigen contains a distinct 
transformation-governing sequence. Journal of virology. 65:5647-5652. 
Martin-Belmonte, F., A. Gassama, A. Datta, W. Yu, U. Rescher, V. Gerke, and K. Mostov. 
2007. PTEN-mediated apical segregation of phosphoinositides controls epithelial 
morphogenesis through Cdc42. Cell. 128:383-397. 
Martin, B.R., C. Wang, A. Adibekian, S.E. Tully, and B.F. Cravatt. 2012. Global profiling 
of dynamic protein palmitoylation. Nat. Methods. 9:84-89. 
Martinez-Palomo, A., I. Meza, G. Beaty, and M. Cereijido. 1980. Experimental 
modulation of occluding junctions in a cultured transporting epithelium. J. Cell 
Biol. 87:736-745. 
Mattey, D.L., and D.R. Garrod. 1986. Calcium-induced desmosome formation in 
cultured kidney epithelial cells. J. Cell Sci. 85:95-111. 
Mazock, G.H., A. Das, C. Base, and R.R. Dubreuil. 2010. Transgene rescue identifies an 
essential function for Drosophila beta spectrin in the nervous system and a 
selective requirement for ankyrin-2-binding activity. Mol. Biol. Cell. 21:2860-2868. 
 164 
Michaely, P., D.R. Tomchick, M. Machius, and R.G. Anderson. 2002. Crystal structure of 
a 12 ANK repeat stack from human ankyrinR. EMBO J. 21:6387-6396. 
Miranda, K.C., T. Khromykh, P. Christy, T.L. Le, C.J. Gottardi, A.S. Yap, J.L. Stow, and 
R.D. Teasdale. 2001. A dileucine motif targets E-cadherin to the basolateral cell 
surface in Madin-Darby canine kidney and LLC-PK1 epithelial cells. J. Biol. Chem. 
276:22565-22572. 
Mohler, P.J., J.Q. Davis, and V. Bennett. 2005. Ankyrin-B coordinates the Na/K ATPase, 
Na/Ca exchanger, and InsP3 receptor in a cardiac T-tubule/SR microdomain. 
PLoS Biol. 3:e423. 
Mohler, P.J., J.Q. Davis, L.H. Davis, J.A. Hoffman, P. Michaely, and V. Bennett. 2004a. 
Inositol 1,4,5-trisphosphate receptor localization and stability in neonatal 
cardiomyocytes requires interaction with ankyrin-B. The Journal of biological 
chemistry. 279:12980-12987. 
Mohler, P.J., A.O. Gramolini, and V. Bennett. 2002a. The ankyrin-B C-terminal domain 
determines activity of ankyrin-B/G chimeras in rescue of abnormal inositol 1,4,5-
trisphosphate and ryanodine receptor distribution in ankyrin-B (-/-) neonatal 
cardiomyocytes. The Journal of biological chemistry. 277:10599-10607. 
Mohler, P.J., A.O. Gramolini, and V. Bennett. 2002b. The -B C-terminal domain 
determines activity of ankyrin-B/G chimeras in rescue of abnormal inositol 1,4,5-
trisphosphate and ryanodine receptor distribution in ankyrin-B (-/-) neonatal 
cardiomyocytes. The Journal of biological chemistry. 277:10599-10607. 
Mohler, P.J., J.A. Healy, H. Xue, A.A. Puca, C.F. Kline, R.R. Allingham, E.G. Kranias, 
H.A. Rockman, and V. Bennett. 2007a. Ankyrin-B syndrome: enhanced cardiac 
function balanced by risk of cardiac death and premature senescence. PloS one. 
2:e1051. 
Mohler, P.J., J.A. Hoffman, J.Q. Davis, K.M. Abdi, C.R. Kim, S.K. Jones, L.H. Davis, K.F. 
Roberts, and V. Bennett. 2004b. Isoform specificity among ankyrins. An 
amphipathic alpha-helix in the divergent regulatory domain of ankyrin-b 
interacts with the molecular co-chaperone Hdj1/Hsp40. The Journal of biological 
chemistry. 279:25798-25804. 
Mohler, P.J., S. Le Scouarnec, I. Denjoy, J.S. Lowe, P. Guicheney, L. Caron, I.M. Driskell, 
J.J. Schott, K. Norris, A. Leenhardt, R.B. Kim, D. Escande, and D.M. Roden. 
2007b. Defining the cellular phenotype of "ankyrin-B syndrome" variants: human 
 165 
ANK2 variants associated with clinical phenotypes display a spectrum of 
activities in cardiomyocytes. Circulation. 115:432-441. 
Mohler, P.J., I. Rivolta, C. Napolitano, G. LeMaillet, S. Lambert, S.G. Priori, and V. 
Bennett. 2004c. Nav1.5 E1053K mutation causing Brugada syndrome blocks 
binding to ankyrin-G and expression of Nav1.5 on the surface of cardiomyocytes. 
Proc. Natl. Acad. Sci. U. S. A. 101:17533-17538. 
Mohler, P.J., J.J. Schott, A.O. Gramolini, K.W. Dilly, S. Guatimosim, W.H. duBell, L.S. 
Song, K. Haurogne, F. Kyndt, M.E. Ali, T.B. Rogers, W.J. Lederer, D. Escande, H. 
Le Marec, and V. Bennett. 2003. Ankyrin-B mutation causes type 4 long-QT 
cardiac arrhythmia and sudden cardiac death. Nature. 421:634-639. 
Mohler, P.J., I. Splawski, C. Napolitano, G. Bottelli, L. Sharpe, K. Timothy, S.G. Priori, 
M.T. Keating, and V. Bennett. 2004d. A cardiac arrhythmia syndrome caused by 
loss of ankyrin-B function. Proceedings of the National Academy of Sciences of the 
United States of America. 101:9137-9142. 
Mohler, P.J., W. Yoon, and V. Bennett. 2004e. Ankyrin-B targets beta2-spectrin to an 
intracellular compartment in neonatal cardiomyocytes. The Journal of biological 
chemistry. 279:40185-40193. 
Mosher, R.A., W.E. Durrant, D. Wang, J. Song, and X. Dong. 2006. A comprehensive 
structure-function analysis of Arabidopsis SNI1 defines essential regions and 
transcriptional repressor activity. The Plant cell. 18:1750-1765. 
Mostov, K.E., A. de Bruyn Kops, and D.L. Deitcher. 1986. Deletion of the cytoplasmic 
domain of the polymeric immunoglobulin receptor prevents basolateral 
localization and endocytosis. Cell. 47:359-364. 
Motley, A., N.A. Bright, M.N. Seaman, and M.S. Robinson. 2003. Clathrin-mediated 
endocytosis in AP-2-depleted cells. J. Cell Biol. 162:909-918. 
Mousavi, S.A., L. Malerod, T. Berg, and R. Kjeken. 2004. Clathrin-dependent 
endocytosis. Biochem. J. 377:1-16. 
Munro, S. 2003. Lipid rafts: elusive or illusive? Cell. 115:377-388. 
Nakatsu, F., J.M. Baskin, J. Chung, L.B. Tanner, G. Shui, S.Y. Lee, M. Pirruccello, M. Hao, 
N.T. Ingolia, M.R. Wenk, and P. De Camilli. 2012. PtdIns4P synthesis by 
PI4KIIIalpha at the plasma membrane and its impact on plasma membrane 
identity. J. Cell Biol. 199:1003-1016. 
 166 
Nejsum, L.N., and W.J. Nelson. 2009. Epithelial cell surface polarity: the early steps. 
Front Biosci (Landmark Ed). 14:1088-1098. 
Nelson, W.J., R.W. Hammerton, A.Z. Wang, and E.M. Shore. 1990a. Involvement of the 
membrane-cytoskeleton in development of epithelial cell polarity. Semin. Cell 
Biol. 1:359-371. 
Nelson, W.J., E.M. Shore, A.Z. Wang, and R.W. Hammerton. 1990b. Identification of a 
membrane-cytoskeletal complex containing the cell adhesion molecule 
uvomorulin (E-cadherin), ankyrin, and fodrin in Madin-Darby canine kidney 
epithelial cells. J. Cell Biol. 110:349-357. 
Nelson, W.J., and P.J. Veshnock. 1987. Ankyrin binding to (Na+ + K+)ATPase and 
implications for the organization of membrane domains in polarized cells. 
Nature. 328:533-536. 
Ohara, O., R. Ohara, H. Yamakawa, D. Nakajima, and M. Nakayama. 1998. 
Characterization of a new beta-spectrin gene which is predominantly expressed 
in brain. Brain Res. Mol. Brain Res. 57:181-192. 
Ohno, H., T. Tomemori, F. Nakatsu, Y. Okazaki, R.C. Aguilar, H. Foelsch, I. Mellman, T. 
Saito, T. Shirasawa, and J.S. Bonifacino. 1999. Mu1B, a novel adaptor medium 
chain expressed in polarized epithelial cells. FEBS Lett. 449:215-220. 
Ohno, Y., A. Kihara, T. Sano, and Y. Igarashi. 2006. Intracellular localization and tissue-
specific distribution of human and yeast DHHC cysteine-rich domain-containing 
proteins. Biochim. Biophys. Acta. 1761:474-483. 
Padron, D., Y.J. Wang, M. Yamamoto, H. Yin, and M.G. Roth. 2003. Phosphatidylinositol 
phosphate 5-kinase Ibeta recruits AP-2 to the plasma membrane and regulates 
rates of constitutive endocytosis. J. Cell Biol. 162:693-701. 
Papal, S., M. Cortese, K. Legendre, N. Sorusch, J. Dragavon, I. Sahly, S. Shorte, U. 
Wolfrum, C. Petit, and A. El-Amraoui. 2013. The giant spectrin betaV couples the 
molecular motors to phototransduction and Usher syndrome type I proteins 
along their trafficking route. Hum. Mol. Genet. 22:3773-3788. 
Parkinson, N.J., C.L. Olsson, J.L. Hallows, J. McKee-Johnson, B.P. Keogh, K. Noben-
Trauth, S.G. Kujawa, and B.L. Tempel. 2001. Mutant beta-spectrin 4 causes 
auditory and motor neuropathies in quivering mice. Nat. Genet. 29:61-65. 
 167 
Pearse, B.M. 1975. Coated vesicles from pig brain: purification and biochemical 
characterization. J. Mol. Biol. 97:93-98. 
Peters, L.L., K.M. John, F.M. Lu, E.M. Eicher, A. Higgins, M. Yialamas, L.C. Turtzo, A.J. 
Otsuka, and S.E. Lux. 1995. Ank3 (epithelial ankyrin), a widely distributed new 
member of the ankyrin gene family and the major ankyrin in kidney, is 
expressed in alternatively spliced forms, including forms that lack the repeat 
domain. J. Cell Biol. 130:313-330. 
Pizzo, P., E. Giurisato, M. Tassi, A. Benedetti, T. Pozzan, and A. Viola. 2002. Lipid rafts 
and T cell receptor signaling: a critical re-evaluation. Eur. J. Immunol. 32:3082-
3091. 
Rameh, L.E., A. Arvidsson, K.L. Carraway, 3rd, A.D. Couvillon, G. Rathbun, A. 
Crompton, B. VanRenterghem, M.P. Czech, K.S. Ravichandran, S.J. Burakoff, D.S. 
Wang, C.S. Chen, and L.C. Cantley. 1997. A comparative analysis of the 
phosphoinositide binding specificity of pleckstrin homology domains. J. Biol. 
Chem. 272:22059-22066. 
Rasband, M.N. 2011. Composition, assembly, and maintenance of excitable membrane 
domains in myelinated axons. Semin. Cell Dev. Biol. 22:178-184. 
Ren, Q., and V. Bennett. 1998. Palmitoylation of neurofascin at a site in the membrane-
spanning domain highly conserved among the L1 family of cell adhesion 
molecules. J Neurochem. 70:1839-1849. 
Rocks, O., M. Gerauer, N. Vartak, S. Koch, Z.P. Huang, M. Pechlivanis, J. Kuhlmann, L. 
Brunsveld, A. Chandra, B. Ellinger, H. Waldmann, and P.I. Bastiaens. 2010. The 
palmitoylation machinery is a spatially organizing system for peripheral 
membrane proteins. Cell. 141:458-471. 
Rodriguez Boulan, E., and D.D. Sabatini. 1978. Asymmetric budding of viruses in 
epithelial monlayers: a model system for study of epithelial polarity. Proc. Natl. 
Acad. Sci. U. S. A. 75:5071-5075. 
Roduit, C., F.G. van der Goot, P. De Los Rios, A. Yersin, P. Steiner, G. Dietler, S. Catsicas, 
F. Lafont, and S. Kasas. 2008. Elastic membrane heterogeneity of living cells 
revealed by stiff nanoscale membrane domains. Biophys. J. 94:1521-1532. 
Rohde, G., D. Wenzel, and V. Haucke. 2002. A phosphatidylinositol (4,5)-bisphosphate 
binding site within mu2-adaptin regulates clathrin-mediated endocytosis. J. Cell 
Biol. 158:209-214. 
 168 
Roth, A.F., Y. Feng, L. Chen, and N.G. Davis. 2002. The yeast DHHC cysteine-rich 
domain protein Akr1p is a palmitoyl transferase. J. Cell Biol. 159:23-28. 
Salaun, C., J. Greaves, and L.H. Chamberlain. 2010. The intracellular dynamic of protein 
palmitoylation. J Cell Biol. 191:1229-1238. 
Salle, L., and F. Brette. 2007. T-tubules: a key structure of cardiac function and 
dysfunction. Arch. Mal. Coeur Vaiss. 100:225-230. 
Sangerman, J., Y. Maksimova, E.J. Edelman, J.S. Morrow, B.G. Forget, and P.G. 
Gallagher. 2008. Ankyrin-linked hereditary spherocytosis in an African-
American kindred. Am. J. Hematol. 83:789-794. 
Santangelo, P.J., A.W. Lifland, P. Curt, Y. Sasaki, G.J. Bassell, M.E. Lindquist, and J.E. 
Crowe, Jr. 2009. Single molecule-sensitive probes for imaging RNA in live cells. 
Nat. Methods. 6:347-349. 
Sato, T., S. Mushiake, Y. Kato, K. Sato, M. Sato, N. Takeda, K. Ozono, K. Miki, Y. Kubo, 
A. Tsuji, R. Harada, and A. Harada. 2007. The Rab8 GTPase regulates apical 
protein localization in intestinal cells. Nature. 448:366-369. 
Scotland, P., D. Zhou, H. Benveniste, and V. Bennett. 1998. Nervous system defects of 
AnkyrinB (-/-) mice suggest functional overlap between the cell adhesion 
molecule L1 and 440-kD AnkyrinB in premyelinated axons. The Journal of cell 
biology. 143:1305-1315. 
Sellers, W.R., B.G. Novitch, S. Miyake, A. Heith, G.A. Otterson, F.J. Kaye, A.B. Lassar, 
and W.G. Kaelin, Jr. 1998. Stable binding to E2F is not required for the 
retinoblastoma protein to activate transcription, promote differentiation, and 
suppress tumor cell growth. Genes & development. 12:95-106. 
Sezgin, E., and P. Schwille. 2011. Fluorescence techniques to study lipid dynamics. Cold 
Spring Harb. Perspect. Biol. 3:a009803. 
Shafaq-Zadah, M., L. Brocard, F. Solari, and G. Michaux. 2012. AP-1 is required for the 
maintenance of apico-basal polarity in the C. elegans intestine. Development. 
139:2061-2070. 
Shewan, A., D.J. Eastburn, and K. Mostov. 2011. Phosphoinositides in cell architecture. 
Cold Spring Harb. Perspect. Biol. 3:a004796. 
 169 
Shotton, D.M., B.E. Burke, and D. Branton. 1979. The molecular structure of human 
erythrocyte spectrin. Biophysical and electron microscopic studies. J. Mol. Biol. 
131:303-329. 
Sibarita, J.B. 2005. Deconvolution microscopy. Adv. Biochem. Eng. Biotechnol. 95:201-243. 
Siliciano, J.D., and D.A. Goodenough. 1988. Localization of the tight junction protein, 
ZO-1, is modulated by extracellular calcium and cell-cell contact in Madin-Darby 
canine kidney epithelial cells. J Cell Biol. 107:2389-2399. 
Simons, K., and M.J. Gerl. 2010. Revitalizing membrane rafts: new tools and insights. 
Nat. Rev. Mol. Cell Biol. 11:688-699. 
Simons, K., and J.L. Sampaio. 2011. Membrane organization and lipid rafts. Cold Spring 
Harb. Perspect. Biol. 3:a004697. 
Simons, K., and D. Toomre. 2000. Lipid rafts and signal transduction. Nat. Rev. Mol. Cell 
Biol. 1:31-39. 
Simons, K., and G. van Meer. 1988. Lipid sorting in epithelial cells. Biochemistry (Mosc.). 
27:6197-6202. 
Simons, K., and W.L. Vaz. 2004. Model systems, lipid rafts, and cell membranes. Annu. 
Rev. Biophys. Biomol. Struct. 33:269-295. 
Singer, S.J., and G.L. Nicolson. 1972. The fluid mosaic model of the structure of cell 
membranes. Science. 175:720-731. 
Sobotzik, J.M., J.M. Sie, C. Politi, D. Del Turco, V. Bennett, T. Deller, and C. Schultz. 
2009. AnkyrinG is required to maintain axo-dendritic polarity in vivo. Proceedings 
of the National Academy of Sciences of the United States of America. 106:17564-17569. 
Spira, F., N.S. Mueller, G. Beck, P. von Olshausen, J. Beig, and R. Wedlich-Soldner. 2012. 
Patchwork organization of the yeast plasma membrane into numerous coexisting 
domains. Nat. Cell Biol. 14:640-648. 
Stabach, P.R., and J.S. Morrow. 2000. Identification and characterization of beta V 
spectrin, a mammalian ortholog of Drosophila beta H spectrin. J. Biol. Chem. 
275:21385-21395. 
Stabach, P.R., I. Simonovic, M.A. Ranieri, M.S. Aboodi, T.A. Steitz, M. Simonovic, and 
J.S. Morrow. 2009. The structure of the ankyrin-binding site of beta-spectrin 
 170 
reveals how tandem spectrin-repeats generate unique ligand-binding properties. 
Blood. 113:5377-5384. 
Stankewich, M.C., W.T. Tse, L.L. Peters, Y. Ch'ng, K.M. John, P.R. Stabach, P. Devarajan, 
J.S. Morrow, and S.E. Lux. 1998. A widely expressed betaIII spectrin associated 
with Golgi and cytoplasmic vesicles. Proc. Natl. Acad. Sci. U. S. A. 95:14158-14163. 
Staufenbiel, M. 1987. Ankyrin-bound fatty acid turns over rapidly at the erythrocyte 
plasma membrane. Mol Cell Biol. 7:2981-2984. 
Staufenbiel, M. 1988. Fatty acids covalently bound to erythrocyte proteins undergo a 
differential turnover in vivo. J Biol Chem. 263:13615-13622. 
Straight, A.F., C.M. Field, and T.J. Mitchison. 2005. Anillin binds nonmuscle myosin II 
and regulates the contractile ring. Mol. Biol. Cell. 16:193-201. 
Susuki, K., K.J. Chang, D.R. Zollinger, Y. Liu, Y. Ogawa, Y. Eshed-Eisenbach, M.T. 
Dours-Zimmermann, J.A. Oses-Prieto, A.L. Burlingame, C.I. Seidenbecher, D.R. 
Zimmermann, T. Oohashi, E. Peles, and M.N. Rasband. 2013. Three mechanisms 
assemble central nervous system nodes of Ranvier. Neuron. 78:469-482. 
Takahashi, D., K. Hase, S. Kimura, F. Nakatsu, M. Ohmae, Y. Mandai, T. Sato, Y. Date, 
M. Ebisawa, T. Kato, Y. Obata, S. Fukuda, Y.I. Kawamura, T. Dohi, T. Katsuno, 
O. Yokosuka, S. Waguri, and H. Ohno. 2011. The epithelia-specific membrane 
trafficking factor AP-1B controls gut immune homeostasis in mice. 
Gastroenterology. 141:621-632. 
Takei, K., and V. Haucke. 2001. Clathrin-mediated endocytosis: membrane factors pull 
the trigger. Trends Cell Biol. 11:385-391. 
Tang, Y., V. Katuri, A. Dillner, B. Mishra, C.X. Deng, and L. Mishra. 2003. Disruption of 
transforming growth factor-beta signaling in ELF beta-spectrin-deficient mice. 
Science. 299:574-577. 
Tang, Y., V. Katuri, R. Srinivasan, F. Fogt, R. Redman, G. Anand, A. Said, T. Fishbein, M. 
Zasloff, E.P. Reddy, B. Mishra, and L. Mishra. 2005. Transforming growth factor-
beta suppresses nonmetastatic colon cancer through Smad4 and adaptor protein 
ELF at an early stage of tumorigenesis. Cancer Res. 65:4228-4237. 
Thomas, G.M., T. Hayashi, S.L. Chiu, C.M. Chen, and R.L. Huganir. 2012. Palmitoylation 
by DHHC5/8 targets GRIP1 to dendritic endosomes to regulate AMPA-R 
trafficking. Neuron. 73:482-496. 
 171 
Thompson, A., R. Nessler, D. Wisco, E. Anderson, B. Winckler, and D. Sheff. 2007. 
Recycling endosomes of polarized epithelial cells actively sort apical and 
basolateral cargos into separate subdomains. Mol. Biol. Cell. 18:2687-2697. 
Trave, G., A. Pastore, M. Hyvonen, and M. Saraste. 1995. The C-terminal domain of 
alpha-spectrin is structurally related to calmodulin. Eur. J. Biochem. 227:35-42. 
Tsui-Pierchala, B.A., M. Encinas, J. Milbrandt, and E.M. Johnson, Jr. 2002. Lipid rafts in 
neuronal signaling and function. Trends Neurosci. 25:412-417. 
Tsutsumi, R., Y. Fukata, J. Noritake, T. Iwanaga, F. Perez, and M. Fukata. 2009. 
Identification of G protein alpha subunit-palmitoylating enzyme. Mol. Cell. Biol. 
29:435-447. 
von Bonsdorff, C.H., S.D. Fuller, and K. Simons. 1985. Apical and basolateral 
endocytosis in Madin-Darby canine kidney (MDCK) cells grown on 
nitrocellulose filters. EMBO J. 4:2781-2792. 
Wang, C., C. Yu, F. Ye, Z. Wei, and M. Zhang. 2012. Structure of the ZU5-ZU5-UPA-DD 
tandem of ankyrin-B reveals interaction surfaces necessary for ankyrin function. 
Proceedings of the National Academy of Sciences of the United States of America. 
109:4822-4827. 
Wang, D.S., R. Miller, R. Shaw, and G. Shaw. 1996. The pleckstrin homology domain of 
human beta I sigma II spectrin is targeted to the plasma membrane in vivo. 
Biochem. Biophys. Res. Commun. 225:420-426. 
Wang, D.S., and G. Shaw. 1995. The association of the C-terminal region of beta I sigma 
II spectrin to brain membranes is mediated by a PH domain, does not require 
membrane proteins, and coincides with a inositol-1,4,5 triphosphate binding site. 
Biochem. Biophys. Res. Commun. 217:608-615. 
Wang, E., P.S. Brown, B. Aroeti, S.J. Chapin, K.E. Mostov, and K.W. Dunn. 2000. Apical 
and basolateral endocytic pathways of MDCK cells meet in acidic common 
endosomes distinct from a nearly-neutral apical recycling endosome. Traffic. 
1:480-493. 
Wiederschain, D., S. Wee, L. Chen, A. Loo, G. Yang, A. Huang, Y. Chen, G. Caponigro, 
Y.M. Yao, C. Lengauer, W.R. Sellers, and J.D. Benson. 2009. Single-vector 
inducible lentiviral RNAi system for oncology target validation. Cell Cycle. 8:498-
504. 
 172 
Wilson, I.A., D.H. Haft, E.D. Getzoff, J.A. Tainer, R.A. Lerner, and S. Brenner. 1985. 
Identical short peptide sequences in unrelated proteins can have different 
conformations: a testing ground for theories of immune recognition. Proceedings 
of the National Academy of Sciences of the United States of America. 82:5255-5259. 
Winkelmann, J.C., J.G. Chang, W.T. Tse, A.L. Scarpa, V.T. Marchesi, and B.G. Forget. 
1990a. Full-length sequence of the cDNA for human erythroid beta-spectrin. J. 
Biol. Chem. 265:11827-11832. 
Winkelmann, J.C., F.F. Costa, B.L. Linzie, and B.G. Forget. 1990b. Beta spectrin in human 
skeletal muscle. Tissue-specific differential processing of 3' beta spectrin pre-
mRNA generates a beta spectrin isoform with a unique carboxyl terminus. J. Biol. 
Chem. 265:20449-20454. 
Winkelmann, J.C., and B.G. Forget. 1993. Erythroid and nonerythroid spectrins. Blood. 
81:3173-3185. 
Xu, K., G. Zhong, and X. Zhuang. 2013. Actin, spectrin, and associated proteins form a 
periodic cytoskeletal structure in axons. Science. 339:452-456. 
Yang, F., Q. Wei, R.S. Adelstein, and P.J. Wang. 2012. Non-muscle myosin IIB is essential 
for cytokinesis during male meiotic cell divisions. Dev. Biol. 369:356-361. 
Yang, Y., Y. Ogawa, K.L. Hedstrom, and M.N. Rasband. 2007. betaIV spectrin is 
recruited to axon initial segments and nodes of Ranvier by ankyrinG. J. Cell Biol. 
176:509-519. 
Yu, J., D.A. Fischman, and T.L. Steck. 1973. Selective solubilization of proteins and 
phospholipids from red blood cell membranes by nonionic detergents. J. 
Supramol. Struct. 1:233-248. 
Zhang, C., K. Susuki, D.R. Zollinger, J.L. Dupree, and M.N. Rasband. 2013. Membrane 
domain organization of myelinated axons requires betaII spectrin. J. Cell Biol. 
203:437-443. 
Zhang, H., A. Kim, N. Abraham, L.A. Khan, D.H. Hall, J.T. Fleming, and V. Gobel. 2012. 
Clathrin and AP-1 regulate apical polarity and lumen formation during C. 
elegans tubulogenesis. Development. 139:2071-2083. 
Zhang, X., and V. Bennett. 1998. Restriction of 480/270-kD ankyrin G to axon proximal 
segments requires multiple ankyrin G-specific domains. J. Cell Biol. 142:1571-
1581. 
 173 
Zhang, X., J.Q. Davis, S. Carpenter, and V. Bennett. 1998. Structural requirements for 
association of neurofascin with ankyrin. The Journal of biological chemistry. 
273:30785-30794. 
Zhou, D., S. Lambert, P.L. Malen, S. Carpenter, L.M. Boland, and V. Bennett. 1998. 
AnkyrinG is required for clustering of voltage-gated Na channels at axon initial 
segments and for normal action potential firing. J. Cell Biol. 143:1295-1304. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 174 
Biography 
 Meng He was born in the city of Bozhou, Anhui Province, China on March 10th, 
1986. He received his bachelor degree from the Department of Biological Science and 
Biotechnology at Tsinghua University in Beijing in July, 2009. He then decided to pursue 
a PhD degree in biomedical science, and was admitted to the Molecular Cancer Biology 
Program at Duke University in 2009. He finished his PhD training with Dr. Vann 
Bennett in 2014. 
Membership 
 American Society for Cell Biology, 2011-2012 
 American Association for the Advancement of Science, 2011-present 
Publications 
 Jenkins, P., He, M. (co-first author), and V. Bennett. 2014. Ankyrin-G and βII-
spectrin control MDCK cell lateral membrane height by opposing clathrin-
mediated endocytosis. (In submission) 
 
 He, M., K. M. Abdi, and V. Bennett. 2014. Ankyrin-G palmitoylation and βII-
spectrin binding to PI(4,5)P2 drive lateral membrane assembly. Journal of Cell 
Biology. (Under peer review)  
 
 He, M., W.C. Tseng, and V. Bennett. 2013. A single divergent exon inhibits 
ankyrin-B association with the plasma membrane. Journal of Biological 
Chemistry. 288:14769-14779. 
 
 He, M., P. Jenkins, and V. Bennett. 2012. Cysteine 70 of ankyrin-G is S-
palmitoylated and is required for function of ankyrin-G in membrane domain 
assembly. Journal of Biological Chemistry. 287:43995-44005. 
